<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">48890</article-id><article-id pub-id-type="doi">10.7554/eLife.48890</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-143618"><name><surname>Tomek</surname><given-names>Jakub</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0157-4386</contrib-id><email>jakub.tomek.mff@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148563"><name><surname>Bueno-Orovio</surname><given-names>Alfonso</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148564"><name><surname>Passini</surname><given-names>Elisa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148565"><name><surname>Zhou</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148566"><name><surname>Minchole</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-124468"><name><surname>Britton</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148567"><name><surname>Bartolucci</surname><given-names>Chiara</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148568"><name><surname>Severi</surname><given-names>Stefano</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4306-8294</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148569"><name><surname>Shrier</surname><given-names>Alvin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148570"><name><surname>Virag</surname><given-names>Laszlo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-148571"><name><surname>Varro</surname><given-names>Andras</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-109654"><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name><email>Blanca.Rodriguez@cs.ox.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Computer Science, British Heart Foundation Centre of Research Excellence</institution><institution>University of Oxford</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Electrical, Electronic, and Information Engineering &quot;Guglielmo Marconi&quot;</institution><institution>University of Bologna</institution><addr-line><named-content content-type="city">Bologna</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Physiology</institution><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Pharmacology and Pharmacotherapy, Faculty of Medicine</institution><institution>University of Szeged</institution><addr-line><named-content content-type="city">Szeged</named-content></addr-line><country>Hungary</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Faraldo-Gómez</surname><given-names>José D</given-names></name><role>Reviewing Editor</role><aff><institution>National Heart, Lung and Blood Institute, National Institutes of Health</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barkai</surname><given-names>Naama</given-names></name><role>Senior Editor</role><aff><institution>Weizmann Institute of Science</institution><country>Israel</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>24</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>8</volume><elocation-id>e48890</elocation-id><history><date date-type="received" iso-8601-date="2019-05-29"><day>29</day><month>05</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-12-18"><day>18</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Tomek et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Tomek et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-48890-v3.pdf"/><abstract><p>Human-based modelling and simulations are becoming ubiquitous in biomedical science due to their ability to augment experimental and clinical investigations. Cardiac electrophysiology is one of the most advanced areas, with cardiac modelling and simulation being considered for virtual testing of pharmacological therapies and medical devices. Current models present inconsistencies with experimental data, which limit further progress. In this study, we present the design, development, calibration and independent validation of a human-based ventricular model (ToR-ORd) for simulations of electrophysiology and excitation-contraction coupling, from ionic to whole-organ dynamics, including the electrocardiogram. Validation based on substantial multiscale simulations supports the credibility of the ToR-ORd model under healthy and key disease conditions, as well as drug blockade. In addition, the process uncovers new theoretical insights into the biophysical properties of the L-type calcium current, which are critical for sodium and calcium dynamics. These insights enable the reformulation of L-type calcium current, as well as replacement of the hERG current model.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Decades of intensive experimental and clinical research have revealed much about how the human heart works. Though incomplete, this knowledge has been used to construct computer models that represent the activity of this organ as a whole, and of its individual chambers (the atria and ventricles), tissues and cells. Such models have been used to better understand life-threatening irregular heartbeats; they are also beginning to be used to guide decisions about the treatment of patients and the development of new drugs by the pharmaceutical industry.</p><p>Yet existing computer models of the electrical activity of the human heart are sometimes inconsistent with experimental data. This problem led Tomek et al. to try to create a new model that was consistent with established biophysical knowledge and experimental data for a wide range of conditions including disease and drug action.</p><p>Tomek et al. designed a strategy that explicitly separated the construction and validation of a model that could recreate the electrical activity of the ventricles in a human heart. This model was able to integrate and explain a wide range of properties of both healthy and diseased hearts, including their response to different drugs. The development of the model also uncovered and resolved theoretical inconsistencies that have been present in almost all models of the heart from the last 25 years. Tomek et al. hope that their new human heart model will enable more basic, translational and clinical research into a range of heart diseases and accelerate the development of new therapies.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>computer simulations</kwd><kwd>heart</kwd><kwd>ventricular myocyte</kwd><kwd>calibration validation</kwd><kwd>computational biology</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>100246/Z/12/Z</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>214290/Z/18/Z</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000274</institution-id><institution>British Heart Foundation</institution></institution-wrap></funding-source><award-id>FS/17/22/32644</award-id><principal-award-recipient><name><surname>Bueno-Orovio</surname><given-names>Alfonso</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>675451</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000849</institution-id><institution>National Centre for the Replacement, Refinement and Reduction of Animals in Research</institution></institution-wrap></funding-source><award-id>NC/P001076/1</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100013322</institution-id><institution>European Federation of Pharmaceutical Industries and Associations</institution></institution-wrap></funding-source><award-id>TransQST project (Innovative Medicines Initiative 2 Joint Undertaking 116030)</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005617</institution-id><institution>BHF Centre of Research Excellence, Oxford</institution></institution-wrap></funding-source><award-id>RE/13/1/30181</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>UK National Supercomputing</institution></institution-wrap></funding-source><award-id>Archer RAP award (322 00180)</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001943</institution-id><institution>Partnership for Advanced Computing in Europe AISBL</institution></institution-wrap></funding-source><award-id>2017174226</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008536</institution-id><institution>Amazon Web Services</institution></institution-wrap></funding-source><award-id>Machine learning research award</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100007601</institution-id><institution>Horizon 2020</institution></institution-wrap></funding-source><award-id>TransQST project (Innovative Medicines Initiative 2 Joint Undertaking 116030)</award-id><principal-award-recipient><name><surname>Rodriguez</surname><given-names>Blanca</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A computer model of human cardiomyocyte was produced and validated on independent datasets, overcoming shortcomings of its predecessors, also yielding broadly relevant insights and results on major ionic currents.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Human-based computer modelling and simulation are a fundamental asset of biomedical research. They augment experimental and clinical research through enabling detailed mechanistic and systematic investigations. Owing to a large body of research across biomedicine, their credibility has expanded beyond academia, with vigorous activity also in regulatory and industrial settings. Thus, human in silico clinical trials are now becoming a central paradigm, for example, in the development of medical therapies (<xref ref-type="bibr" rid="bib58">Pappalardo et al., 2018</xref>). They exploit mature human-based modelling and simulation technology to perform virtual testing of pharmacological therapies or devices.</p><p>Human cardiac electrophysiology is one of the most advanced areas in physiological modelling and simulation. Current human models of cardiac electrophysiology include detailed information on the ionic processes underlying the action potential such as the sodium, potassium and calcium ionic currents, exchangers such as the Na/Ca exchanger and pumps such as the Na/K pump. They also include representation of the excitation-contraction coupling system in the sarcoplasmic reticulum, an important modulator of the calcium transient, through the calcium-induced calcium-release mechanisms and the SERCA pump. Several human models have been proposed for ventricular electrophysiology, and amongst them the ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). Its key strengths are the representation of CaMKII signalling, capability to manifest arrhythmia precursors such as alternans and early afterdepolarisation, and good response to simulated drug block and disease remodelling (<xref ref-type="bibr" rid="bib22">Dutta et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>; <xref ref-type="bibr" rid="bib59">Passini et al., 2016</xref>; <xref ref-type="bibr" rid="bib76">Tomek et al., 2017</xref>). Consequently, ORd was selected by a panel of experts as the model best suited for regulatory purposes (<xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>).</p><p>Most of the ORd model development has focused on repolarisation properties such as its response to drug block, repolarisation abnormalities and its rate dependence. However, a more holistic comparison of ORd-based simulations with human ventricular experimental data reveals important inconsistencies. Firstly, the plateau of the action potential (AP) is significantly higher in the ORd model than in experimental data used for ORd model construction (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>; <xref ref-type="bibr" rid="bib7">Britton et al., 2017</xref>) and in data from additional studies using human cardiomyocytes (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Jost et al., 2013</xref>). Secondly, the dynamics of accommodation of the AP duration (APD) to heart rate acceleration, which are known to be modulated by sodium dynamics, show only limited agreement with a comparable experimental dataset (<xref ref-type="bibr" rid="bib26">Franz et al., 1988</xref>; <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). Thirdly, we identify that simulations of the sodium current block has an inotropic effect in the ORd model, increasing the amplitude of the calcium transient, in disagreement with its established negatively inotropic effect in experimental/clinical data (encainide, flecainide, and TTX) (<xref ref-type="bibr" rid="bib32">Gottlieb et al., 1990</xref>; <xref ref-type="bibr" rid="bib80">Tucker et al., 1982</xref>; <xref ref-type="bibr" rid="bib42">Legrand et al., 1983</xref>; <xref ref-type="bibr" rid="bib2">Bhattacharyya and Vassalle, 1982</xref>). All those properties, namely AP plateau potential, APD adaptation and response to sodium current block, have strong dependencies on sodium and calcium dynamics. We therefore hypothesise that ionic balances during repolarisation require further research. We specifically focus on an in-depth re-evaluation of the L-type calcium current (I<sub>CaL</sub>) formulation, given its fundamental role in determining the AP, the calcium transient and sodium homeostasis through the Na/Ca exchanger. The second main focus is the re-assessment of the rapid delayed rectifier current (I<sub>Kr</sub>), the dominant repolarisation current in human ventricle, under conditions that reflect experimental data-driven plateau potentials.</p><p>Using a development strategy based on strictly separated model calibration and validation, we sought to design, develop, calibrate and validate a novel model of human ventricular electrophysiology and excitation contraction coupling, the ToR-ORd model (for Tomek, Rodriguez – following ORd). Our aim for simulations using the ToR-ORd model is to be able to reproduce all key depolarisation, repolarisation and calcium dynamics properties in healthy ventricular cardiomyocytes, under drug block, and in key diseased conditions such as hyperkalemia (central to acute myocardial ischemia), and hypertrophic cardiomyopathy.</p></sec><sec id="s2" sec-type="materials|methods"><title>Materials and methods</title><sec id="s2-1"><title>Strategy for construction, calibration and validation of the ToR-ORd model</title><p><xref ref-type="table" rid="table1">Table 1</xref> lists the properties (left column) and key references (right column) of experimental and clinical datasets considered for the calibration (top) and independent validation (bottom) of the ToR-ORd model. This represents a comprehensive list of properties, known to characterize human ventricular electrophysiology under multiple stimulation rates, and also drug action and disease. The recordings in were obtained in human ventricular preparations primarily using measurements with microelectrode recordings, unipolar electrograms, and monophasic APs, therefore avoiding photon scattering effects or potential dye artefacts present in optical mapping experiments. In addition, the ToR-ORd model was calibrated to manifest depolarisation of resting membrane potential in response to an I<sub>K1</sub> block, based on evidence in a range of studies summarised in <xref ref-type="bibr" rid="bib19">Dhamoon and Jalife (2005)</xref>. The calibration criteria are chosen to be fundamental properties of ionic currents, action potential and single-cell pro-arrhythmic phenomena (described in more detail in Appendix 1-1). The validation criteria include response to rate changes, drug action and disease, to explore the predictive power of the model under clinically-relevant conditions.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Criteria and human-based studies used in ToR-ORd calibration and validation.</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" valign="top">Calibration</th></tr></thead><tbody><tr><td valign="top">Action potential morphology</td><td valign="top">(<xref ref-type="bibr" rid="bib7">Britton et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Jost et al., 2013</xref>)</td></tr><tr><td valign="top">Calcium transient time to peak, duration, and amplitude</td><td valign="top">(<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>)</td></tr><tr><td valign="top">I-V relationship and steady-state inactivation of L-type calcium current</td><td valign="top">(<xref ref-type="bibr" rid="bib47">Magyar et al., 2000</xref>)</td></tr><tr><td valign="top">Sodium blockade is negatively inotropic</td><td valign="top">(<xref ref-type="bibr" rid="bib32">Gottlieb et al., 1990</xref>; <xref ref-type="bibr" rid="bib80">Tucker et al., 1982</xref>; <xref ref-type="bibr" rid="bib42">Legrand et al., 1983</xref>; <xref ref-type="bibr" rid="bib2">Bhattacharyya and Vassalle, 1982</xref>).</td></tr><tr><td valign="top">L-type calcium current blockade shortens the action potential</td><td valign="top">(<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</td></tr><tr><td valign="top">Early depolarisation formation under hERG block</td><td valign="top">(<xref ref-type="bibr" rid="bib34">Guo et al., 2011</xref>)</td></tr><tr><td valign="top">Alternans formation at rapid pacing</td><td valign="top">(<xref ref-type="bibr" rid="bib39">Koller et al., 2005</xref>)</td></tr><tr><td valign="top">Conduction velocity of ca. 65 m/s</td><td valign="top">(<xref ref-type="bibr" rid="bib74">Taggart et al., 2000</xref>)</td></tr><tr><th colspan="2" valign="top">Validation</th></tr><tr><td valign="top">Action potential accommodation</td><td valign="top">(<xref ref-type="bibr" rid="bib26">Franz et al., 1988</xref>)</td></tr><tr><td valign="top">S1-S2 restitution</td><td valign="top">(<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</td></tr><tr><td valign="top">Drug blocks and action potential duration</td><td valign="top">(<xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>; <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</td></tr><tr><td valign="top">Hyperkalemia promotes postrepolarisation refractoriness</td><td valign="top">(<xref ref-type="bibr" rid="bib16">Coronel et al., 2012</xref>)</td></tr><tr><td valign="top">Hypertrophic cardiomyopathy phenotype</td><td valign="top">(<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>)</td></tr><tr><td valign="top">Drug safety prediction using populations of models</td><td valign="top">(<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>)</td></tr><tr><td valign="top">Physiological QRS and QT intervals in ECG</td><td valign="top">(<xref ref-type="bibr" rid="bib25">Engblom et al., 2005</xref>; <xref ref-type="bibr" rid="bib81">van Oosterom et al., 2000</xref>; <xref ref-type="bibr" rid="bib4">Bousseljot et al., 1995</xref>; <xref ref-type="bibr" rid="bib31">Goldberger et al., 2000</xref>)</td></tr></tbody></table></table-wrap><p>We initially performed the evaluation of the ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>) by conducting simulations for each of the calibration criteria in <xref ref-type="table" rid="table1">Table 1</xref>. Further details are described throughout the Materials and methods section and Appendix 1-15.1. Simulations with the existing versions of the ORd model failed to fulfil key criteria such as AP morphology, calcium transient duration, several properties of the L-type calcium current, negative inotropic effect of sodium blockers, or the depolarising effect of I<sub>K1</sub> block. The results are later demonstrated in Figures 2 and 3, and <italic>Methods</italic>: <italic>Calibration of I<sub>K1</sub> block and resting membrane potential</italic>. Secondly, we attempted parameter optimisation using a multiobjective genetic algorithm (<xref ref-type="bibr" rid="bib79">Torres et al., 2012</xref>). However, simulations with the ORd-based models were unable to fulfil key criteria such as AP and Ca morphology, and the effect of sodium and calcium block on calcium transient amplitude and APD, respectively.</p><p>We then proceeded to reevaluate the ionic current formulations based on experimental data and biophysical knowledge. Key currents included I<sub>CaL</sub> and specifically its driving force and activation, as well as the I<sub>Na</sub>, I<sub>Kr</sub>, I<sub>K1</sub> and chloride currents. The multiobjective genetic algorithm optimisation was repeated several times, throughout the introduction of structural changes to the model. Once simulations with an optimised model fulfilled all calibration criteria, validation was conducted through evaluation against additional experimental recordings for drug block, disease, tissue and whole-ventricular simulations.</p><p>Details concerning the simulations are given in Appendix 1-15.1, namely the description of simulation protocols and ionic concentrations used (Appendix 1-15.1.1), representation of heart disease (Appendix 1-15.1.2), 1D fibre simulations (Appendix 1-15.1.3), population-of-models and drug safety assessment (Appendix 1-15.1.4), transmurality and whole-heart simulations with ECG extraction (Appendix 1-15.1.5), and a technical note on the update to the Matlab ODE solver which facilitates efficient simulation of the multiobjective GA (Appendix 1-15.1.6). Unless specified otherwise, the baseline ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>) was used for comparison with the ToR-ORd model.</p></sec><sec id="s2-2"><title>ToR-ORd model structure</title><p>The ToR-ORd model follows the general ORd structure (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The cardiomyocyte is subdivided into several compartments: main cytosolic space, junctional subspace, and the sarcoplasmic reticulum (SR, further subdivided into junctional and network SR). Within these compartments are placed ionic currents and fluxes described by Hodgkin-Huxley equations or Markov models. The main ionic current formulations altered compared to ORd are highlighted in orange in <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Model structure.</title><p>(<bold>A</bold>) A schematic of the novel human ventricular myocyte model for electrophysiology and calcium handling. Orange indicates components, substituted, or added, compared to the original ORd model. ‘SS’ indicates junctional subspace compartment, where calcium influx via L-type calcium current occurs and where calcium is released from the sarcoplasmic reticulum. ‘JSR’ and ‘NSR’ are junctional and network sarcoplasmic reticulum compartments, respectively. ‘Main cytosolic pool’ is the remaining intracellular space. Transmembrane currents are indicated with an ‘I’ in their name, with fluxes indicated as ‘J’. Components with a green underscore are modulated by CaMKII signalling. (<bold>B</bold>) The structure of the Lu-Vandenberg (<xref ref-type="bibr" rid="bib44">Lu et al., 2001</xref>) Markov model used for the rapidly activating delayed rectifier repolarisation current (I<sub>Kr</sub>). The transition rates are given in Appendix 1-15.3.5.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig1-v3.tif"/></fig></sec><sec id="s2-3"><title>In-depth revision of the L-type calcium current</title><p>The I<sub>CaL</sub> current was deeply revisited, particularly with respect to its driving force, based on biophysical principles. This reformulation is of relevance to almost all models of cardiac electrophysiology.</p><p>The I<sub>CaL</sub> formulation in the ORd model is based on Hodgkin-Huxley equations, with the total current being a product of three components: 1) Open channel permeability, 2) A set of gating variables determining the fraction of channels being open, 3) The electrochemical driving force which acts on ions to move through the open channel based on the membrane potential and ionic concentrations on both sides of the membrane (more details in Appendix 1-5). In most Hodgkin-Huxley models of cardia currents, the driving force is computed as (V-E<sub>ion</sub>), that is, the membrane potential minus equilibrium potential, either computed from the Nernst equation, or measured experimentally. However, starting with the Luo-Rudy model (LRd) of 1994 (<xref ref-type="bibr" rid="bib45">Luo and Rudy, 1994</xref>), the driving force of ions via I<sub>CaL</sub> in cardiac models is modelled based on the Goldman-Hodgkin-Katz (GHK) flux equation. The driving force based on the GHK equation is:<disp-formula id="equ1"><mml:math id="m1"><mml:msub><mml:mrow><mml:mi>φ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo> <mml:mi/><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac><mml:mo>∙</mml:mo> <mml:mi/><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>∙</mml:mo><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>z</mml:mi><mml:mo>∙</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>z</mml:mi><mml:mo>∙</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math></disp-formula>where <italic>z</italic> is the charge of the given ion, <italic>V</italic> is the membrane potential, <italic>F</italic>,<italic>R</italic>,<italic>T</italic> are conventional thermodynamic constants, and <italic>[S]<sub>i</sub></italic>, <italic>[S]<sub>o</sub></italic> are intracellular and extracellular activities of the given ionic specie. <inline-formula><mml:math id="inf1"><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>γ</mml:mi> <mml:mi/><mml:mo>∙</mml:mo><mml:mi>m</mml:mi></mml:math></inline-formula>, where <inline-formula><mml:math id="inf2"><mml:mi>γ</mml:mi></mml:math></inline-formula> is the ionic activity coefficient and <inline-formula><mml:math id="inf3"><mml:mi>m</mml:mi></mml:math></inline-formula> the concentration (in either the intracellular or extracellular space, yielding <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> or <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>).</p><sec id="s2-3-1"><title>Determining ionic activity coefficients</title><p>In order to compute the ionic driving force via the GHK equation, it is necessary to know the ionic activity coefficients of the intracellular (<italic>γ<sub>i</sub></italic>) and extracellular (<italic>γ<sub>o</sub></italic>) space. The Luo-Rudy model and other Rudy-family models use <italic>γ<sub>o</sub></italic> = 0.341 for extracellular space and <italic>γ<sub>i</sub></italic> = 1 for the intracellular space. Models based on the Shannon model (<xref ref-type="bibr" rid="bib71">Shannon et al., 2004</xref>) use 0.341 for both intracellular and extracellular space, but we were unable to find the motivation for this change.</p><p>The Debye-Hückel theory is commonly used to compute the activity coefficients. We used the Davies equation, which extends the basic Debye-Hückel equation to be accurate for ionic concentrations found in living cells (<xref ref-type="bibr" rid="bib52">Mortimer, 2008</xref>):<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">log</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo> <mml:mi/><mml:mo>-</mml:mo><mml:mi>A</mml:mi> <mml:mi/><mml:msubsup><mml:mrow><mml:mo>∙</mml:mo><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo> <mml:mi/><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:msqrt><mml:mi>I</mml:mi></mml:msqrt></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msqrt><mml:mi>I</mml:mi></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mn>0.3</mml:mn><mml:mo>∙</mml:mo><mml:mi>I</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula>where <italic>A</italic> is a constant (~0.5 for water at 25°C, ~0.5238 at 37°C), <italic>z<sub>i</sub></italic> is the charge of the respective ion, and <italic>I</italic> is the ionic strength of the solution. The ionic strength is defined as:<disp-formula id="equ3"><mml:math id="m3"><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mo>∙</mml:mo> <mml:mi/><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:math></disp-formula>where <italic>m<sub>i</sub></italic> is the concentration of the <italic>i</italic>-th ionic specie present. For concentrations in a study measuring properties of I<sub>CaL</sub> (<xref ref-type="bibr" rid="bib47">Magyar et al., 2000</xref>), <italic>I</italic> is ca. 0.15-0.17. This warrants the use of Davies equation, which was shown to be accurate for <italic>I</italic> up to 0.5, unlike the basic Debye-Hückel equation, which is accurate for <italic>I</italic> up to 0.01 only (<xref ref-type="bibr" rid="bib52">Mortimer, 2008</xref>).</p><p>We implemented the computation of ionic coefficients based on the Davies equation dynamically, so that the activity coefficients are estimated at every simulation step. This allows accurate representation of the driving force when ionic concentrations are disturbed, such as at varying pacing rates, or during homeostatic imbalance. The dynamic computation is also used to estimate ionic activity coefficients for potassium and sodium flowing through the calcium channels, taking into account their different charge.</p><p>Throughout our simulations, both intracellular and extracellular activity coefficients generally lie between 0.61 and 0.66. Importantly, this estimate shows that the intracellular and extracellular activity coefficients are relatively similar (corresponding to the broadly similar total concentration of charged molecules), in contrast with the original values. Particularly, the origin of the intracellular activity coefficient <italic>γ<sub>i</sub></italic> = 1 in the Luo-Rudy model is unclear, as by the Davies (or by any Debye-Hückel variant) equation, <italic>I</italic> would have to be zero, which is possible only when there are no ions present.</p></sec><sec id="s2-3-2"><title>Activation curve extraction</title><p>An additional improvement in the I<sub>CaL</sub> formulation is the estimation of its activation curve. In brief, we implement a consistent use of the GHK equation for the extraction of the activation curve and for the I<sub>CaL</sub> formulation in the ToR-ORd model. The activation curve is obtained via dividing the experimentally measured I-V relationship of the current by the expected driving force for each pulse potential (see Appendix 1-3 for a graphical overview of the process). However, we identified a theoretical inconsistency in previous cardiac models across species (e.g. <xref ref-type="bibr" rid="bib45">Luo and Rudy, 1994</xref>; <xref ref-type="bibr" rid="bib37">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Shannon et al., 2004</xref>; <xref ref-type="bibr" rid="bib33">Grandi et al., 2010</xref>; <xref ref-type="bibr" rid="bib11">Carro et al., 2011</xref>): whereas the Nernstian driving force of (V-E<sub>Ca</sub>) is used to derive the activation curve, the GHK driving force is then used to calculate I<sub>CaL</sub>. Indeed, experimental studies reporting the activation curve of I<sub>CaL</sub> generally use the Nernstian driving force of (V-E<sub>Ca</sub>) with E<sub>Ca</sub> being the experimentally measured reversal potential of approximately 60 mV. This is explicitly stated in <xref ref-type="bibr" rid="bib43">Linz and Meyer (2000)</xref>, and also the activation curve by <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref> used in the ORd model is consistent with dividing the IV relationship with (V-60).</p><p>In this study, we propose that, for consistency, the same equation needs to be applied both to obtain the activation curve from the I-V curve and to represent the driving force in the current formulation. Thus, in the ToR-ORd model, the activation curve for I<sub>CaL</sub> was obtained by dividing the I-V curve from <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref> by the GHK-based driving force, computed using ionic activity coefficients based on the Davies equation (as explained in the previous Section) and intracellular and extracellular ionic concentrations as in <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref>. The following capped Gompertz function (a flexible sigmoid) was found to be the best fit to the resulting steady-state activation curve:<disp-formula id="equ4"><mml:math id="m4"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo> <mml:mi/><mml:mfenced separators="|"><mml:mrow><mml:mn>1.0763</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1.007</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>0.0829</mml:mn><mml:mo>∙</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi> <mml:mi/><mml:mi>V</mml:mi><mml:mo>≤</mml:mo><mml:mn>31.4978</mml:mn> <mml:mi/></mml:mrow><mml:mrow><mml:mn>1</mml:mn> <mml:mi/><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mfenced><mml:mo>,</mml:mo> <mml:mi/></mml:math></disp-formula>where <italic>V</italic> is the membrane potential.</p></sec><sec id="s2-3-3"><title>Other I<sub>CaL</sub> changes</title><p>20% of I<sub>CaL</sub> was placed in the main cytosolic space, consistent with the literature (<xref ref-type="bibr" rid="bib70">Scriven et al., 2010</xref>). This increases the plateau-supporting capability of I<sub>CaL</sub>, given that the myoplasmic I<sub>CaL</sub> is subject to a weaker calcium-dependent inactivation than I<sub>CaL</sub> in the junctional subspace. Other minor changes are given in Appendix 1-15.3.3.</p></sec></sec><sec id="s2-4"><title>I<sub>Kr</sub> replacement</title><p>The calibration of the ToR-ORd model’s AP morphology to experimental data resulted in problematic response to calcium blockade during an early phase of the model development when the original I<sub>Kr</sub> formulation was used (further details in Appendix 1-12). I<sub>CaL</sub> block is known to shorten APD experimentally (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>) but resulted in a major APD prolongation in simulations instead. This discrepancy could not be resolved through parameter optimisation. A mechanistic analysis revealed that this follows from the lack of ORd I<sub>Kr</sub> activation, which is however not consistent with relevant experimental data (<xref ref-type="bibr" rid="bib44">Lu et al., 2001</xref>). We therefore considered alternative I<sub>Kr</sub> formulations and specifically the Lu-Vandenberg (<xref ref-type="bibr" rid="bib44">Lu et al., 2001</xref>) Markov model (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The Lu-Vandenberg I<sub>Kr</sub> model is based on extensive experimental data allowing the dissection of activation and recovery from inactivation and provided the best agreement with experimental data, specifically when considering the AP plateau potentials reported experimentally. In Appendix 1-12, we: (1) provide a detailed explanation of origins of AP prolongation following I<sub>CaL</sub> block in a model which manifests experimental data-like plateau potentials and which contains the ORd I<sub>Kr</sub> formulation; (2) explain why this phenomenon occurs only in a model with experimental data-like plateau potentials, but not in the original high-plateau ORd model; (3) compare the ORd and Lu-Vandenberg I<sub>Kr</sub> formulations with experimental data, demonstrating the good agreement with experimental data of the Lu-Vandenberg formulation but not the ORd.</p><p>Following the inclusion of the Lu-Vandenberg I<sub>Kr</sub> formulation, all models generated during model calibration exhibited APD shortening in response to I<sub>CaL</sub> block.</p></sec><sec id="s2-5"><title>Changes in I<sub>Na,</sub> I<sub>(Ca)Cl,</sub> I<sub>Clb</sub> and I<sub>K1</sub></title><p>The I<sub>Na</sub> current formulation was replaced by an alternative human-based formulation (<xref ref-type="bibr" rid="bib33">Grandi et al., 2010</xref>), given established limitations of the original model with regards to conduction velocity and excitability (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>), comment on article from 05 Oct 2012). The Grandi I<sub>Na</sub> model was updated to account for CaMKII phosphorylation (Appendix 1-15.3.1).</p><p>Also from the Grandi model, we added the calcium-sensitive chloride current I<sub>(Ca)Cl</sub> and background chloride current I<sub>Clb</sub> formulation (<xref ref-type="bibr" rid="bib33">Grandi et al., 2010</xref>). Neither model was changed compared to the original formulations, but the intracellular concentration of Cl<sup>-</sup> was slightly increased (Appendix 1-15.1.1). In accordance with recent observations, I<sub>(Ca)Cl</sub> was placed in the junctional subspace (<xref ref-type="bibr" rid="bib48">Magyar et al., 2017</xref>). The motivation to add these currents was to facilitate the shaping of post-peak AP morphology (via I<sub>(Ca)Cl</sub>), with I<sub>Clb</sub> playing a dual role stemming from its reversal potential of ca. −50 mV. It slightly reduces plateau potentials during the action potential, but during the diastole, it depolarises the cell slightly, improving the reaction to I<sub>K1</sub> block as explained in the next subsection.</p><p>The I<sub>K1</sub> model was replaced with the human-based formulation by <xref ref-type="bibr" rid="bib11">Carro et al. (2011)</xref>, as it was shown to be key for simulations of hyperkalemic conditions. The I<sub>K1</sub> replacement was done before hyperkalemia simulation, not violating the classification of hyperkalemia criterion as a validation step. Extracellular potassium concentration in a healthy cell was reduced from 5.4 to 5 mM to fall within the physiological range (<xref ref-type="bibr" rid="bib86">Zacchia et al., 2016</xref>).</p></sec><sec id="s2-6"><title>Calibration of I<sub>K1</sub> block and resting membrane potential</title><p>When evaluating the baseline ORd model against the selected criteria, we observed that a reduction in I<sub>K1</sub> results in hyperpolarisation of the cell (from −88 to −88.16 mV at 1 Hz pacing). However, it is established that I<sub>K1</sub> reduction depolarises cells experimentally (<xref ref-type="bibr" rid="bib19">Dhamoon and Jalife, 2005</xref>). Changes made during ToR-ORd calibration (predominantly the altered balance of currents during diastole and the inclusion of background chloride current) result in ToR-ORd manifesting depolarization in response to I<sub>K1</sub> block, consistent with experimental data.</p></sec><sec id="s2-7"><title>Multiobjective genetic algorithm</title><p>We applied a multiobjective genetic algorithm (MGA, @gamultiobj function in Matlab, <xref ref-type="bibr" rid="bib18">Deb, 2001</xref>) to automatically re-fit various model parameters. Based on preliminary experimentation, we used a two-dimensional fitness. We used MGA rather than an ordinary genetic algorithm or particle swarm optimisation, given that MGA optimises towards a Pareto front rather than a single optimum, implicitly maintaining population diversity. The Pareto front is the set of all creatures which are not <italic>dominated</italic> by any other creature in the population, that is creatures for which there is no other creature better in all fitness dimensions. Therefore, a subpopulation of diverse solutions is maintained, and the optimiser consequently has less of a tendency to converge to a single local optimum compared to single-number fitness approaches. In addition, the crossover operator of GA is well suited for a task where multiple criteria are optimised, given that creatures in the population may efficiently share partial solutions to various subcriteria. The fitness used in this study is described in greater detail in Appendix 1-1.</p></sec><sec id="s2-8"><title>Evaluation pipeline and code</title><p>To facilitate the model validation and future work, we also provide an automated ‘single-click’ evaluation pipeline. It runs automatic simulations to extract and visualise single-cell biomarkers including those related to AP morphology, effect of key channel blockers, early afterdepolarisations (EAD), and alternans measurement. The pipeline generates a single HTML report containing all the results; see Appendix 1-15.2 for a visualisation. The code for our model (Matlab and CellML), the validation pipeline, and the experimental data on human AP morphology are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/jtmff/torord">https://github.com/jtmff/torord</ext-link> (<xref ref-type="bibr" rid="bib78">Tomek, 2019</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/torord">https://github.com/elifesciences-publications/torord</ext-link>). An informal blog giving further insight into the choices we made, as well as general thoughts on the development of ToR-ORd and computer models in general, is available at <ext-link ext-link-type="uri" xlink:href="https://underlid.blogspot.com/">https://underlid.blogspot.com/.</ext-link></p><p>We designed the Matlab code used to simulate our model so that the simulation core is structured into functions computing currents, making the high-level organisation of code clear, and facilitating inclusion of alternative current formulations. In addition, a CellML file encoding our model is also provided. This makes the model readily runnable in several simulators in addition to Matlab (e.g. Chaste [<xref ref-type="bibr" rid="bib63">Pitt-Francis et al., 2009</xref>] and OpenCOR [<xref ref-type="bibr" rid="bib28">Garny and Hunter, 2015</xref>]). Furthermore, the Myokit library (<xref ref-type="bibr" rid="bib13">Clerx et al., 2016</xref>) enables conversion of the CellML file to other languages (such as C or Python).</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Calibration based on AP, calcium transient, and L-type calcium current properties</title><p>The AP morphology of the ToR-ORd is within or at the border of the interquartile range of the Szeged-ORd experimental data (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This is a major improvement compared to the original ORd morphology, which overestimates plateau potentials, particularly during early plateau (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The fact that the early plateau potential is around 20–23 mV is clearly apparent from experimental recordings and is further corroborated by additional studies in human tissue samples (<xref ref-type="bibr" rid="bib38">Jost et al., 2013</xref>, Figure 6) and isolated human cardiomyocytes (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>). We note that compared to the Szeged-ORd dataset (<xref ref-type="bibr" rid="bib7">Britton et al., 2017</xref>), our model manifests a slightly increased peak membrane potential in the single-cell form, similar to single-cell experimental data (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>). This is a design choice related to the fact that the Szeged-ORd dataset contains recordings of small tissue samples, which are expected to manifest a reduced peak potential compared to single-cell. When coupled in a fibre, ToR-ORd manifests conduction velocity of 65 cm/s, which is consistent with clinical data (<xref ref-type="bibr" rid="bib74">Taggart et al., 2000</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Action potential, calcium transient, and I<sub>CaL</sub> in ToR-ORd.</title><p>Action potential (<bold>A</bold>) and calcium transient (<bold>B</bold>) at 1 Hz obtained with the ToR-ORd model following calibration, compared to those obtained with the ORd model and experimental data from <xref ref-type="bibr" rid="bib56">O'Hara et al. (2011)</xref> and <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>, respectively. The purple and green zones in (<bold>B</bold>) stand for mean ± standard deviation. The duration of calcium transient at 90% recovery was extracted from figures in <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>, adding the time to peak and time from peak to 90% recovery. (<bold>C</bold>) Activation curves used in the ToR-ORd and ORd models (blue and red lines, respectively). The points correspond to the IV relationship measured in <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref> normalised by the Nernstian driving force (d.f.) assuming reversal potential of +60 mV (blue points) and the GHK driving force (red points). (<bold>D, E</bold>) I-V relationship and steady-state inactivation as measured in ToR-ORd (red line) versus ORd model (blue line) versus experimental data from <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref> (black points with line). I<sub>CaL,tot</sub> is the sum of currents corresponding to all ions (Ca<sup>2+</sup>, Na<sup>+</sup>, and K<sup>+</sup>) passing through the L-type calcium current channels. (<bold>F</bold>) L-type calcium current of a midmyocardial cell, showing current reversal in ORd, but not in ToR-ORd. Only the calcium component of I<sub>CaL,tot</sub> is shown to demonstrate that the current reversal is not due to other ions. We note that the difference in total amplitude of I<sub>CaL</sub>in <xref ref-type="fig" rid="fig2">Figure 2F</xref> follows predominantly from different action potential shape in ToR-ORd vs ORd, consistent with the I-V relationship.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig2-v3.tif"/></fig><p>Both time to peak calcium and duration of calcium transient at 90% recovery obtained with the ToR-ORd model are within the standard deviation of experimental data in isolated human myocytes (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>), whereas ORd slightly overestimated the calcium transient duration (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The calcium transient amplitude of ToR-ORd also matches the Coppini et al. data after accounting for the different APD (Appendix 1-8).</p><p>As described in Materials and methods, the ToR-ORd I<sub>CaL</sub> activation curve was extracted from experimental data, using the Goldman-Hodgkin-Katz formulation of ionic driving force, ensuring theoretical consistency, unlike the ORd I<sub>CaL</sub> formulation (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This considerably improves the results of simulated protocols to obtain IV relationship (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), validating the theory-driven changes (see Appendix 1-4 for the demonstration of how the updated activation curve underlies the improvement). The simulation of the protocol measuring steady-state inactivation also reveals improved agreement of ToR-ORd with experimental data compared to ORd (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). The difference between measured ORd steady state inactivation and the experimental data (ca. two times stronger inactivation at around −15 mV, which is relevant for EAD formation) is initially surprising, given that the equation of ORd I<sub>CaL</sub> steady-state inactivation curve provides a good fit to the same experimental data. This difference follows from the formulation of calcium-dependent inactivation of I<sub>CaL</sub> (see Appendix 1-5 for details).</p><p>We observed that in cases of elevated I<sub>CaL</sub> (e.g. in midmyocardial cells), ORd reverses current direction towards positive values, which is an unexpected behaviour given its reversal potential of 60 mV. Conversely, the ToR-ORd model yields negative I<sub>CaL</sub> values in such conditions, consistent with it being an inward current (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). This is a direct consequence of the updates to the extracellular/intracellular calcium activity coefficients (as explained in Appendix 1-6), which supports their credibility and it is important for cases of elevated I<sub>CaL</sub>, such as under ß-adrenergic stimulation.</p><p>We have also simulated a P2/P1 protocol as measured experimentally by <xref ref-type="bibr" rid="bib27">Fülöp et al. (2004)</xref>, where two rectangular pulses are applied with varying interval between them. Both ORd and ToR-ORd qualitatively agree with the experimental data (Appendix 1-7).</p></sec><sec id="s3-2"><title>Calibration: inotropic effects of sodium blockers</title><p><xref ref-type="fig" rid="fig3">Figure 3A-D</xref> illustrates AP and calcium transient changes caused by block of sodium currents in ToR-ORd (left) and ORd (right). As sodium blockers act on channel Na<sub>v</sub>1.5 mediating both the fast (I<sub>Na</sub>) and late (I<sub>NaL</sub>) sodium current (<xref ref-type="bibr" rid="bib50">Makielski, 2016</xref>), we simulate the effect of combined partial I<sub>Na</sub> and I<sub>NaL</sub> block. The ToR-ORd model manifests a small reduction in calcium transient amplitude (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), unlike ORd, which gives a sizeable increase (<xref ref-type="fig" rid="fig3">Figure 3D</xref>); ToR-ORd is thus consistent with the observed negative inotropy of sodium blockers (<xref ref-type="bibr" rid="bib32">Gottlieb et al., 1990</xref>; <xref ref-type="bibr" rid="bib80">Tucker et al., 1982</xref>; <xref ref-type="bibr" rid="bib42">Legrand et al., 1983</xref>; <xref ref-type="bibr" rid="bib2">Bhattacharyya and Vassalle, 1982</xref>). This is a major improvement in the ToR-ORd model, as sodium current reduction is involved in a range of disease conditions in addition to pharmacological block.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Sodium blockade in ToR-ORd and ORd.</title><p>Simulated effect of sodium current block on the action potential (<bold>A, B</bold>) and calcium transient (<bold>C,D</bold>) using the ToR-ORd (left) and ORd (right) models. Control simulations are shown as blue traces, whereas results for 50% block of I<sub>Na</sub> and I<sub>NaL</sub> are shown as red traces. Panels (<bold>E,F</bold>) show values of changes in calcium transient amplitude with respect to control (‘rel. CaTA’) for varying degrees of I<sub>Na</sub>/I<sub>NaL</sub> block for ToR-ORd and ORd respectively (one is no change, values &gt; 1 correspond to an increase the calcium transient amplitude).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig3-v3.tif"/></fig><p>Experimental evidence shows that the ratio of I<sub>Na</sub> and I<sub>NaL</sub> block is drug and dose-dependent, with I<sub>NaL</sub> usually being blocked more than I<sub>Na</sub> (Appendix 1-9). <xref ref-type="fig" rid="fig3">Figure 3E,F</xref> illustrates the change in calcium transient amplitude obtained with the ToR-ORd and ORd models, respectively, for several combinations of I<sub>Na</sub> and I<sub>NaL</sub> availability. Both models show a similar general trend where reduced I<sub>Na</sub> availability increases calcium transient amplitude and reduced I<sub>NaL</sub> availability diminishes it; however, the models differ strongly in relative contributions of these components. The ToR-ORd model shows negative inotropy for almost all combinations of blocks. A mild increase in inotropy may be achieved only under near-exclusive I<sub>Na</sub> block. Conversely, ORd shows a general tendency for increased calcium transient amplitude; a reduction occurs only when the sodium current block targets near-exclusively I<sub>NaL</sub>. ToR-ORd presents a greater calcium transient amplitude reduction than ORd in response to I<sub>NaL</sub> block, as the current has a greater role in indirect modulation the cell’s calcium loading via APD change. At the same time, ToR-ORd shows a much smaller calcium transient amplitude increase in response to I<sub>Na</sub> block than ORd because of the updated I<sub>CaL</sub> activation curve (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), as well as closer-to experimental data AP morphology (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and its effect on I<sub>CaL</sub>. A detailed explanation is given in Appendix 1-10.</p><p>Fibre simulations carried out to assess the effect of cell coupling on the effect of sodium block are consistent with the single-cell simulations (Appendix 1-11). The difference in response to half-block of I<sub>Na</sub> and I<sub>NaL</sub> between ToR-ORd and ORd is even larger, as ToR-ORd in fibre predicts a greater reduction in calcium transient amplitude than in single cell (−14% vs −6% respectively), while ORd in fibre predicts a slightly greater increase in calcium transient amplitude than in single cell (+25% vs +24%).</p><p>With the ToR-ORd model, the 14% reduction in CaT amplitude in the electrically coupled fibre with 50% block of both I<sub>Na</sub> and I<sub>NaL</sub> is generally consistent with clinical data on sodium blockers: Encainide reduced stroke work index by 15% and cardiac index by 8% (<xref ref-type="bibr" rid="bib80">Tucker et al., 1982</xref>). In another study using encainide, the cardiac index was reduced by 18% and the stroke volume index by 28% (<xref ref-type="bibr" rid="bib32">Gottlieb et al., 1990</xref>). Flecainide reduced left ventricular stroke index by 12% and the left ventricular ejection fraction by 9% (<xref ref-type="bibr" rid="bib42">Legrand et al., 1983</xref>). Simulations with the ToR-ORd model show overall agreement with the clinical data. However, a direct quantitative comparison is challenging given the different indices of contractility measured (CaT amplitude versus clinical indices) and that it is not possible to estimate the exact ratios of I<sub>Na</sub> and I<sub>NaL</sub> block in clinical data (Appendix 1-9).</p></sec><sec id="s3-3"><title>Calibration: proarrhythmic behaviours (alternans and early afterdepolarisations)</title><p>EADs are an important precursor to arrhythmia, manifesting as a membrane potential depolarisation during late plateau and/or early repolarisation. They are thought to arise mainly from I<sub>CaL</sub> current reactivation (<xref ref-type="bibr" rid="bib84">Weiss et al., 2010</xref>). The ToR-ORd model manifests EADs at conditions used experimentally in nondiseased human endocardium (<xref ref-type="bibr" rid="bib34">Guo et al., 2011</xref>) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The amplitude of simulated EADs is 14 mV (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), which matches the maximum EAD amplitude shown by <xref ref-type="bibr" rid="bib34">Guo et al. (2011)</xref>. We also note that the experimental data by Guo et al. manifest early plateau potential of ca. 23 mV (which is matched by ToR-ORd), in line with other studies we referred to previously regarding this matter.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>EADs and alternans.</title><p>(<bold>A</bold>) Experimentally observed EADs produced in nondiseased human myocytes exposed to 0.1 µM dofetilide (∼85% I<sub>Kr</sub> block) paced at 0.25 Hz (<xref ref-type="bibr" rid="bib34">Guo et al., 2011</xref>) and the corresponding simulation using the ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>), figure reproduced as allowed by the CC-BY license). See Appendix 1-15.1.1 for ionic concentrations used. (<bold>B</bold>) An EAD produced by the ToR-ORd model at the same conditions. (<bold>C,E</bold>) APD and calcium transient amplitude versus pacing base cycle length (bcl); the bifurcation indicates alternans. (<bold>D,F</bold>) Example of APD and calcium transient alternans at the bcl of 260 ms.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig4-v3.tif"/></fig><p>Repolarisation alternans is another established precursor to arrhythmia, facilitating the formation of conduction block (<xref ref-type="bibr" rid="bib83">Weiss et al., 2006</xref>). It is induced by rapid pacing and it is mostly thought to arise from calcium transient amplitude oscillations being translated to APD oscillations (<xref ref-type="bibr" rid="bib64">Pruvot et al., 2004</xref>), although purely voltage-driven mechanism was also proposed (<xref ref-type="bibr" rid="bib55">Nolasco and Dahlen, 1968</xref>). Alternans in the ToR-ORd model is calcium-driven and appears via the same mechanism as in the ORd: sarcoplasmic reticulum calcium cycling refractoriness (<xref ref-type="bibr" rid="bib77">Tomek et al., 2018</xref>). It occurs at rapid pacing, in both calcium and APD (<xref ref-type="fig" rid="fig4">Figure 4C–F</xref>). The peak APD alternans amplitude (difference in APD between consecutive beats) is 12 ms, which is matches the value 11 ± 2 ms reported in human hearts without a structural disease (<xref ref-type="bibr" rid="bib39">Koller et al., 2005</xref>). Direct quantitative comparison is however slightly limited by the fact that the data were recorded in RV septum, which may or may not differ from endocardial cells in alternans amplitude.</p></sec><sec id="s3-4"><title>Validation: drug-induced effects on rate dependence of APD</title><p><xref ref-type="fig" rid="fig5">Figure 5</xref> illustrates simulations of drug action using the ToR-ORd model (red traces), compared to experimental data (black traces) and to simulations with the ORd model reparametrised by <xref ref-type="bibr" rid="bib23">Dutta et al. (2017a)</xref> (blue dashed lines). APD is shown in the presence of I<sub>Kr</sub> block (E-4031, <xref ref-type="fig" rid="fig5">Figure 5A</xref>), I<sub>Ks</sub> block (HMR-1556 <xref ref-type="fig" rid="fig5">Figure 5B</xref>), multichannel block of I<sub>NaL</sub>, I<sub>CaL</sub>, I<sub>Kr</sub> (mexiletine, <xref ref-type="fig" rid="fig5">Figure 5C</xref>), and a I<sub>CaL</sub> block (nisoldipine, <xref ref-type="fig" rid="fig5">Figure 5D</xref>), at base cycle lengths of 500, 1000, and 2000 ms. We note that while the Dutta et al. model was specifically optimised for response of APD to these drug blocks, no such treatment was applied to the ToR-ORd model, making the results presented here an independent validation. Appendix 1-13 contains further details on the choice and use of the drug data.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Drug block and APD.</title><p>All four panels contain mean and standard deviation of experimental data (black) as measured in <xref ref-type="bibr" rid="bib56">O'Hara et al. (2011)</xref> for three basic cycle lengths (bcl), predictions of the Dutta optimised dynamic-I<sub>Kr</sub> ORd model (blue, <xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>), and the predictions of the ToR-ORd model (red). (<bold>A</bold>) 1 µM E-4031 (70% I<sub>Kr</sub> block). (<bold>B</bold>) 1 µM HMR-1556 (90% I<sub>Ks</sub> block). (<bold>C</bold>) 10 µM mexiletine (54% I<sub>NaL</sub>, 9% I<sub>Kr</sub>, 20% I<sub>CaL</sub> block). (<bold>D</bold>) 1 µM nisoldipine (90% I<sub>CaL</sub> block). Drug concentrations and their effects on channel blocks are based on <xref ref-type="bibr" rid="bib24">Dutta et al. (2017b)</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig5-v3.tif"/></fig><p>The predictions produced by the ToR-ORd model are in good agreement with experimental data, particularly given the lack of optimisation towards this result. Simulating E-4031, ToR-ORd provides a prediction similar to the experimental data mean and the Dutta model (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). This is crucial, given the key role of I<sub>Kr</sub> in the repolarisation reserve of human cardiomyocytes. The response to I<sub>Ks</sub> blockade via HMR-1556 is even better in ToR-ORd than in the Dutta model, which is also within standard deviation of the data, but carries a clear trend towards AP prolongation (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). When simulating the multichannel blocker mexiletine, ToR-ORd prediction is within standard deviation of the experimental data, with the Dutta model giving similar or closer-to-mean predictions at 0.5 and 1 Hz (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The predicted effect of the calcium blocker nisoldipine in the ToR-ORd model matches well the experimental data mean (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), even better than the Dutta model (also within standard deviation). We note that the good performance of the simulated nisoldipine effect critically relies on the I<sub>Kr</sub> replacement (Materials and methods and Appendix 1-12).</p></sec><sec id="s3-5"><title>Validation: APD accommodation and S1-S2 restitution</title><p>Experimental measurements in human cardiomyocytes (<xref ref-type="bibr" rid="bib26">Franz et al., 1988</xref>; <xref ref-type="bibr" rid="bib9">Bueno-Orovio et al., 2012</xref>) show how the APD shortens upon increase in pacing frequency, and then prolongs again, as the pacing frequency returns to control (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, top). APD adaptation dynamics with changes in heart rate are regulated by changes in sodium homeostasis (<xref ref-type="bibr" rid="bib68">Pueyo et al., 2011</xref>), and their manifestation in QT adaptation have been shown to be useful for arrhythmia risk prediction (<xref ref-type="bibr" rid="bib66">Pueyo et al., 2004</xref>). While simulations with the ORd model capture the general trend of APD accommodation, there are differences compared to the experimental data (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). First, changes in pacing rate are followed by slow-dynamics (~30 s) APD prolongation not present in the experimental recordings. Second, the time constant of accommodation is generally slow. Conversely, the ToR-ORd model reproduces the pattern of accommodation well, where the change in APD soon after change in frequency is relatively fast, and then gradually slows down (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). This suggests that the ionic balance in ToR-ORd is likely to have been improved compared to ORd.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>APD accommodation and S1-S2 protocol.</title><p>(<bold>A</bold>) APD accommodation measured experimentally (<xref ref-type="bibr" rid="bib26">Franz et al., 1988</xref>) and in simulation of the ORd model (reproduced as allowed by the CC-BY licence from <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). (<bold>B</bold>) APD accommodation in ToR-ORd. (<bold>C</bold>) S1-S2 restitution curve (S1 = 1000 ms) in ToR-ORd fibre, ORd fibre (including I<sub>Na</sub> modification to facilitate propagation <xref ref-type="bibr" rid="bib59">Passini et al., 2016</xref>) and human tissue samples data (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig6-v3.tif"/></fig><p>A second indicator of how a model responds to a change in pacing frequency is the S1-S2 restitution protocol. The S1-S2 restitution curve obtained with the ToR-ORd model is given in Figure (<xref ref-type="fig" rid="fig6">Figure 6C</xref>), showing a good agreement with the experimental data (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>).</p></sec><sec id="s3-6"><title>Validation: populations of models and drug safety prediction</title><p>Drug safety testing is one of the key applications of computer modelling which has yielded highly promising results (<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>). To assess the suitability of ToR-ORd for drug safety testing, we replicated the study by <xref ref-type="bibr" rid="bib60">Passini et al. (2017)</xref>, which was carried out using populations of models based on the ORd model. Two populations were created based on ToR-ORd similarly to the original study, altering conductances of important currents within the ranges of 50–150% and 0–200%. Models in both populations are stable under significant perturbation of ionic conductances, which supports the robustness of the model (<xref ref-type="fig" rid="fig7">Figure 7A</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Populations of models and drug safety prediction.</title><p>(<bold>A</bold>) Percentile-based summary of AP and calcium transient traces for the two populations of human ToR-ORd models (left side) and distribution of ionic current conductances among models in the population (right side), in the ranges [50-150]% (top row) and [0–200]% (bottom row) of the baseline values. (<bold>B</bold>) A comparison of 0–200% populations based on ToR-ORd (left) and ORd (right, based on <xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>) in response to high-dose mexiletine (100-fold effective therapeutic dose). Traces classified as EADs are plotted in red (manifesting only in the ORd population). (<bold>C</bold>) TdP score obtained for simulations of the 62 reference compounds, based on the occurrence of drug-induced repolarisation abnormalities at all tested concentrations in the [0–200]% population of ToR-ORd models. The colours associated with drugs signify their established torsadogenicity as specified in Appendix 1-15.1.4. The logarithmic scale was considered to maximise the visual separation between safe and risky drugs. The classification based on the TdP score is summarised as a confusion matrix on the right, and also compared with the corresponding results obtained in a population of models based on the original ORd model (<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig7-v3.tif"/></fig><p>Prediction of the risk of drug-induced Torsades de Pointes based on simulated drug-induced repolarisation abnormalities using ToR-ORd population yielded similar results to the original study, with predicted risk being correct for 54 out of 62 compounds (87% accuracy). Compared to <xref ref-type="bibr" rid="bib60">Passini et al. (2017)</xref>, the assessment of Mexiletine (a predominantly sodium blocker that is safe) was improved from false positive to true negative. High-dose Mexiletine led to formation of many EADs in ORd, but not in ToR-ORd (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), highlighting the importance of the advances on sodium blockers presented in this work. At the same time, Procainamide and Metrodinazole were misclassified as false negatives compared to <xref ref-type="bibr" rid="bib60">Passini et al. (2017)</xref>. However, these drugs are controversial, as Metrodinazole is considered non-torsadogenic by <xref ref-type="bibr" rid="bib41">Lancaster and Sobie (2016)</xref>, and this study predicted both the drugs to be non-risky. Torsadogenic risk for all evaluated compounds and the confusion matrix of the classification are given in <xref ref-type="fig" rid="fig7">Figure 7C</xref>.</p></sec><sec id="s3-7"><title>Validation: response to disease</title><sec id="s3-7-1"><title>Hyperkalemia</title><p>Hyperkalemia, the elevation of extracellular potassium, is a hallmark of acute myocardial ischemia caused by the occlusion of coronary artery. It was shown that hyperkalemia can significantly inhibit sodium channel excitability following repolarisation, leading to the prolongation of postrepolarisation refractoriness (<xref ref-type="bibr" rid="bib16">Coronel et al., 2012</xref>). The dispersion of effective refractory periods (ERPs) between normal and ischemic zones forms a substrate for the initiation of re-entrant arrhythmia. In this new model, we tested the effect of hyperkalemia on tissue excitability using 1D fibres. As shown in <xref ref-type="fig" rid="fig8">Figure 8A</xref>, the elevation of extracellular potassium level led to an increase of the resting membrane potential (RMP) and the decrease of AP upstroke amplitude. As a result of weaker upstroke and more depolarised RMP, the APD shortened under hyperkalemia; however, the ERPs were prolonged due to the stronger sodium channel inactivation caused by the elevation of RMP (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). Therefore, this new model successfully reproduced the longer post-repolarization refractoriness under hyperkalemia observed in experiments, and it can be used in the simulations of re-entrant arrhythmia under acute ischemia. In this regard, it presents an improvement over the original ORd model, which did not manifest postrepolarisation refractoriness without further modifications (<xref ref-type="bibr" rid="bib24">Dutta et al., 2017b</xref>).</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Simulation of hypertrophic cardiomyopathy (HCM) and hyperkalemia.</title><p>(<bold>A</bold>) The effect of hyperkalemia on AP morphology; measured in the centre of a simulated fibre. (<bold>B</bold>) APD90 and effective refractory period (ERP) at varying extracellular potassium concentration. For extracellular potassium higher than 9 mM, full AP did not develop, but low-amplitude activation propagated through the fibre (Appendix 1-14). Membrane potential (<bold>C</bold>) and calcium transient (<bold>D</bold>) at 1 Hz pacing compared between a single healthy and HCM cell. (<bold>E</bold>) 50% I<sub>Kr</sub> block induces EADs in HCM cell, but not in a healthy one.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig8-v3.tif"/></fig></sec><sec id="s3-7-2"><title>Hypertrophic cardiomyopathy</title><p>Hypertrophic cardiomyopathy (HCM) is among the most common cardiomyopathies, manifesting as abnormal thickening of the cardiac muscle without an obvious cause (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>). Beyond mechanical remodelling, the disease predisposes the hearts to arrhythmia formation, increasing the vulnerability to early afterdepolarisations. HCM induces complex multifactorial remodelling of cell electrophysiology and calcium handling, making it a challenging validation problem for a computer model. We applied the available human experimental data on HCM remodelling (based predominantly on <xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>) to our baseline model using an approach similar to <xref ref-type="bibr" rid="bib59">Passini et al. (2016)</xref>, observing that the dominant features of the remodelling observed by Coppini et al. are captured. The HCM variant of the computer model corresponds to experimental data in the AP morphology, manifesting a significantly higher plateau potential and an overall APD prolongation (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). The calcium transient amplitude of the HCM model is slightly reduced, has longer time to peak, and a noticeably longer duration at 90% recovery (<xref ref-type="fig" rid="fig8">Figure 8D</xref>), also consistent with the data by <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>. Ultimately, the HCM variant of our model is more prone to the formation of EADs (<xref ref-type="fig" rid="fig8">Figure 8E</xref>), as was shown experimentally (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>). This difference is in line with postulated key role of I<sub>CaL</sub> and NCX in EAD formation (<xref ref-type="bibr" rid="bib45">Luo and Rudy, 1994</xref>; <xref ref-type="bibr" rid="bib84">Weiss et al., 2010</xref>), both of which are markedly increased in HCM. Excessive prolongation of APD due to a strong increase in late sodium current in HCM also contributes to the EAD formation as well, as shown by <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>.</p></sec></sec><sec id="s3-8"><title>Validation: human whole-ventricular simulations - from ionic currents to ECG</title><p>We conducted 3D electrophysiological simulations using the ToR-ORd model, representing the membrane kinetics of endocardial, epicardial and mid-myocardial cells to investigate their ability to simulate the ECG (see Appendix 1-15.1.5). Transmural and apex-to-base spatial heterogeneities as well as fibre orientations based on the Streeter rule were incorporated into a human ventricular anatomical model derived from cardiac magnetic resonance (<xref ref-type="bibr" rid="bib46">Lyon et al., 2018</xref>).</p><p><xref ref-type="fig" rid="fig9">Figure 9A</xref> shows the resulting electrocardiogram computed based on virtual electrodes positioned on a torso model shown in <xref ref-type="fig" rid="fig9">Figure 9B</xref>. The ECG manifests a QRS duration of 80 ms (normal range 78 ± 8 ms), and a QT interval of 350 ms (healthy:&lt;430 ms); all of these quantitative measurements are in the range of ECGs of healthy persons (<xref ref-type="bibr" rid="bib25">Engblom et al., 2005</xref>; <xref ref-type="bibr" rid="bib81">van Oosterom et al., 2000</xref>). ECG morphology also showed normal features, such as R wave progression in the precordial leads from V1 to V6, isoelectric ST segment, and upright T waves in leads V2 to V6, with inverted T wave in aVR. <xref ref-type="fig" rid="fig9">Figure 9C</xref> shows the activation sequence is in agreement with <xref ref-type="bibr" rid="bib21">Durrer et al. (1970)</xref>. The APD map shows longer APD in the endocardium and the base, and shorter APDs in the epicardium and the apex, respectively (<xref ref-type="fig" rid="fig9">Figure 9D</xref>).</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Simulated and clinical 12-lead electrocardiogram.</title><p>(<bold>A</bold>) 12-lead ECGs at 1 Hz: simulation using the ToR-ORd model in an MRI-based human torso-ventricular model (top) and a healthy patient ECG record (bottom, <ext-link ext-link-type="uri" xlink:href="https://physionet.org">https://physionet.org</ext-link>, PTB database, subject 122; <xref ref-type="bibr" rid="bib4">Bousseljot et al., 1995</xref>; <xref ref-type="bibr" rid="bib31">Goldberger et al., 2000</xref>). (<bold>B</bold>) Electrode positions on the simulated torso. (<bold>C</bold>) Activation time map. (<bold>D</bold>) APD map.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-fig9-v3.tif"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>In this study, we present a new model of human ventricular electrophysiology and excitation contraction coupling, which is able to replicate key features of human ventricular depolarisation, repolarisation and calcium transient dynamics. The ToR-ORd model was developed using a defined set of calibration criteria and subsequently validated on features not considered during calibration to demonstrate its predictive power. This article also unravels several important theoretical findings with implications for computational electrophysiology reaching beyond the ToR-ORd model and cardiac electrophysiology: firstly, the reformulation of the L-type calcium current, which is broadly relevant and generally applicable to human and other species, and secondly, the mechanistically guided replacement of I<sub>Kr</sub>. Discovering the necessity to carry out these theoretical reformulations was enabled by the comprehensive set of calibration criteria and the use of a genetic algorithm to fulfil them. Finally, to enable reproducibility, we openly provide an automated model evaluation pipeline, which provides a rapid assessment of a comprehensive set of calibration or validation criteria.</p><p>The AP morphology of ToR-ORd is in agreement with the Szeged endocardial myocyte dataset used to construct the state-of-the art ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). The agreement is considerably better than that of ORd itself, which has important implications for multiple aspects studied in this work. The calcium transient also recapitulates key features of human myocyte measurements (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>). The validation of ToR-ORd shows that the model responds well to drug block with regards to APD (<xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>). Good APD accommodation (reaction to abrupt, but persisting changes in pacing frequency) indicates a good balance between ionic currents (<xref ref-type="bibr" rid="bib26">Franz et al., 1988</xref>; <xref ref-type="bibr" rid="bib67">Pueyo et al., 2010</xref>). Replication of arrhythmia precursors such as early afterdepolarisations (<xref ref-type="bibr" rid="bib34">Guo et al., 2011</xref>) and alternans (<xref ref-type="bibr" rid="bib39">Koller et al., 2005</xref>) makes the model useful for simulations and understanding of arrhythmogenesis. This is particularly important in the context of heart disease, where ToR-ORd is shown to replicate key features of hyperkalemia (<xref ref-type="bibr" rid="bib16">Coronel et al., 2012</xref>) and hypertrophic cardiomyopathy (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>). The model is also shown to be promising in drug safety testing, and whole-heart simulations demonstrate physiological conduction velocity (<xref ref-type="bibr" rid="bib74">Taggart et al., 2000</xref>) and produce a plausible ECG signal. Among the improved behaviours compared to the state-of-the-art ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>), the good response of the ToR-ORd model to sodium blockade is particularly noteworthy. ToR-ORd predicts the negative inotropic effect of sodium blockade, consistent with data (<xref ref-type="bibr" rid="bib32">Gottlieb et al., 1990</xref>; <xref ref-type="bibr" rid="bib80">Tucker et al., 1982</xref>; <xref ref-type="bibr" rid="bib42">Legrand et al., 1983</xref>; <xref ref-type="bibr" rid="bib2">Bhattacharyya and Vassalle, 1982</xref>), unlike ORd, which suggests a strong pro-inotropic effect. The improvement in ToR-ORd follows from the relatively complex interplay of the theoretically driven reformulation of the L-type calcium current and data-driven changes to the AP morphology. This result is of great importance in the context of pharmacological sodium blockers, but it also plays a crucial role in disease modelling, where both fast (<xref ref-type="bibr" rid="bib65">Pu and Boyden, 1997</xref>) and late (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>) sodium current are altered.</p><p>An important feature of a model is its predictive power, and validation of a model using data not employed in model calibration is a central aspect of model credibility (<xref ref-type="bibr" rid="bib62">Pathmanathan and Gray, 2018</xref>; <xref ref-type="bibr" rid="bib12">Carusi et al., 2012</xref>). With this in mind, we designed our study to first calibrate the developed model using a set of given criteria, with subsequent validation of the model using separate data that were not optimised for during development. The fact that ToR-ORd manifests a wide range of behaviours consistent with experimental studies, even though it was not optimised for these purposes, suggests its generality and a large degree of credibility. To facilitate future model development, we also created an automated ‘single-click’ pipeline, which evaluates a wide range of calibration and validation criteria and creates a comprehensive HTML report. New follow-up models can thus be immediately tested against criteria presented here, making it clear which features of the model are improved and/or deteriorated by any changes made.</p><p>The greatest theoretical contribution of this work is the theory-driven reformulation of the L-type calcium current, namely the ionic activity coefficients and activation curve extraction. Activation curve of the current in previous cardiac models was based on the use of Nernst driving force in experimental studies, but the models then used Goldman-Hodgkin-Katz driving force to compute the current. This yields a theoretical inconsistency present in existing influential models of guinea pig, rabbit, dog, or human, for example (<xref ref-type="bibr" rid="bib45">Luo and Rudy, 1994</xref>; <xref ref-type="bibr" rid="bib37">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Shannon et al., 2004</xref>; <xref ref-type="bibr" rid="bib33">Grandi et al., 2010</xref>; <xref ref-type="bibr" rid="bib11">Carro et al., 2011</xref>). We propose and demonstrate that in order to obtain consistent behaviour, the experimental I-V relationship measurements are to be normalised using the Goldman-Hodgkin-Katz driving force instead. Updated ionic activity coefficients and activation of the L-type calcium current improve key features of the current observed in the study underlying the ORd L-type calcium current model (<xref ref-type="bibr" rid="bib47">Magyar et al., 2000</xref>), and strongly contribute to the improved reaction of the model to sodium blockade. The changes made are relevant in development of future models which use the Goldman-Hodgkin-Katz equation for L-type calcium current or other currents.</p><p>A second major contribution of this work reaching beyond the model itself is the set of observations on modelling of I<sub>Kr</sub>, the dominant repolarising current in human ventricle. We noticed limitations of the ORd I<sub>Kr</sub> model, which may be a result of the single-pulse voltage clamp protocol to characterise the current behaviour. Approaches enabling the dissection of activation and recovery from inactivation based on more comprehensive experimental data, such as <xref ref-type="bibr" rid="bib44">Lu et al. (2001)</xref> used in our work, may yield a more general and plausible model. In this study, this change was important predominantly for the response of the ventricular cell to calcium block, but our observations are highly relevant also for models of cells with naturally low plateau, such as Purkinje fibres or atrial myocytes.</p><p>We anticipate that the main future development of the presented model will focus on the ryanodine receptor and the respective release from sarcoplasmic reticulum. Similarly to most existing cardiac models, the equations governing the release depend directly on the L-type calcium current, rather than on the calcium concentration adjacent to the ryanodine receptors, which is the case in cardiomyocytes. Future development of the ryanodine receptor model and calcium handling will extend the applicability of the model to other calcium-driven modes of arrhythmogenesis, such as delayed afterdepolarisations. Also, while the model represents to a certain degree the locality of I<sub>CaL</sub> calcium influx and calcium release via the utilization of the junctional calcium subspace, a more direct representation of local control (<xref ref-type="bibr" rid="bib72">Stern, 1992</xref>; <xref ref-type="bibr" rid="bib35">Hinch et al., 2004</xref>), realistic spatially distributed calcium handling (<xref ref-type="bibr" rid="bib14">Colman et al., 2017</xref>), or representation of stochasticity, may improve the insights the model can give into calcium-driven arrhythmogenesis. However, we note that such changes (particularly the detailed distributed calcium handling) will increase computational cost of the model's simulation. In addition, further research on the mechanisms regulating AP dependence on extracellular calcium concentration is needed to update this feature, not currently reproduced by most current human models (<xref ref-type="bibr" rid="bib61">Passini and Severi, 2014</xref>).</p></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Prof. Yoram Rudy, Prof. Derek Terrar, and Dr. Derek Leishman for very useful discussions.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Software, Formal analysis, Investigation, Visualization, Methodology, Project administration</p></fn><fn fn-type="con" id="con2"><p>Resources, Software, Formal analysis, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con4"><p>Software, Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con6"><p>Data curation</p></fn><fn fn-type="con" id="con7"><p>Investigation</p></fn><fn fn-type="con" id="con8"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con9"><p>Methodology</p></fn><fn fn-type="con" id="con10"><p>Data curation</p></fn><fn fn-type="con" id="con11"><p>Data curation</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Project administration</p></fn></fn-group></sec><sec id="s6" sec-type="data-availability"><title>Data availability</title><p>No new experimental data were created. However, codes for simulations are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/jtmff/torord">https://github.com/jtmff/torord</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://github.com/elifesciences-publications/torord">https://github.com/elifesciences-publications/torord</ext-link>).</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beattie</surname> <given-names>KA</given-names></name><name><surname>Hill</surname> <given-names>AP</given-names></name><name><surname>Bardenet</surname> <given-names>R</given-names></name><name><surname>Cui</surname> <given-names>Y</given-names></name><name><surname>Vandenberg</surname> <given-names>JI</given-names></name><name><surname>Gavaghan</surname> <given-names>DJ</given-names></name><name><surname>de Boer</surname> <given-names>TP</given-names></name><name><surname>Mirams</surname> <given-names>GR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sinusoidal voltage protocols for rapid characterisation of ion channel kinetics</article-title><source>The Journal of Physiology</source><volume>596</volume><fpage>1813</fpage><lpage>1828</lpage><pub-id pub-id-type="doi">10.1113/JP275733</pub-id><pub-id pub-id-type="pmid">29573276</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname> <given-names>ML</given-names></name><name><surname>Vassalle</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Effects of tetrodotoxin on electrical and mechanical activity of cardiac purkinje fibers</article-title><source>Journal of Electrocardiology</source><volume>15</volume><fpage>351</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1016/S0022-0736(82)81008-X</pub-id><pub-id pub-id-type="pmid">6292321</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukens</surname> <given-names>BJ</given-names></name><name><surname>Sulkin</surname> <given-names>MS</given-names></name><name><surname>Gloschat</surname> <given-names>CR</given-names></name><name><surname>Ng</surname> <given-names>FS</given-names></name><name><surname>Vigmond</surname> <given-names>EJ</given-names></name><name><surname>Efimov</surname> <given-names>IR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Transmural APD gradient synchronizes repolarization in the human left ventricular wall</article-title><source>Cardiovascular Research</source><volume>108</volume><fpage>188</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvv202</pub-id><pub-id pub-id-type="pmid">26209251</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousseljot</surname> <given-names>R</given-names></name><name><surname>Kreiseler</surname> <given-names>D</given-names></name><name><surname>Schnabel</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Nutzung der EKG-Signaldatenbank CARDIODAT der PTB über das internet</article-title><source>Biomedizinische Technik</source><volume>40</volume><fpage>317</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1515/bmte.1995.40.s1.317</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname> <given-names>E</given-names></name><name><surname>Webb</surname> <given-names>TI</given-names></name><name><surname>Hollywood</surname> <given-names>MA</given-names></name><name><surname>Sergeant</surname> <given-names>GP</given-names></name><name><surname>McHale</surname> <given-names>NG</given-names></name><name><surname>Thornbury</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The cardiac sodium current <sub>na(v</sub>)1.5 is functionally expressed in rabbit bronchial smooth muscle cells</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>305</volume><fpage>C427</fpage><lpage>C435</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00034.2013</pub-id><pub-id pub-id-type="pmid">23784541</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britton</surname> <given-names>OJ</given-names></name><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Van Ammel</surname> <given-names>K</given-names></name><name><surname>Lu</surname> <given-names>HR</given-names></name><name><surname>Towart</surname> <given-names>R</given-names></name><name><surname>Gallacher</surname> <given-names>DJ</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology</article-title><source>PNAS</source><volume>110</volume><fpage>E2098</fpage><lpage>E2105</lpage><pub-id pub-id-type="doi">10.1073/pnas.1304382110</pub-id><pub-id pub-id-type="pmid">23690584</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Britton</surname> <given-names>OJ</given-names></name><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Virág</surname> <given-names>L</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The electrogenic na<sup>+</sup>/K<sup>+</sup>Pump Is a Key Determinant of Repolarization Abnormality Susceptibility in Human Ventricular Cardiomyocytes: A Population-Based Simulation Study</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>278</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00278</pub-id><pub-id pub-id-type="pmid">28529489</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Cherry</surname> <given-names>EM</given-names></name><name><surname>Fenton</surname> <given-names>FH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Minimal model for human ventricular action potentials in tissue</article-title><source>Journal of Theoretical Biology</source><volume>253</volume><fpage>544</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1016/j.jtbi.2008.03.029</pub-id><pub-id pub-id-type="pmid">18495166</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Hanson</surname> <given-names>BM</given-names></name><name><surname>Gill</surname> <given-names>JS</given-names></name><name><surname>Taggart</surname> <given-names>P</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>In vivo human left-to-right ventricular differences in rate adaptation transiently increase pro-arrhythmic risk following rate acceleration</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e52234</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0052234</pub-id><pub-id pub-id-type="pmid">23284948</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardone-Noott</surname> <given-names>L</given-names></name><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Mincholé</surname> <given-names>A</given-names></name><name><surname>Zemzemi</surname> <given-names>N</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Human ventricular activation sequence and the simulation of the electrocardiographic QRS complex and its variability in healthy and intraventricular block conditions</article-title><source>EP Europace</source><volume>18</volume><fpage>iv4</fpage><lpage>iv15</lpage><pub-id pub-id-type="doi">10.1093/europace/euw346</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carro</surname> <given-names>J</given-names></name><name><surname>Rodríguez</surname> <given-names>JF</given-names></name><name><surname>Laguna</surname> <given-names>P</given-names></name><name><surname>Pueyo</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A human ventricular cell model for investigation of cardiac arrhythmias under hyperkalaemic conditions</article-title><source>Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences</source><volume>369</volume><fpage>4205</fpage><lpage>4232</lpage><pub-id pub-id-type="doi">10.1098/rsta.2011.0127</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carusi</surname> <given-names>A</given-names></name><name><surname>Burrage</surname> <given-names>K</given-names></name><name><surname>Rodríguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bridging experiments, models and simulations: an integrative approach to validation in computational cardiac electrophysiology</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>303</volume><fpage>H144</fpage><lpage>H155</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01151.2011</pub-id><pub-id pub-id-type="pmid">22582088</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clerx</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>P</given-names></name><name><surname>de Lange</surname> <given-names>E</given-names></name><name><surname>Volders</surname> <given-names>PG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Myokit: a simple interface to cardiac cellular electrophysiology</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>120</volume><fpage>100</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2015.12.008</pub-id><pub-id pub-id-type="pmid">26721671</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colman</surname> <given-names>MA</given-names></name><name><surname>Pinali</surname> <given-names>C</given-names></name><name><surname>Trafford</surname> <given-names>AW</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Kitmitto</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A computational model of spatio-temporal cardiac intracellular calcium handling with realistic structure and spatial flux distribution from sarcoplasmic reticulum and t-tubule reconstructions</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005714</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005714</pub-id><pub-id pub-id-type="pmid">28859079</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppini</surname> <given-names>R</given-names></name><name><surname>Ferrantini</surname> <given-names>C</given-names></name><name><surname>Yao</surname> <given-names>L</given-names></name><name><surname>Fan</surname> <given-names>P</given-names></name><name><surname>Del Lungo</surname> <given-names>M</given-names></name><name><surname>Stillitano</surname> <given-names>F</given-names></name><name><surname>Sartiani</surname> <given-names>L</given-names></name><name><surname>Tosi</surname> <given-names>B</given-names></name><name><surname>Suffredini</surname> <given-names>S</given-names></name><name><surname>Tesi</surname> <given-names>C</given-names></name><name><surname>Yacoub</surname> <given-names>M</given-names></name><name><surname>Olivotto</surname> <given-names>I</given-names></name><name><surname>Belardinelli</surname> <given-names>L</given-names></name><name><surname>Poggesi</surname> <given-names>C</given-names></name><name><surname>Cerbai</surname> <given-names>E</given-names></name><name><surname>Mugelli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy</article-title><source>Circulation</source><volume>127</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.134932</pub-id><pub-id pub-id-type="pmid">23271797</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coronel</surname> <given-names>R</given-names></name><name><surname>Janse</surname> <given-names>MJ</given-names></name><name><surname>Opthof</surname> <given-names>T</given-names></name><name><surname>Wilde</surname> <given-names>AA</given-names></name><name><surname>Taggart</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period</article-title><source>Heart Rhythm</source><volume>9</volume><fpage>977</fpage><lpage>982</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2012.01.021</pub-id><pub-id pub-id-type="pmid">22293142</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crumb</surname> <given-names>WJ</given-names></name><name><surname>Vicente</surname> <given-names>J</given-names></name><name><surname>Johannesen</surname> <given-names>L</given-names></name><name><surname>Strauss</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel</article-title><source>Journal of Pharmacological and Toxicological Methods</source><volume>81</volume><fpage>251</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.vascn.2016.03.009</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Deb</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2001">2001</year><source>Multi-Objective Optimization Using Evolutionary Algorithms: An Introduction (Wiley-Interscience Series in Systems and Optimization</source><publisher-name>Wiley</publisher-name></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhamoon</surname> <given-names>AS</given-names></name><name><surname>Jalife</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The inward rectifier current (IK1) controls cardiac excitability and is involved in arrhythmogenesis</article-title><source>Heart Rhythm</source><volume>2</volume><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2004.11.012</pub-id><pub-id pub-id-type="pmid">15851327</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drouin</surname> <given-names>E</given-names></name><name><surname>Charpentier</surname> <given-names>F</given-names></name><name><surname>Gauthier</surname> <given-names>C</given-names></name><name><surname>Laurent</surname> <given-names>K</given-names></name><name><surname>Le Marec</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells</article-title><source>Journal of the American College of Cardiology</source><volume>26</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(95)00167-X</pub-id><pub-id pub-id-type="pmid">7797750</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durrer</surname> <given-names>D</given-names></name><name><surname>van Dam</surname> <given-names>RT</given-names></name><name><surname>Freud</surname> <given-names>GE</given-names></name><name><surname>Janse</surname> <given-names>MJ</given-names></name><name><surname>Meijler</surname> <given-names>FL</given-names></name><name><surname>Arzbaecher</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="1970">1970</year><article-title>Total excitation of the isolated human heart</article-title><source>Circulation</source><volume>41</volume><fpage>899</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.41.6.899</pub-id><pub-id pub-id-type="pmid">5482907</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname> <given-names>S</given-names></name><name><surname>Mincholé</surname> <given-names>A</given-names></name><name><surname>Zacur</surname> <given-names>E</given-names></name><name><surname>Quinn</surname> <given-names>TA</given-names></name><name><surname>Taggart</surname> <given-names>P</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Early afterdepolarizations promote transmural reentry in ischemic human ventricles with reduced repolarization reserve</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>120</volume><fpage>236</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2016.01.008</pub-id><pub-id pub-id-type="pmid">26850675</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname> <given-names>S</given-names></name><name><surname>Chang</surname> <given-names>KC</given-names></name><name><surname>Beattie</surname> <given-names>KA</given-names></name><name><surname>Sheng</surname> <given-names>J</given-names></name><name><surname>Tran</surname> <given-names>PN</given-names></name><name><surname>Wu</surname> <given-names>WW</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Strauss</surname> <given-names>DG</given-names></name><name><surname>Colatsky</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Optimization of an <italic>in silico</italic> Cardiac Cell Model for Proarrhythmia Risk Assessment</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>616</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00616</pub-id><pub-id pub-id-type="pmid">28878692</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname> <given-names>S</given-names></name><name><surname>Mincholé</surname> <given-names>A</given-names></name><name><surname>Quinn</surname> <given-names>TA</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Electrophysiological properties of computational human ventricular cell action potential models under acute ischemic conditions</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>129</volume><fpage>40</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2017.02.007</pub-id><pub-id pub-id-type="pmid">28223156</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engblom</surname> <given-names>H</given-names></name><name><surname>Foster</surname> <given-names>JE</given-names></name><name><surname>Martin</surname> <given-names>TN</given-names></name><name><surname>Groenning</surname> <given-names>B</given-names></name><name><surname>Pahlm</surname> <given-names>O</given-names></name><name><surname>Dargie</surname> <given-names>HJ</given-names></name><name><surname>Wagner</surname> <given-names>GS</given-names></name><name><surname>Arheden</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The relationship between electrical Axis by 12-lead electrocardiogram and anatomical Axis of the heart by cardiac magnetic resonance in healthy subjects</article-title><source>American Heart Journal</source><volume>150</volume><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2004.10.041</pub-id><pub-id pub-id-type="pmid">16169332</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname> <given-names>MR</given-names></name><name><surname>Swerdlow</surname> <given-names>CD</given-names></name><name><surname>Liem</surname> <given-names>LB</given-names></name><name><surname>Schaefer</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies</article-title><source>Journal of Clinical Investigation</source><volume>82</volume><fpage>972</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1172/JCI113706</pub-id><pub-id pub-id-type="pmid">3417875</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fülöp</surname> <given-names>L</given-names></name><name><surname>Bányász</surname> <given-names>T</given-names></name><name><surname>Magyar</surname> <given-names>J</given-names></name><name><surname>Szentandrássy</surname> <given-names>N</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Nánási</surname> <given-names>PP</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Reopening of L-type calcium channels in human ventricular myocytes during applied epicardial action potentials</article-title><source>Acta Physiologica Scandinavica</source><volume>180</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1046/j.0001-6772.2003.01223.x</pub-id><pub-id pub-id-type="pmid">14706111</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garny</surname> <given-names>A</given-names></name><name><surname>Hunter</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>OpenCOR: a modular and interoperable approach to computational biology</article-title><source>Frontiers in Physiology</source><volume>6</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2015.00026</pub-id><pub-id pub-id-type="pmid">25705192</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibor</surname> <given-names>G</given-names></name><name><surname>Yakubovich</surname> <given-names>D</given-names></name><name><surname>Peretz</surname> <given-names>A</given-names></name><name><surname>Attali</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>External barium affects the gating of KCNQ1 potassium channels and produces a pore block via two discrete sites</article-title><source>The Journal of General Physiology</source><volume>124</volume><fpage>83</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1085/jgp.200409068</pub-id><pub-id pub-id-type="pmid">15226366</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gima</surname> <given-names>K</given-names></name><name><surname>Rudy</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Ionic current basis of electrocardiographic waveforms: a model study</article-title><source>Circulation Research</source><volume>90</volume><fpage>889</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000016960.61087.86</pub-id><pub-id pub-id-type="pmid">11988490</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberger</surname> <given-names>AL</given-names></name><name><surname>Amaral</surname> <given-names>LAN</given-names></name><name><surname>Glass</surname> <given-names>L</given-names></name><name><surname>Hausdorff</surname> <given-names>JM</given-names></name><name><surname>Ivanov</surname> <given-names>PC</given-names></name><name><surname>Mark</surname> <given-names>RG</given-names></name><name><surname>Mietus</surname> <given-names>JE</given-names></name><name><surname>Moody</surname> <given-names>GB</given-names></name><name><surname>Peng</surname> <given-names>C-K</given-names></name><name><surname>Stanley</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>PhysioBank, PhysioToolkit, and PhysioNet</article-title><source>Circulation</source><volume>101</volume><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.23.e215</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname> <given-names>SS</given-names></name><name><surname>Kukin</surname> <given-names>ML</given-names></name><name><surname>Medina</surname> <given-names>N</given-names></name><name><surname>Yushak</surname> <given-names>M</given-names></name><name><surname>Packer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Comparative hemodynamic effects of procainamide, Tocainide, and encainide in severe chronic heart failure</article-title><source>Circulation</source><volume>81</volume><fpage>860</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.81.3.860</pub-id><pub-id pub-id-type="pmid">2106401</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grandi</surname> <given-names>E</given-names></name><name><surname>Pasqualini</surname> <given-names>FS</given-names></name><name><surname>Bers</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A novel computational model of the human ventricular action potential and ca transient</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>48</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.09.019</pub-id><pub-id pub-id-type="pmid">19835882</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Liu</surname> <given-names>T</given-names></name><name><surname>Elliott</surname> <given-names>G</given-names></name><name><surname>Gingras</surname> <given-names>M</given-names></name><name><surname>Kowey</surname> <given-names>PR</given-names></name><name><surname>Yan</surname> <given-names>GX</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes</article-title><source>Journal of Cardiovascular Pharmacology</source><volume>57</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1097/FJC.0b013e3181ffe8b3</pub-id><pub-id pub-id-type="pmid">20980921</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinch</surname> <given-names>R</given-names></name><name><surname>Greenstein</surname> <given-names>JL</given-names></name><name><surname>Tanskanen</surname> <given-names>AJ</given-names></name><name><surname>Xu</surname> <given-names>L</given-names></name><name><surname>Winslow</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A simplified local control model of calcium-induced calcium release in cardiac ventricular myocytes</article-title><source>Biophysical Journal</source><volume>87</volume><fpage>3723</fpage><lpage>3736</lpage><pub-id pub-id-type="doi">10.1529/biophysj.104.049973</pub-id><pub-id pub-id-type="pmid">15465866</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname> <given-names>B</given-names></name><name><surname>Banyasz</surname> <given-names>T</given-names></name><name><surname>Jian</surname> <given-names>Z</given-names></name><name><surname>Hegyi</surname> <given-names>B</given-names></name><name><surname>Kistamas</surname> <given-names>K</given-names></name><name><surname>Nanasi</surname> <given-names>PP</given-names></name><name><surname>Izu</surname> <given-names>LT</given-names></name><name><surname>Chen-Izu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dynamics of the late na(+) current during cardiac action potential and its contribution to afterdepolarizations</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>64</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2013.08.010</pub-id><pub-id pub-id-type="pmid">24012538</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hund</surname> <given-names>TJ</given-names></name><name><surname>Decker</surname> <given-names>KF</given-names></name><name><surname>Kanter</surname> <given-names>E</given-names></name><name><surname>Mohler</surname> <given-names>PJ</given-names></name><name><surname>Boyden</surname> <given-names>PA</given-names></name><name><surname>Schuessler</surname> <given-names>RB</given-names></name><name><surname>Yamada</surname> <given-names>KA</given-names></name><name><surname>Rudy</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Role of activated CaMKII in abnormal calcium homeostasis and I(Na) remodeling after myocardial infarction: insights from mathematical modeling</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>45</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.06.007</pub-id><pub-id pub-id-type="pmid">18639555</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jost</surname> <given-names>N</given-names></name><name><surname>Virág</surname> <given-names>L</given-names></name><name><surname>Comtois</surname> <given-names>P</given-names></name><name><surname>Ordög</surname> <given-names>B</given-names></name><name><surname>Szuts</surname> <given-names>V</given-names></name><name><surname>Seprényi</surname> <given-names>G</given-names></name><name><surname>Bitay</surname> <given-names>M</given-names></name><name><surname>Kohajda</surname> <given-names>Z</given-names></name><name><surname>Koncz</surname> <given-names>I</given-names></name><name><surname>Nagy</surname> <given-names>N</given-names></name><name><surname>Szél</surname> <given-names>T</given-names></name><name><surname>Magyar</surname> <given-names>J</given-names></name><name><surname>Kovács</surname> <given-names>M</given-names></name><name><surname>Puskás</surname> <given-names>LG</given-names></name><name><surname>Lengyel</surname> <given-names>C</given-names></name><name><surname>Wettwer</surname> <given-names>E</given-names></name><name><surname>Ravens</surname> <given-names>U</given-names></name><name><surname>Nánási</surname> <given-names>PP</given-names></name><name><surname>Papp</surname> <given-names>JG</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Nattel</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs</article-title><source>The Journal of Physiology</source><volume>591</volume><fpage>4189</fpage><lpage>4206</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2013.261198</pub-id><pub-id pub-id-type="pmid">23878377</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname> <given-names>ML</given-names></name><name><surname>Maier</surname> <given-names>SK</given-names></name><name><surname>Gelzer</surname> <given-names>AR</given-names></name><name><surname>Bauer</surname> <given-names>WR</given-names></name><name><surname>Meesmann</surname> <given-names>M</given-names></name><name><surname>Gilmour</surname> <given-names>RF</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Altered dynamics of action potential restitution and alternans in humans with structural heart disease</article-title><source>Circulation</source><volume>112</volume><fpage>1542</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.502831</pub-id><pub-id pub-id-type="pmid">16157783</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristóf</surname> <given-names>A</given-names></name><name><surname>Husti</surname> <given-names>Z</given-names></name><name><surname>Koncz</surname> <given-names>I</given-names></name><name><surname>Kohajda</surname> <given-names>Z</given-names></name><name><surname>Szél</surname> <given-names>T</given-names></name><name><surname>Juhász</surname> <given-names>V</given-names></name><name><surname>Biliczki</surname> <given-names>P</given-names></name><name><surname>Jost</surname> <given-names>N</given-names></name><name><surname>Baczkó</surname> <given-names>I</given-names></name><name><surname>Papp</surname> <given-names>JG</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Virág</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e53255</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053255</pub-id><pub-id pub-id-type="pmid">23300901</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lancaster</surname> <given-names>MC</given-names></name><name><surname>Sobie</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Improved prediction of Drug-Induced torsades de pointes through simulations of dynamics and machine learning algorithms</article-title><source>Clinical Pharmacology &amp; Therapeutics</source><volume>100</volume><fpage>371</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1002/cpt.367</pub-id><pub-id pub-id-type="pmid">26950176</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legrand</surname> <given-names>V</given-names></name><name><surname>Vandormael</surname> <given-names>M</given-names></name><name><surname>Collignon</surname> <given-names>P</given-names></name><name><surname>Kulbertus</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease</article-title><source>The American Journal of Cardiology</source><volume>51</volume><fpage>422</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(83)80073-3</pub-id><pub-id pub-id-type="pmid">6823856</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linz</surname> <given-names>KW</given-names></name><name><surname>Meyer</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Profile and kinetics of L-type calcium current during the cardiac ventricular action potential compared in guinea-pigs, rats and rabbits</article-title><source>PflGers Archiv European Journal of Physiology</source><volume>439</volume><fpage>588</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1007/s004240050982</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Mahaut-Smith</surname> <given-names>MP</given-names></name><name><surname>Varghese</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>CL</given-names></name><name><surname>Kemp</surname> <given-names>PR</given-names></name><name><surname>Vandenberg</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Effects of premature stimulation on HERG K(+) channels</article-title><source>The Journal of Physiology</source><volume>537</volume><fpage>843</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2001.012690</pub-id><pub-id pub-id-type="pmid">11744759</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>CH</given-names></name><name><surname>Rudy</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>A dynamic model of the cardiac ventricular action potential. II. afterdepolarizations, triggered activity, and potentiation</article-title><source>Circulation Research</source><volume>74</volume><fpage>1097</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1161/01.RES.74.6.1097</pub-id><pub-id pub-id-type="pmid">7514510</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname> <given-names>A</given-names></name><name><surname>Ariga</surname> <given-names>R</given-names></name><name><surname>Mincholé</surname> <given-names>A</given-names></name><name><surname>Mahmod</surname> <given-names>M</given-names></name><name><surname>Ormondroyd</surname> <given-names>E</given-names></name><name><surname>Laguna</surname> <given-names>P</given-names></name><name><surname>de Freitas</surname> <given-names>N</given-names></name><name><surname>Neubauer</surname> <given-names>S</given-names></name><name><surname>Watkins</surname> <given-names>H</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>213</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00213</pub-id><pub-id pub-id-type="pmid">29593570</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magyar</surname> <given-names>J</given-names></name><name><surname>Iost</surname> <given-names>N</given-names></name><name><surname>Körtvély</surname> <given-names>Á.</given-names></name><name><surname>Bányász</surname> <given-names>T</given-names></name><name><surname>Virág</surname> <given-names>L</given-names></name><name><surname>Szigligeti</surname> <given-names>P</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Opincariu</surname> <given-names>M</given-names></name><name><surname>Szécsi</surname> <given-names>J</given-names></name><name><surname>Papp</surname> <given-names>JG</given-names></name><name><surname>Nánási</surname> <given-names>PP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes</article-title><source>Pflügers Archiv</source><volume>441</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1007/s004240000400</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magyar</surname> <given-names>J</given-names></name><name><surname>Horváth</surname> <given-names>B</given-names></name><name><surname>Váczi</surname> <given-names>K</given-names></name><name><surname>Hegyi</surname> <given-names>B</given-names></name><name><surname>Gönczi</surname> <given-names>M</given-names></name><name><surname>Dienes</surname> <given-names>B</given-names></name><name><surname>Kistamás</surname> <given-names>K</given-names></name><name><surname>Bányász</surname> <given-names>T</given-names></name><name><surname>Baczkó</surname> <given-names>I</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Seprényi</surname> <given-names>G</given-names></name><name><surname>Csernoch</surname> <given-names>L</given-names></name><name><surname>Nánási</surname> <given-names>PP</given-names></name><name><surname>Szentandrássy</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Calcium activated chloride current in mammalian ventricular myocytes</article-title><source>Biophysical Journal</source><volume>112</volume><elocation-id>36a</elocation-id><pub-id pub-id-type="doi">10.1016/j.bpj.2016.11.227</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahajan</surname> <given-names>A</given-names></name><name><surname>Shiferaw</surname> <given-names>Y</given-names></name><name><surname>Sato</surname> <given-names>D</given-names></name><name><surname>Baher</surname> <given-names>A</given-names></name><name><surname>Olcese</surname> <given-names>R</given-names></name><name><surname>Xie</surname> <given-names>LH</given-names></name><name><surname>Yang</surname> <given-names>MJ</given-names></name><name><surname>Chen</surname> <given-names>PS</given-names></name><name><surname>Restrepo</surname> <given-names>JG</given-names></name><name><surname>Karma</surname> <given-names>A</given-names></name><name><surname>Garfinkel</surname> <given-names>A</given-names></name><name><surname>Qu</surname> <given-names>Z</given-names></name><name><surname>Weiss</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart rates</article-title><source>Biophysical Journal</source><volume>94</volume><fpage>392</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1529/biophysj.106.98160</pub-id><pub-id pub-id-type="pmid">18160660</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makielski</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Late sodium current: a mechanism for angina, heart failure, and arrhythmia</article-title><source>Trends in Cardiovascular Medicine</source><volume>26</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2015.05.006</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mincholé</surname> <given-names>A</given-names></name><name><surname>Zacur</surname> <given-names>E</given-names></name><name><surname>Ariga</surname> <given-names>R</given-names></name><name><surname>Grau</surname> <given-names>V</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MRI-Based computational torso/Biventricular multiscale models to investigate the impact of anatomical variability on the ECG QRS complex</article-title><source>Frontiers in Physiology</source><volume>10</volume><elocation-id>1103</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2019.01103</pub-id><pub-id pub-id-type="pmid">31507458</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mortimer</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="2008">2008</year><chapter-title><italic>The Activities of Nonvolatile Solutes</italic></chapter-title><source>Physical Chemistry</source><volume>274</volume><edition>3rd Edition</edition><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muszkiewicz</surname> <given-names>A</given-names></name><name><surname>Britton</surname> <given-names>OJ</given-names></name><name><surname>Gemmell</surname> <given-names>P</given-names></name><name><surname>Passini</surname> <given-names>E</given-names></name><name><surname>Sánchez</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Carusi</surname> <given-names>A</given-names></name><name><surname>Quinn</surname> <given-names>TA</given-names></name><name><surname>Burrage</surname> <given-names>K</given-names></name><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Variability in cardiac electrophysiology: using experimentally-calibrated populations of models to move beyond the single virtual physiological human paradigm</article-title><source>Progress in Biophysics and Molecular Biology</source><volume>120</volume><fpage>115</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2015.12.002</pub-id><pub-id pub-id-type="pmid">26701222</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagatomo</surname> <given-names>T</given-names></name><name><surname>January</surname> <given-names>CT</given-names></name><name><surname>Makielski</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) Antiarrhythmic flecainide</article-title><source>Molecular Pharmacology</source><volume>57</volume><fpage>101</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">10617684</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolasco</surname> <given-names>JB</given-names></name><name><surname>Dahlen</surname> <given-names>RW</given-names></name></person-group><year iso-8601-date="1968">1968</year><article-title>A graphic method for the study of alternation in cardiac action potentials</article-title><source>Journal of Applied Physiology</source><volume>25</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1152/jappl.1968.25.2.191</pub-id><pub-id pub-id-type="pmid">5666097</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hara</surname> <given-names>T</given-names></name><name><surname>Virág</surname> <given-names>L</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Rudy</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation</article-title><source>PLOS Computational Biology</source><volume>7</volume><elocation-id>e1002061</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002061</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname> <given-names>J</given-names></name><name><surname>Washio</surname> <given-names>T</given-names></name><name><surname>Maehara</surname> <given-names>A</given-names></name><name><surname>Momomura</surname> <given-names>S</given-names></name><name><surname>Sugiura</surname> <given-names>S</given-names></name><name><surname>Hisada</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transmural and apicobasal gradients in repolarization contribute to T-wave genesis in human surface ECG</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>301</volume><fpage>200</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01241.2010</pub-id><pub-id pub-id-type="pmid">21460196</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappalardo</surname> <given-names>F</given-names></name><name><surname>Russo</surname> <given-names>G</given-names></name><name><surname>Tshinanu</surname> <given-names>FM</given-names></name><name><surname>Viceconti</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>In silico clinical trials: concepts and early adoptions</article-title><source>Briefings in Bioinformatics</source><volume>20</volume><fpage>1699</fpage><lpage>1708</lpage><pub-id pub-id-type="doi">10.1093/bib/bby043</pub-id><pub-id pub-id-type="pmid">29868882</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passini</surname> <given-names>E</given-names></name><name><surname>Mincholé</surname> <given-names>A</given-names></name><name><surname>Coppini</surname> <given-names>R</given-names></name><name><surname>Cerbai</surname> <given-names>E</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name><name><surname>Severi</surname> <given-names>S</given-names></name><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>96</volume><fpage>72</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.09.003</pub-id><pub-id pub-id-type="pmid">26385634</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passini</surname> <given-names>E</given-names></name><name><surname>Britton</surname> <given-names>OJ</given-names></name><name><surname>Lu</surname> <given-names>HR</given-names></name><name><surname>Rohrbacher</surname> <given-names>J</given-names></name><name><surname>Hermans</surname> <given-names>AN</given-names></name><name><surname>Gallacher</surname> <given-names>DJ</given-names></name><name><surname>Greig</surname> <given-names>RJH</given-names></name><name><surname>Bueno-Orovio</surname> <given-names>A</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human <italic>in Silico</italic> Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity</article-title><source>Frontiers in Physiology</source><volume>8</volume><elocation-id>668</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2017.00668</pub-id><pub-id pub-id-type="pmid">28955244</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passini</surname> <given-names>E</given-names></name><name><surname>Severi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Computational analysis of extracellular calcium effect on action potential duration</article-title><source>Biophysical Journal</source><volume>106</volume><elocation-id>721a</elocation-id><pub-id pub-id-type="doi">10.1016/j.bpj.2013.11.3985</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathmanathan</surname> <given-names>P</given-names></name><name><surname>Gray</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Validation and trustworthiness of multiscale models of cardiac electrophysiology</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.00106</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitt-Francis</surname> <given-names>J</given-names></name><name><surname>Pathmanathan</surname> <given-names>P</given-names></name><name><surname>Bernabeu</surname> <given-names>MO</given-names></name><name><surname>Bordas</surname> <given-names>R</given-names></name><name><surname>Cooper</surname> <given-names>J</given-names></name><name><surname>Fletcher</surname> <given-names>AG</given-names></name><name><surname>Mirams</surname> <given-names>GR</given-names></name><name><surname>Murray</surname> <given-names>P</given-names></name><name><surname>Osborne</surname> <given-names>JM</given-names></name><name><surname>Walter</surname> <given-names>A</given-names></name><name><surname>Chapman</surname> <given-names>SJ</given-names></name><name><surname>Garny</surname> <given-names>A</given-names></name><name><surname>van Leeuwen</surname> <given-names>IMM</given-names></name><name><surname>Maini</surname> <given-names>PK</given-names></name><name><surname>Rodríguez</surname> <given-names>B</given-names></name><name><surname>Waters</surname> <given-names>SL</given-names></name><name><surname>Whiteley</surname> <given-names>JP</given-names></name><name><surname>Byrne</surname> <given-names>HM</given-names></name><name><surname>Gavaghan</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Chaste: a test-driven approach to software development for biological modelling</article-title><source>Computer Physics Communications</source><volume>180</volume><fpage>2452</fpage><lpage>2471</lpage><pub-id pub-id-type="doi">10.1016/j.cpc.2009.07.019</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruvot</surname> <given-names>EJ</given-names></name><name><surname>Katra</surname> <given-names>RP</given-names></name><name><surname>Rosenbaum</surname> <given-names>DS</given-names></name><name><surname>Laurita</surname> <given-names>KR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Role of calcium cycling versus restitution in the mechanism of repolarization alternans</article-title><source>Circulation Research</source><volume>94</volume><fpage>1083</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000125629.72053.95</pub-id><pub-id pub-id-type="pmid">15016735</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname> <given-names>J</given-names></name><name><surname>Boyden</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Alterations of na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness</article-title><source>Circulation Research</source><volume>81</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1161/01.res.81.1.110</pub-id><pub-id pub-id-type="pmid">9201034</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pueyo</surname> <given-names>E</given-names></name><name><surname>Smetana</surname> <given-names>P</given-names></name><name><surname>Caminal</surname> <given-names>P</given-names></name><name><surname>deLuna</surname> <given-names>AB</given-names></name><name><surname>Malik</surname> <given-names>M</given-names></name><name><surname>Laguna</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Characterization of QT interval adaptation to RR interval changes and its use as a Risk-Stratifier of arrhythmic mortality in Amiodarone-Treated survivors of acute myocardial infarction</article-title><source>IEEE Transactions on Biomedical Engineering</source><volume>51</volume><fpage>1511</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1109/TBME.2004.828050</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pueyo</surname> <given-names>E</given-names></name><name><surname>Husti</surname> <given-names>Z</given-names></name><name><surname>Hornyik</surname> <given-names>T</given-names></name><name><surname>Baczkó</surname> <given-names>I</given-names></name><name><surname>Laguna</surname> <given-names>P</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Rodríguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>298</volume><fpage>H1577</fpage><lpage>H1587</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00936.2009</pub-id><pub-id pub-id-type="pmid">20207815</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pueyo</surname> <given-names>E</given-names></name><name><surname>Corrias</surname> <given-names>A</given-names></name><name><surname>Virág</surname> <given-names>L</given-names></name><name><surname>Jost</surname> <given-names>N</given-names></name><name><surname>Szél</surname> <given-names>T</given-names></name><name><surname>Varró</surname> <given-names>A</given-names></name><name><surname>Szentandrássy</surname> <given-names>N</given-names></name><name><surname>Nánási</surname> <given-names>PP</given-names></name><name><surname>Burrage</surname> <given-names>K</given-names></name><name><surname>Rodríguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A multiscale investigation of repolarization variability and its role in cardiac arrhythmogenesis</article-title><source>Biophysical Journal</source><volume>101</volume><fpage>2892</fpage><lpage>2902</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2011.09.060</pub-id><pub-id pub-id-type="pmid">22208187</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>P</given-names></name><name><surname>Griffiths</surname> <given-names>PJ</given-names></name><name><surname>Watkins</surname> <given-names>H</given-names></name><name><surname>Redwood</surname> <given-names>CS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments</article-title><source>Circulation Research</source><volume>101</volume><fpage>1266</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.156380</pub-id><pub-id pub-id-type="pmid">17932326</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scriven</surname> <given-names>DR</given-names></name><name><surname>Asghari</surname> <given-names>P</given-names></name><name><surname>Schulson</surname> <given-names>MN</given-names></name><name><surname>Moore</surname> <given-names>ED</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Analysis of Cav1.2 and ryanodine receptor clusters in rat ventricular myocytes</article-title><source>Biophysical Journal</source><volume>99</volume><fpage>3923</fpage><lpage>3929</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2010.11.008</pub-id><pub-id pub-id-type="pmid">21156134</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname> <given-names>TR</given-names></name><name><surname>Wang</surname> <given-names>F</given-names></name><name><surname>Puglisi</surname> <given-names>J</given-names></name><name><surname>Weber</surname> <given-names>C</given-names></name><name><surname>Bers</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A mathematical treatment of integrated ca dynamics within the ventricular myocyte</article-title><source>Biophysical Journal</source><volume>87</volume><fpage>3351</fpage><lpage>3371</lpage><pub-id pub-id-type="doi">10.1529/biophysj.104.047449</pub-id><pub-id pub-id-type="pmid">15347581</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Theory of excitation-contraction coupling in cardiac muscle</article-title><source>Biophysical Journal</source><volume>63</volume><fpage>497</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(92)81615-6</pub-id><pub-id pub-id-type="pmid">1330031</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streeter</surname> <given-names>DD</given-names></name><name><surname>Spotnitz</surname> <given-names>HM</given-names></name><name><surname>Patel</surname> <given-names>DP</given-names></name><name><surname>Ross</surname> <given-names>J</given-names></name><name><surname>Sonnenblick</surname> <given-names>EH</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Fiber orientation in the canine left ventricle during diastole and Systole</article-title><source>Circulation Research</source><volume>24</volume><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1161/01.RES.24.3.339</pub-id><pub-id pub-id-type="pmid">5766515</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taggart</surname> <given-names>P</given-names></name><name><surname>Sutton</surname> <given-names>PM</given-names></name><name><surname>Opthof</surname> <given-names>T</given-names></name><name><surname>Coronel</surname> <given-names>R</given-names></name><name><surname>Trimlett</surname> <given-names>R</given-names></name><name><surname>Pugsley</surname> <given-names>W</given-names></name><name><surname>Kallis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Inhomogeneous transmural conduction during early ischaemia in patients with coronary artery disease</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>32</volume><fpage>621</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1006/jmcc.2000.1105</pub-id><pub-id pub-id-type="pmid">10756118</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taggart</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia</article-title><source>Cardiovascular Research</source><volume>50</volume><fpage>454</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/S0008-6363(01)00223-1</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomek</surname> <given-names>J</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name><name><surname>Bub</surname> <given-names>G</given-names></name><name><surname>Heijman</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>β-Adrenergic receptor stimulation inhibits proarrhythmic alternans in postinfarction border zone cardiomyocytes: a computational analysis</article-title><source>American Journal of Physiology-Heart and Circulatory Physiology</source><volume>313</volume><fpage>H338</fpage><lpage>H353</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00094.2017</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomek</surname> <given-names>J</given-names></name><name><surname>Tomková</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Bub</surname> <given-names>G</given-names></name><name><surname>Rodriguez</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modulation of cardiac alternans by altered sarcoplasmic reticulum calcium release: a simulation study</article-title><source>Frontiers in Physiology</source><volume>9</volume><elocation-id>1306</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2018.01306</pub-id><pub-id pub-id-type="pmid">30283355</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Tomek</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Repository for the cardiac model ToR-ORd</data-title><source>GitHub</source><version designator="4ffab13">4ffab13</version><ext-link ext-link-type="uri" xlink:href="https://github.com/jtmff/torord">https://github.com/jtmff/torord</ext-link></element-citation></ref><ref id="bib79"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Torres</surname> <given-names>A</given-names></name><name><surname>Torres</surname> <given-names>D</given-names></name><name><surname>Enriquez</surname> <given-names>S</given-names></name><name><surname>León</surname> <given-names>EPde</given-names></name><name><surname>Díaz</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><chapter-title>Evolutionary Multi-Objective Algorithms</chapter-title><source>Real-World Applications of Genetic Algorithms</source><publisher-name>In Tech</publisher-name></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname> <given-names>CR</given-names></name><name><surname>Winkle</surname> <given-names>RA</given-names></name><name><surname>Peters</surname> <given-names>FA</given-names></name><name><surname>Harrison</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Acute hemodynamic effects of intravenous encainide in patients with heart disease</article-title><source>American Heart Journal</source><volume>104</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(82)90194-6</pub-id><pub-id pub-id-type="pmid">6808816</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Oosterom</surname> <given-names>A</given-names></name><name><surname>Hoekema</surname> <given-names>R</given-names></name><name><surname>Uijen</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Geometrical factors affecting the interindividual variability of the ECG and the VCG</article-title><source>Journal of Electrocardiology</source><volume>33 Suppl</volume><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1054/jelc.2000.20356</pub-id><pub-id pub-id-type="pmid">11265725</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weerapura</surname> <given-names>M</given-names></name><name><surname>Nattel</surname> <given-names>S</given-names></name><name><surname>Courtemanche</surname> <given-names>M</given-names></name><name><surname>Doern</surname> <given-names>D</given-names></name><name><surname>Ethier</surname> <given-names>N</given-names></name><name><surname>Hébert</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>State‐dependent barium block of wild‐type and inactivation‐deficient HERG channels in <italic>xenopus</italic> oocytes</article-title><source>The Journal of Physiology</source><volume>526</volume><fpage>265</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.t01-1-00265.x</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>JN</given-names></name><name><surname>Karma</surname> <given-names>A</given-names></name><name><surname>Shiferaw</surname> <given-names>Y</given-names></name><name><surname>Chen</surname> <given-names>PS</given-names></name><name><surname>Garfinkel</surname> <given-names>A</given-names></name><name><surname>Qu</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>From pulsus to pulseless: the Saga of cardiac alternans</article-title><source>Circulation Research</source><volume>98</volume><fpage>1244</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000224540.97431.f0</pub-id><pub-id pub-id-type="pmid">16728670</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname> <given-names>JN</given-names></name><name><surname>Garfinkel</surname> <given-names>A</given-names></name><name><surname>Karagueuzian</surname> <given-names>HS</given-names></name><name><surname>Chen</surname> <given-names>PS</given-names></name><name><surname>Qu</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Early afterdepolarizations and cardiac arrhythmias</article-title><source>Heart Rhythm</source><volume>7</volume><fpage>1891</fpage><lpage>1899</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2010.09.017</pub-id><pub-id pub-id-type="pmid">20868774</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Woosley</surname> <given-names>RL</given-names></name><name><surname>Romero</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>QTdrugs list</data-title><ext-link ext-link-type="uri" xlink:href="https://www.crediblemeds.org">https://www.crediblemeds.org</ext-link></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacchia</surname> <given-names>M</given-names></name><name><surname>Abategiovanni</surname> <given-names>ML</given-names></name><name><surname>Stratigis</surname> <given-names>S</given-names></name><name><surname>Capasso</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Potassium: from physiology to clinical implications</article-title><source>Kidney Diseases</source><volume>2</volume><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1159/000446268</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><boxed-text><sec id="s7" sec-type="appendix"><title>1. Calibration criteria</title><p>This section provides additional information to the criteria listed in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>The AP morphology was based primarily on the large experimental dataset of human undiseased endocardial recordings from the Varró lab, published in <xref ref-type="bibr" rid="bib7">Britton et al. (2017)</xref>. The ORd model (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>) was based on a subset of these recordings. We aimed for similarity with the median of the AP data during the plateau and repolarization phase (from 15 ms after the AP peak). Two other datasets were used to confirm that early plateau potentials are ca. 20 mV, rather than the &gt;30 mV as in ORd (<xref ref-type="bibr" rid="bib15">Coppini et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Jost et al., 2013</xref>).</p><p>The calcium transient morphology (CaT amplitude and duration at 90% recovery) was based on <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>, particularly given it is clear that the AP morphology is similar in their experimental recordings and the simulations with the TOR-ORd model. The aim was for the two CaT properties to lie within standard deviation of mean. A correction for the difference in APD with regards to CaT amplitude was made in Appendix 1-8.</p><p>The properties of I<sub>CaL</sub>, the I-V relationship and steady-state inactivation were taken as reported in <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref>, as this is the primary dataset used in the ORd I<sub>CaL</sub> construction. Visual assessment of simulations versus data was used.</p><p>Negative inotropy of sodium blockers was based on <xref ref-type="bibr" rid="bib32">Gottlieb et al. (1990)</xref>; <xref ref-type="bibr" rid="bib80">Tucker et al. (1982)</xref>; <xref ref-type="bibr" rid="bib42">Legrand et al. (1983)</xref>; <xref ref-type="bibr" rid="bib2">Bhattacharyya and Vassalle (1982)</xref>, which report 8–28% reduction in whole-heart contractility, depending on drug, dose and index of contractility. Given the variability, throughout the calibration of a single-cell model, we aimed for any reduction in CaT amplitude following 50% reduction of I<sub>Na</sub> and I<sub>NaL</sub>.</p><p>The blockade of I<sub>CaL</sub> is known to shorten APD across species, including human (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). Within the process of calibration, we aimed for any APD shortening at 50% I<sub>CaL</sub> reduction.</p><p>EADs were shown to form under ca. 85% I<sub>Kr</sub> block in human myocytes at 0.25 Hz pacing (<xref ref-type="bibr" rid="bib34">Guo et al., 2011</xref>). Thus, we aimed for the new model to manifest EADs of similar amplitude as in the data (ca. 14 mV) in corresponding conditions.</p><p>APD alternans was observed in undiseased human cells at rapid pacing (<xref ref-type="bibr" rid="bib39">Koller et al., 2005</xref>). We aimed for a model manifesting APD alternans, with the onset at basic cycle length shorter than 300 ms.</p><p>The reported conduction velocity in human heart is 65 m/s (<xref ref-type="bibr" rid="bib74">Taggart et al., 2000</xref>), and we compared this value to the result of a fibre simulation using the developed ToR-ORd model.</p></sec><sec id="s8" sec-type="appendix"><title>2. Genetic algorithm fitness</title><p>The fitness function has 18 inputs, 16 of which are the multipliers of conductances for the following currents and fluxes: I<sub>Na</sub>, I<sub>CaL</sub>, I<sub>to</sub>, I<sub>NaL</sub>, I<sub>Kr</sub>, I<sub>Ks</sub>, I<sub>K1</sub>, I<sub>Kb</sub>, I<sub>NaCa</sub>, I<sub>NaK</sub>, I<sub>Nab</sub>, I<sub>Cab</sub>, I<sub>pCa</sub>, I<sub>CaCl</sub>, J<sub>rel</sub>, J<sub>up</sub>. Also varied were <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi mathvariant="normal">K</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula><sub>,Rel</sub>, a parameter of J<sub>rel</sub> (constrained between 0.9 and 1.7) and the fraction of I<sub>NaCa</sub> in the junctional subspace (constrained between 0.18 and 0.4).</p><p>If the genetic algorithm (GA) employed symmetric percentual variations of raw current multipliers (e.g., + /- 50%), it would not sample the input space evenly – for example, a symmetric Gaussian mutation is much more likely to halve a parameter than to double it (assuming the Gaussian curve being centred at 1, the density in 0.5 is the same as in 1.5, but not in 2), while the likelihood should be arguably the same. The initial population would also likely be highly skewed towards current reduction. In order to avoid these issues, we made the GA work internally with logarithms of multipliers, which makes the sampling symmetrical (-log(0.5)=log(2), etc.). The fitness function first exponentiates the log-multipliers to obtain the actual multipliers, and these are subsequently used in further simulation.</p><p>Within the fitness function, the evolved model is pre-paced for 130 beats at 1 Hz, with the final state X<sub>130</sub>. Subsequently, 20 more beats are simulated at the following conditions, with X<sub>130</sub> as the starting state: a) no change to parameters, b) sodium blockade (50% I<sub>Na</sub> block, 50% I<sub>NaL</sub> block), c) calcium blockade (50% I<sub>CaL</sub> block), d) I<sub>K1</sub> blockade (50% block). 150 beats in total for the control condition is a compromise between total runtime and similarity to the stable-state behaviour. The 20 beats at various conditions following 130 beats of prepacing are sufficient to manifest the effects of the respective blocks , while keeping the runtime low (When the model is evaluated in the manuscript, the outputs are based on 1000 beats of pre-pacing; the 150 or 130+20 beats are used only during model refitting to allow sufficiently fast runtime.).</p><p>Based on these simulations, a two-element fitness vector is obtained; the first element describes similarity of action potential (AP) morphology to the reference, with the second element aggregating other criteria (calcium transient duration and amplitude, calcium transient amplitude reduction with sodium blockade, action potential duration (APD) reduction with calcium blockade, and a depolarisation with I<sub>K1</sub> block).</p><p>Not all calibration criteria (<xref ref-type="table" rid="table1">Table 1</xref>) were represented in the fitness function, as simulating all corresponding protocols would be prohibitively slow. Instead, the calibration criteria not optimized using the genetic algorithm were subsequently fulfilled by mechanistically informed manual changes, while making sure the already optimised criteria were not violated.</p></sec><sec id="s9" sec-type="appendix"><title>3. Extraction of I<sub>CaL</sub> activation from I-V relationship</title><p>The experimental protocol to measure I-V relationship of the I<sub>CaL</sub> uses square pulse stimuli to measure peak current for different pulse potentials (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>, top left). The peak current can be seen as the product of two components: activation (how open the channels are) and driving force (the strength of the diffusion and electrical gradients that produce ionic flow through the open channels). To obtain the activation value for each pulse potential, the corresponding peak current is divided by the theoretical estimate of the driving force. The resulting curve can then be scaled to 0–1, producing estimated fractional activation (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>, top right). The driving force may be computed based on the linear equation V-E<sub>Ca</sub>, or the nonlinear Goldman-Hodgkin-Katz (GHK) flux equation (<xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>, bottom left and bottom right, respectively). This yields the two corresponding activation curves in <xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref>, top right.</p><fig id="app1fig1" position="float"><label>Appendix 1—figure 1.</label><caption><title>Diagram of how activation curves are extracted from the I-V relationship.</title><p>The activation curves (top right) are obtained by dividing values in the I-V curve (top left) at each pulse potential by the driving force considering either V-E<sub>Ca</sub><bold>-</bold>based driving force (bottom right) or the Goldman-Hodgkin-Katz (GHK) flux equation (bottom left).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig1-v3.tif"/></fig><p><xref ref-type="fig" rid="app1fig1">Appendix 1—figure 1</xref> can be also used to illustrate the theoretical inconsistency in the ORd model and many other models (e.g. <xref ref-type="bibr" rid="bib45">Luo and Rudy, 1994</xref>; <xref ref-type="bibr" rid="bib37">Hund et al., 2008</xref>; <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Shannon et al., 2004</xref>; <xref ref-type="bibr" rid="bib33">Grandi et al., 2010</xref>; <xref ref-type="bibr" rid="bib11">Carro et al., 2011</xref>): the V-E<sub>Ca</sub> driving force is used to obtain the activation curve, but then the I<sub>CaL</sub> is computed using the GHK driving force, which does not yield the original data, as illustrated in the Results section. Returning to the notion of I-V relationship as a product of activation and driving force, the same shape of I-V relationship can be obtained by pointwise multiplication of the blue driving force (bottom, left) with blue activation (top, right), or the red driving force (bottom, right) with red activation (top, right). However, simulating the I-V relationship using the ORd model corresponds to the product of blue activation and the red driving force, which then naturally does not match greatly the original I-V relationship (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, or <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref> in Appendix 1-4).</p><fig id="app1fig2" position="float"><label>Appendix 1—figure 2.</label><caption><title>Effect of the proposed changes in the activation curve and activation coefficient on the I-V relationship of I<sub>CaL</sub> in ORd versus ToR-ORd.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig2-v3.tif"/></fig></sec><sec id="s10" sec-type="appendix"><title>4.I<sub>CaL</sub> updates and the I-V relationship</title><p><xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref> illustrates the effect that updates in activation curve and activation coefficients have on the simulated I<sub>CaL</sub> I-V relationship considering four models:</p><list list-type="bullet"><list-item><p>Control ORd</p></list-item><list-item> <p>ORd with updated activity coefficients as in ToR-ORd (fixed to 0.6532/0.6117 for intracellular/extracellular calcium, 0.89/0.88 for intracellular/extracellular sodium; the same also for potassium)</p> </list-item><list-item><p>ORd with updated activation curve as in ToR-ORd • ToR-ORd model.</p></list-item></list><p>The I-V curves were normalised to a minimum of −1, in order to focus on the shape of the I-V curve rather than its amplitude (which is modulated by maximal conductance). Considering the new activation curve extracted using the GHK equation in the ORd model yields a near-identical I-V curve to the ToR-ORd model (<xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>). This demonstrates this is the key mechanism in the I-V curve improvement. The update of activity coefficients did not alter the shape of the I-V relationship noticeably compared to the ORd model (<xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref>), but played a key role in avoiding the reversal of I<sub>CaL</sub> illustrated in <xref ref-type="fig" rid="fig2">Figure 2F</xref> and a good response to sodium block, as explained in the next section.</p></sec><sec id="s11" sec-type="appendix"><title>5. Extraction of steady-state inactivation of I<sub>CaL</sub></title><p>As shown in <xref ref-type="fig" rid="fig2">Figure 2E</xref> of the main manuscript, the steady-state inactivation curve of the ORd model differs from the experimental data. This is surprising, given that both the steady state voltage and calcium inactivation in the model are a direct fit to the experimental data. The explanation of this phenomenon lies in the construction of the I<sub>CaL</sub> equation in the ORd model, which is as follows (only the non-phosphorylated part is given; the phosphorylated is analogous):<disp-formula id="equ5"><mml:math id="m5"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo> <mml:mi/><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>-</mml:mo></mml:mover><mml:mo>∙</mml:mo><mml:mi>d</mml:mi><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>f</mml:mi><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>n</mml:mi><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula>where <inline-formula><mml:math id="inf7"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> is the product of driving force and channel conductance, <inline-formula><mml:math id="inf8"><mml:mi>d</mml:mi></mml:math></inline-formula> is activation, <inline-formula><mml:math id="inf9"><mml:mi>f</mml:mi></mml:math></inline-formula> is voltage-driven inactivation, <inline-formula><mml:math id="inf10"><mml:mi>n</mml:mi></mml:math></inline-formula> is a weight of calcium inactivation, <inline-formula><mml:math id="inf11"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is calcium-driven inactivation, and <inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> corresponds to recovery from inactivation. In the ORd model, stable-state values of <inline-formula><mml:math id="inf13"><mml:mi>f</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo> <mml:mi/><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are all fit to the steady-state inactivation in <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref>. During a long voltage clamp pulse used to inactivate I<sub>CaL</sub>, <inline-formula><mml:math id="inf14"><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> and <inline-formula><mml:math id="inf15"><mml:mi>d</mml:mi></mml:math></inline-formula> can be assumed to be constant, leaving the remaining parentheses as the factor determining measured inactivation. If <inline-formula><mml:math id="inf16"><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> was equal to 1, then the equation would reduce to the experimentally observed inactivation in the steady state (however, this prevents formation of EADs). However, given that <inline-formula><mml:math id="inf17"><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> effectively acts as a second inactivation, the <inline-formula><mml:math id="inf18"><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>∙</mml:mo> <mml:mi/><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> product corresponds to a square of the experimentally observed inactivation, making the inactivation stronger. Thus, for <inline-formula><mml:math id="inf19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>n</mml:mi><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mstyle></mml:math></inline-formula>, this I<sub>CaL</sub> model manifests total steady-state inactivation stronger than the one from <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref>.</p><p>As shown in <xref ref-type="fig" rid="fig2">Figure 2E</xref> of the main manuscript, this problem is not present in the ToR-ORd model, which yields a better match with experimental data than ORd. Inspecting state variables at the inactivating pulse potentials where the models differ (approximately between -30 and -5 mV), we observed that the ORd model has a higher level of calcium in the subspace, increasing the value of the <inline-formula><mml:math id="inf20"><mml:mi>n</mml:mi></mml:math></inline-formula> variable, making the contribution of the overestimated inactivation stronger. The higher calcium level in the subspace in the ORd model seems to arise from a combination of two factors: (1) Overestimated activation and thus enhanced calcium entry in ORd (evident from <xref ref-type="fig" rid="fig2">Figure 2 C, D</xref> in the main manuscript), accompanied by small differences in J<sub>rel</sub> formulation translating into more SR release in ORd; (2) less total NCX in the subspace, corresponding to less calcium clearance.</p><p>It is worth noting that the exact shape of the simulation-based inactivation curve depends on how exactly the conditions in <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref> are represented. As explained in Appendix 1-15.1.1, intracellular and potassium are fixed when the steady-state inactivation is measured, but calcium is not fixed. If the intracellular calcium in the model was also clamped to the zero concentration of the pipette, <inline-formula><mml:math id="inf21"><mml:mi>n</mml:mi></mml:math></inline-formula> would be zero and both ORd and ToR-ORd would fit the inactivation curve well.</p></sec><sec id="s12" sec-type="appendix"><title>6. I<sub>CaL</sub> reversal and ionic activity coefficients</title><p>As illustrated in <xref ref-type="fig" rid="fig2">Figure 2F</xref>, the ToR-ORd model yields a consistently inward I<sub>CaL</sub> during the AP, whereas for the ORd, there is a reversal to outward I<sub>CaL</sub> following the peak of the AP. For the ORd midmyocardial cell, I<sub>CaL</sub> is highly positive (I<sub>CaL</sub> = 3.32 pA/pF) at t = 4.3 ms. This can be explained by the update in the ionic activity coefficients described in section <italic>Methods: Determining ionic activity coefficients</italic>. The sign of I<sub>CaL</sub> is determined by the sign of the driving force (other components of I<sub>CaL</sub> are the permeability constant, and gating variables, both of which are nonnegative). The GHK equation for driving force (with all elements explained in Materials and methods of the main manuscript) can be divided into four components for clarity (<xref ref-type="fig" rid="app1fig3">Appendix 1—figure 3</xref>). Components 1 and 4 are positive (V = 33 mV at this point of simulation) and thus do not affect the sign; therefore, the sign of the driving force in this case is determined by the relative size of components 2 and 3. In control ORd (with activity coefficients of 1 and 0.341 for intracellular/extracellular space), we have, for components C2 and C3:<disp-formula id="equ6"><mml:math id="m6"><mml:mi>C</mml:mi><mml:mn>2</mml:mn><mml:mo>=</mml:mo> <mml:mi/><mml:msub><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>∙</mml:mo><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>z</mml:mi><mml:mo>∙</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>∙</mml:mo><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>z</mml:mi><mml:mo>∙</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>∙</mml:mo><mml:mn>0.0822</mml:mn><mml:mo>∙</mml:mo><mml:mn>11.6794</mml:mn><mml:mo>=</mml:mo><mml:mn>0.9598</mml:mn></mml:math></disp-formula><disp-formula id="equ7"><mml:math id="m7"><mml:mi>C</mml:mi><mml:mn>3</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mfenced close="]" open="[" separators="|"><mml:mrow><mml:mi>S</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.341</mml:mn><mml:mo>∙</mml:mo><mml:mn>1.8</mml:mn><mml:mo>=</mml:mo><mml:mn>0.6138</mml:mn></mml:math></disp-formula>where <inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>,</mml:mo> <mml:mi/> <mml:mi/><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are intra/extracellular activity coefficients, <inline-formula><mml:math id="inf23"><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the calcium concentration in junctional subspace, and <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is extracellular calcium concentration. Therefore, C2 &gt; C3 and the sign of driving force (and thus also I<sub>CaL</sub>) is positive.</p><fig id="app1fig3" position="float"><label>Appendix 1—figure 3.</label><caption><title>Goldman-Hodgkin-Katz equation with colour coding of components.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig3-v3.tif"/></fig><p>However, if we use ionic activity coefficients based on ToR-ORd (0.6532 and 0.6117 for intracellular/extracellular), we get:<disp-formula id="equ8"><mml:math id="m8"><mml:mi>C</mml:mi><mml:mn>2</mml:mn><mml:mo>=</mml:mo> <mml:mi/><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo>∙</mml:mo><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>z</mml:mi><mml:mo>∙</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>0.6532</mml:mn><mml:mo>∙</mml:mo><mml:mn>0.0822</mml:mn><mml:mo>∙</mml:mo><mml:mn>11.6794</mml:mn><mml:mo>=</mml:mo><mml:mn>0.6269</mml:mn></mml:math></disp-formula><disp-formula id="equ9"><mml:math id="m9"><mml:mi>C</mml:mi><mml:mn>3</mml:mn><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.6117</mml:mn><mml:mo>∙</mml:mo><mml:mn>1.8</mml:mn><mml:mo>=</mml:mo><mml:mn>1.1011</mml:mn></mml:math></disp-formula></p><p>Therefore, in this case, C2 &lt; C3, and the sign of driving force and I<sub>CaL</sub> is negative and thus consistently inward during the AP.</p></sec><sec id="s13" sec-type="appendix"><title>7. P2/P1 protocol for I<sub>CaL</sub></title><p>We compared the results of the ToR-ORd and ORd models to experimental data in human myocytes for the P2/P1 protocol reported by <xref ref-type="bibr" rid="bib27">Fülöp et al. (2004)</xref> as previously shown in the original ORd model study (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). In this protocol, two rectangular pulses (from −40 mV to 10 mV, lasting either 25 ms or 100 ms) are applied, and the ratio of peak I<sub>CaL</sub> during the second pulse versus the first one is computed. Simulated curves with both models are consistent with the data in that a) 25 ms pulse curve lies above the 100 ms pulse curve, b) shorter coupling interval is associated with less current availability (<xref ref-type="fig" rid="app1fig4">Appendix 1—figure 4</xref>). Both models show an offset to the experimental data. This could be due to a) Difference in I<sub>CaL</sub> behaviour/density and/or calcium loading (affecting inactivation) between the Fülöp (P2/P1 protocol) and Magyar (the main basis for the I<sub>CaL</sub> model) studies. It could be also linked to mechanisms of I<sub>CaL</sub> inactivation not represented in the model (e.g. the inactivation by the calcium flow through the channel, represented for example by <xref ref-type="bibr" rid="bib49">Mahajan et al., 2008</xref>).</p><fig id="app1fig4" position="float"><label>Appendix 1—figure 4.</label><caption><title>P2/P1 protocol for two pulse durations.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig4-v3.tif"/></fig></sec><sec id="s14" sec-type="appendix"><title>8. Calcium transient amplitude in ToR-ORd</title><p>The calcium transient amplitude of 312 nM in baseline ToR-ORd is slightly below the mean ± std range of 350 (330-370) nM in <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>. However, we hypothesised that the difference might be due to the different APD, which affects the calcium loading of the cell by modulating I<sub>CaL</sub> duration. When the APD of the ToR-ORd was extended to 351.5 ms (close to ca. 350 ms reported by Coppini et al.) by reducing I<sub>Kr</sub> by 45%, the calcium transient amplitude increased to 360 nM, which is close to the data mean. After such an AP prolongation, both time to peak (54 ms) and calcium transient duration at 90% recovery (459 ms) remained within standard deviation of the data.</p></sec><sec id="s15" sec-type="appendix"><title>9. Summary of literature on sodium blockers, I<sub>Na</sub>, and I<sub>NaL</sub> reduction</title><p>The exact ratio of pharmacological block of I<sub>Na</sub> and I<sub>NaL</sub> is drug and dose-dependent, with late sodium current generally being blocked somewhat more than the fast sodium current. For flecainide applied to wild-type Na<sub>v</sub>1.5, the IC50 value of I<sub>Na</sub> and I<sub>NaL</sub> were 127 ± 6 and 44 ± 2 μM, respectively; for example, for 50% I<sub>Na</sub> block, a 75% I<sub>NaL</sub> block would be expected (<xref ref-type="bibr" rid="bib54">Nagatomo et al., 2000</xref>). In the case of TTX, the IC50 values appear to be more similar for the two currents: 1.2 μM for I<sub>Na</sub> (<xref ref-type="bibr" rid="bib5">Bradley et al., 2013</xref>) and 0.95 μM for I<sub>NaL</sub> (<xref ref-type="bibr" rid="bib36">Horvath et al., 2013</xref>). Lidocaine also appears to block I<sub>NaL</sub> preferentially: the measured IC50 for I<sub>NaL</sub> is 10.79 μM (<xref ref-type="bibr" rid="bib17">Crumb et al., 2016</xref>), which is lower than 44 μM measured for I<sub>Na</sub> (Janssen Pharmaceutical internal database, referred to in <xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>). However, we note that comparing IC50 values between studies has limited quantitative relevance, given expected differences between conditions and protocols.</p></sec><sec id="s16" sec-type="appendix"><title>10. Role of I<sub>CaL</sub> properties and AP morphology in calcium transient changes by sodium blockade</title><p>The changes in AP morphology and I<sub>CaL</sub> introduced in the ToR-ORd model improved its response to Na currents block, particularly with respect to reduction of the Ca transient amplitude (illustrated in <xref ref-type="fig" rid="fig3">Figure 3</xref>). To further dissect the contribution of differences between ToR-ORd and ORd in AP morphology and I<sub>CaL</sub> properties, we simulated two AP clamp scenarios using the four different models considered previously in <xref ref-type="fig" rid="app1fig2">Appendix 1—figure 2</xref> (i.e. ORd, ORd and ToR-ORd activity coefficients, ORd and ToR-ORd I<sub>CaL</sub> activation curve, and ToR-ORd). The first scenario applied an AP clamp based on ORd AP morphologies for control and for 50/50% I<sub>Na</sub>/I<sub>NaL</sub> block (as shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref>). The second scenario considered AP clamps based on ToR-ORd AP morphologies in control and 50/50% I<sub>Na</sub>/I<sub>NaL</sub> block (as shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref>). For each of the four models and the two AP clamp scenarios, the ratio of calcium transient amplitudes (sodium-block versus control) was computed (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>). This allowed quantifying the importance of differences in AP morphology and updates to the I<sub>CaL</sub> representation with regard to CaT amplitude changes under sodium block.</p><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>Dissection of improvement in reaction to sodium blockade.</title><p>Ratios of calcium transient amplitudes for AP clamps corresponding to baseline and sodium-blocked models, arising from ORd and ToR-ORd. Row/column numbering used in the text does not include the header and the first column which describes the models (i.e. the text refers to four rows and two numerical columns).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Model</th><th valign="top">ORd AP clamps</th><th valign="top">ToR-ORd AP clamps</th></tr></thead><tbody><tr><td valign="top">M1 (ORd)</td><td valign="top">1.366</td><td valign="top">1.061</td></tr><tr><td valign="top">M2 (ORd with ToR-ORd activity coefficients)</td><td valign="top">1.301</td><td valign="top">0.999</td></tr><tr><td valign="top">M3 (ORd with ToR-ORd activation curve)</td><td valign="top">1.326</td><td valign="top">1.015</td></tr><tr><td valign="top">M4 (ToR-ORd)</td><td valign="top">1.193</td><td valign="top">0.985</td></tr></tbody></table></table-wrap><p>A value below one in <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> indicates the expected decrease in calcium transient amplitude with sodium block compared to control. This was achieved only by using the ToR-ORd AP clamp with the ToR-ORd model (row 4, column 2), and also but to a lesser extent with the ToR-ORd AP clamp and the ORd with ToR-ORd activity coefficients (row 2, column 2). Considering the ToR-ORd AP morphology (versus I<sub>CaL</sub> activation coefficients or activation curves) has the strongest effect in changes in calcium transient amplitude with sodium blockade. This is demonstrated by the universally lower values in the second column of <xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref> compared to the first column. The update of ionic activity coefficients alone leads to a reduced increase in CaT amplitude (in ORd), or a reduction in CaT amplitude (in ToR-ORd) following sodium blockade (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>, row 2 versus 1). Updated activation curve leads to a less pronounced increase in calcium transient amplitude in both models (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>, row 3 versus 1). Using the fully updated ToR-ORd model for simulations gave the most pronounced reduction in how much the calcium transient is increased upon sodium blockade using ORd AP clamps (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>, row 4 versus 1; column 1). It also yielded the most pronounced reduction in calcium transient amplitude following sodium blockade when using ToR-ORd AP clamps (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>, row 4 versus 1; column 2).</p><p>AP morphology and peak AP levels regulate calcium transient amplitude through I<sub>CaL</sub>, and specifically through its voltage-dependency of activation curve, driving force and inactivation. It is important to note key differences between ToR-ORd and ORd models in this respect. In the ToR-ORd model, the AP morphology and the I<sub>CaL</sub> activation curve (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) mean that I<sub>Na</sub> blockade leads to a reduction of peak I<sub>CaL</sub> activation. Conversely, in ORd, the activation curve is flat from 15 mV on (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), and activation is not affected when sodium block reduces peak and early-plateau potential from 40 mV to 30–35 mV. At the same time, lowered peak and early-plateau potentials following sodium blockade increase I<sub>CaL</sub> driving force and weaken the voltage-driven inactivation, enhancing total I<sub>CaL</sub>. Furthermore, in the ToR-ORd model, AP with and without sodium block reach a near-identical notch and early-plateau potential soon after the peak (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). However, in the ORd, the difference in early-plateau membrane potentials lasts almost 30 ms after the peak (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), prolonging the effect of increased driving force and reduced inactivation on I<sub>CaL</sub>, which is furthermore not compensated by reduction in activation.</p><p>To further explore the impact of AP morphology on I<sub>CaL</sub> properties, I<sub>CaL</sub> activation and driving force was computed with the ToR-ORd model, again under four AP clamps considering AP morphologies shown in <xref ref-type="fig" rid="fig3">Figure 3A,B</xref> (obtained with ToR-ORd control and 50/50% I<sub>Na</sub>/I<sub>Na</sub>L block, and ORd control and 50/50% I<sub>Na</sub>/I<sub>NaL</sub> block). The results are presented in <xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5</xref>. The activation with ToR-ORd AP clamp is reduced with sodium block versus control AP clamp morphologies (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5A</xref>, yellow vs purple), given the difference in peak membrane potentials (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and their position on the activation curve (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). However, the activation over time is similar with ORd AP morphology in control versus sodium block (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5A</xref>, red vs blue), as the membrane potential is so high that full activation is reached in both cases.</p><fig id="app1fig5" position="float"><label>Appendix 1—figure 5.</label><caption><title>Effect of AP morphology on I<sub>CaL</sub> variables under sodium blockade.</title><p>(<bold>A</bold>) I<sub>CaL</sub> activation. (<bold>B</bold>) ICaL driving force. In (<bold>C</bold>) are shown ratios of curves from (<bold>B</bold>) red pointwise-divided by blue (shown in light blue) and purple pointwise-divided by yellow (shown in green).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig5-v3.tif"/></fig><p>Furthermore, the I<sub>CaL</sub> driving force obtained with the four AP clamps is shown in <xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5B</xref> (more negative values correspond to a greater driving force), and <xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5C</xref> displays the ratio of the driving forces between sodium-blocked AP clamp and control AP clamp for ORd and ToR-ORd morphologies. It is clear that the driving force elevation under sodium-block AP morphology versus control is much smaller and shorter lasting when clamping to ToR-ORd than ORd AP morphologies (<xref ref-type="fig" rid="app1fig5">Appendix 1—figure 5C</xref>).</p><p>Therefore, the combination of ToR-ORd AP morphology and I<sub>CaL</sub> activation curve (which is consistent with experiments and with lower peak and early plateau voltages compared to ORd) result in reduction in both activation and driving force of I<sub>CaL</sub> with sodium bock. This explains how I<sub>Na</sub> block causes a smaller increase in I<sub>CaL</sub> and thus also in calcium transient amplitude using the ToR-ORd versus ORd models (<xref ref-type="fig" rid="fig3">Figure 3E and F</xref>). This smaller calcium increase due to I<sub>Na</sub> block is further compensated by the reduction in calcium entry and loading caused by I<sub>NaL</sub> block. The effect of I<sub>NaL</sub> on the simulated cell’s calcium loading is mediated by the NCX (reduced sodium influx via I<sub>NaL</sub> reduces calcium influx via NCX) and by I<sub>CaL</sub> (APD shortening induced by I<sub>NaL</sub> reduction also shortens I<sub>CaL</sub>, reducing calcium influx). Given that the effect of fixed-amount I<sub>NaL</sub> reduction on APD is stronger in ToR-ORd compared to ORd (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref>), I<sub>NaL</sub> loss reduces calcium transient amplitude more in ToR-ORd.</p></sec><sec id="s17" sec-type="appendix"><title>11. Sodium block in fibre</title><p>In order to assess how cell coupling affects the sodium block behaviour, we simulated half-blocks of I<sub>Na</sub> and I<sub>NaL</sub> in fibre (<xref ref-type="fig" rid="app1fig6">Appendix 1—figure 6</xref>). The effect of the respective blocks is generally consistent with single-cell behaviour (<xref ref-type="fig" rid="fig3">Figure 3</xref>) in that I<sub>Na</sub> block increases calcium transient amplitude, and I<sub>NaL</sub> block reduces it. The effect of both half-blocks combined shows the same trend as the single-cell but is of greater magnitude: ToR-ORd shows a greater reduction in the calcium transient amplitude, while ORd shows a greater increase. In this section, a version of ORd with updated I<sub>Na</sub> to allow for good propagation was used (<xref ref-type="bibr" rid="bib59">Passini et al., 2016</xref>), and the tissue conductivity was set to achieve the conduction velocity of 63 m/s.</p><fig id="app1fig6" position="float"><label>Appendix 1—figure 6.</label><caption><title>Effect of sodium blockers on ToR-ORd and ORd in fibre.</title><p>Membrane potential in fibre at four simulated conditions (control, half block of fast sodium, half block of late sodium, and half block of both fast and late sodium currents) in ToR-ORd (<bold>A</bold>) and ORd (<bold>B</bold>). In (<bold>C, D</bold>) is given the corresponding calcium transient. The measurements were taken in the node at the half of the fibre; consequently, action potentials in the conditions including I<sub>Na</sub> block are delayed to the other traces, given corresponding conduction delay.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig6-v3.tif"/></fig></sec><sec id="s18" sec-type="appendix"><title>12. Calibration: I<sub>CaL</sub> block and I<sub>Kr</sub> replacement</title><p>During the model development (with the original ORd formulation of I<sub>Kr</sub> being used at the stage), we observed that in models with good AP morphology and response to sodium block, 50% I<sub>CaL</sub> block resulted in APD prolongation, which is in conflict with experimental evidence. Dissecting the cause of this phenomenon, we noticed considerably diminished I<sub>Kr</sub> density upon such treatment. Given that I<sub>Kr</sub> is the dominant repolarising current in human ventricle and human-specific computer models, this led to a net APD prolongation. The diminished I<sub>Kr</sub> density is due to the lack of activation of I<sub>Kr</sub> following from the combination of data-like AP morphology and formulation of fast and slow time constant of activation (Figure 3A in <xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). These time constants indicate a rapid activation between 25 and 40 mV, but when the membrane potential is reduced below 15 mV, activation time increases steeply (both fast and slow time constant are &gt;1000 ms at 0 mV). Therefore, when the 50% I<sub>CaL</sub> block reduces plateau potential (a reduction of ca. 10 mV from control data-driven values of ca. 20 mV at 10 ms, 10 mV at 100 ms), I<sub>Kr</sub> activation is slowed greatly, producing a reduction in current density.</p><p>Subsequently, we sought to understand why this problem was not present in the original ORd model, which was shown to respond well to I<sub>CaL</sub> block with regard to APD (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>; <xref ref-type="bibr" rid="bib23">Dutta et al., 2017a</xref>). This follows from the high-plateau AP configuration of ORd (ca. 38 mV at 10 ms and 20 mV at 100 ms); when such a high plateau is lowered by 10 mV, it still falls within the zone of rapid I<sub>Kr</sub> activation. Under such conditions, the loss of I<sub>CaL</sub> shortens the APD much more than the minor loss of I<sub>Kr</sub> prolongs it, with the net effect being APD shortening.</p><p>Importantly, the article describing the Lu-Vandenberg model of I<sub>Kr</sub> (<xref ref-type="bibr" rid="bib44">Lu et al., 2001</xref>) used in the final version of ToR- ORd also provides I<sub>Kr</sub> measurements under AP clamp. The study utilises AP clamps of both normal-plateau ventricular AP and low-plateau Purkinje AP (which can be taken as a proxy for I<sub>CaL</sub> blocked ventricular cell). The experimentally measured peak I<sub>Kr</sub> is slightly reduced in low-plateau AP clamp versus the high-plateau one (reduction to 70%). This is generally captured by simulations using our version of the Lu-Vandenberg model (reduction to 57%, <xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7</xref>). However, peak I<sub>Kr</sub> in ORd reduces to mere 15% in the low-plateau AP clamp versus high-plateau one (<xref ref-type="fig" rid="app1fig7">Appendix 1—figure 7</xref>), which is due to the slow time constant of activation as described above. The fact that I<sub>Kr</sub> is capable of rapid activation (or recovery from inactivation, mimicking activation) is independently corroborated also by the elegant study of sinusoidal voltage pulse protocols by <xref ref-type="bibr" rid="bib1">Beattie et al. (2018)</xref>, where I<sub>Kr</sub> responds noticeably to membrane potential changes around 0 mV.</p><fig id="app1fig7" position="float"><label>Appendix 1—figure 7.</label><caption><title>AP clamps and resulting I<sub>Kr</sub>.</title><p>(<bold>A,B</bold>) Endocardial and Purkinje AP used as an AP clamp (5th beat of the simulation shown). (<bold>C</bold>) I<sub>Kr</sub> produced by the endocardial AP. (<bold>D</bold>) I<sub>Kr</sub> produced by the Purkinje AP. Shown are data manually extracted from <xref ref-type="bibr" rid="bib44">Lu et al. (2001)</xref>, as well as simulations using ORd and ToR-ORd (L-V, coding for Lu-Vandenberg hERG model). A normalisation was performed in (<bold>C</bold>), (<bold>D</bold>) to facilitate the relative loss of I<sub>Kr</sub> using the low-plateau AP shape. In (<bold>C</bold>), the three traces were normalised to 0–1 range via division by maxima of the traces: max<sub>Data</sub>, max<sub>ORd</sub>, max<sub>LV</sub>. Subsequently, in (<bold>D</bold>), the data trace was divided by max<sub>Data</sub>, ORd simulation by max<sub>ORd</sub>, and the ToR-ORd model simulation by max<sub>LV</sub>. Thus, both traces produced by a given model (or measured experimentally) are divided by the same number, allowing the assessment of relative reduction of I<sub>Kr</sub> at the low-plateau AP.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig7-v3.tif"/></fig></sec><sec id="s19" sec-type="appendix"><title>13. Validation: drug block and APD</title><p>In addition to four drugs and their effect on APD reported in the main manuscript <xref ref-type="bibr" rid="bib24">Dutta et al. (2017b)</xref>, also studied the effect of BaCl<sub>2</sub>, modelled as a 90% IK<sub>1</sub> block. However, we excluded considering this drug fundamentally due to the uncertainty on its multichannel effects on several potassium currents, in addition to I<sub>K1</sub>. Specifically, it was previously shown that BaCl<sub>2</sub> also blocks I<sub>Kr</sub> and I<sub>Ks</sub> at the used concentration (<xref ref-type="bibr" rid="bib82">Weerapura et al., 2004</xref>; <xref ref-type="bibr" rid="bib29">Gibor et al., 2004</xref>). Furthermore, as shown in <xref ref-type="bibr" rid="bib40">Kristóf et al. (2012)</xref>, even a lower dose of BaCl<sub>2</sub> prolongs the AP plateau and early phase of repolarization, thus at membrane potentials at which IK<sub>1</sub> is not activated. This corroborates that BaCl<sub>2</sub> is likely to block I<sub>Kr</sub> and I<sub>Ks</sub>, in addition to I<sub>K1</sub>, but to an uncertain degree. Furthermore, pure block of I<sub>K1</sub> in the ORd model results in APD prolongation from around −50 mV only, which indicates a clear discrepancy with the experimental data.</p><p>To further explore this issue, we simulated the effect of pure 90% I<sub>K1</sub> block (which is consistent with the concentration of BaCl<sub>2</sub> used in the experiments) as well as additional I<sub>Kr</sub> block using the ToR-ORd. The results are shown in <xref ref-type="table" rid="app1table2">Appendix 1—table 2</xref>.</p><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>Effect of BaCl<sub>2</sub> on APD90 in experiments and simulations using the ToR-ORd model with different degrees of I<sub>K1</sub> and I<sub>Kr</sub> block.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Basic cycle length</th><th valign="top">Experimental data (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>)</th><th valign="top">Simulated 90% I<sub>K1</sub> block</th><th valign="top">Simulated 90% I<sub>K1</sub> + 15% I<sub>Kr</sub> block</th><th valign="top">Simulated 90% I<sub>K</sub>1 + 30% I<sub>Kr</sub> block</th></tr></thead><tbody><tr><td valign="top">500 ms</td><td valign="top">271 (±50) ms</td><td valign="top">250 ms</td><td valign="top">271 ms</td><td valign="top">297 ms</td></tr><tr><td valign="top">1000 ms</td><td valign="top">306 (±50) ms</td><td valign="top">281 ms</td><td valign="top">307 ms</td><td valign="top">341 ms</td></tr><tr><td valign="top">2000 ms</td><td valign="top">361 (±50) ms</td><td valign="top">286 ms</td><td valign="top">311 ms</td><td valign="top">342 ms</td></tr></tbody></table></table-wrap><p>For the three basic cycle length tested, the simulations are in overall agreement with the experimental data (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>), with an improved match for 90% I<sub>K1</sub> + 15% I<sub>Kr</sub> block. It is however uncertain (albeit likely) whether the block of other currents, such as for example I<sub>Ks</sub> contributes to explain the effect of BaCl<sub>2</sub> on the APD.</p><p>A second matter discussed in this section is whether the assessment of nisoldipine in <xref ref-type="fig" rid="fig5">Figure 5D</xref> classifies as a calibration or validation result. With respect to I<sub>CaL</sub> block, the genetic algorithm optimisation contained a criterion promoting APD shortening in response to a 50% calcium blockade; however, the degree of block was different (90% when assessing nisoldipine), and the optimiser did not aim specifically for the APD reported by <xref ref-type="bibr" rid="bib23">Dutta et al. (2017a)</xref>. Additionally, the I<sub>Kr</sub> formulation substitution was motivated by the poor performance of the original I<sub>Kr</sub> model in response to 50% I<sub>CaL</sub> blockade. After the substitution was performed and the I<sub>Kr</sub> conductance scaled to achieve similar APD at 1 Hz pacing at control conditions, no further optimization towards the experimental data in <xref ref-type="fig" rid="fig5">Figure 5D</xref> was carried out. Specifically, at no time during development was the model adjusted to provide predictions close to <xref ref-type="bibr" rid="bib23">Dutta et al. (2017a)</xref> in reaction to 90% I<sub>CaL</sub>. Therefore, APD shortening with I<sub>CaL</sub> blockade could be considered a partially calibration criterion, but quantitatively a validation one.</p></sec><sec id="s20" sec-type="appendix"><title>14. Validation: propagation at extreme hyperkalemia</title><p>For extracellular potassium higher than 9 mM, a fibre was too inexcitable to support the propagation of a full AP. However, a partial activation was observed to propagate throughout the fibre, reaching ca. −30 mV and lasting ca. 50 ms (<xref ref-type="fig" rid="app1fig8">Appendix 1—figure 8</xref>). In case of localised hyperkalemia, such as during acute myocardial infarction, it is possible that even such low-peak wave might reactivate nonischemic cells upon exit of the ischemic zone, triggering re-entry and arrhythmia.</p><fig id="app1fig8" position="float"><label>Appendix 1—figure 8.</label><caption><title>Subthreshold fibre activation under extreme hyperkalemia.</title><p>This trace was measured at the centre of the simulated fibre.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig8-v3.tif"/></fig></sec><sec id="s21" sec-type="appendix"><title>15.Simulation methods</title><sec id="s21-1"><title>15.1 Simulation details</title><p>Cells were stimulated using a conservative potassium stimulus of −53 mV for 1 ms. Fixed concentrations in the model are: K<sub>o</sub> = 5 mM (extracellular potassium), Na<sub>o</sub> = 140 mM (extracellular sodium), Ca<sub>o</sub> = 1.8 mM (extracellular calcium), Cl<sub>o</sub> = 150 mM (extracellular chloride), Cl<sub>i</sub> = 24 mM (intracellular chloride).</p><sec id="s21-1-1"><title>15.1.1 Single-cell simulation protocols</title><p>All results are shown at the end of a 1000-beat long pre-pacing train of stimuli. Fixed ionic concentrations were as stated above with two exceptions, where we matched concentrations to the respective studies (this was done both for ToR-ORd and ORd models when generating respective figures). The first exception is the replication of the IV relationship and steady-state inactivation of I<sub>CaL</sub>, based on <xref ref-type="bibr" rid="bib47">Magyar et al. (2000)</xref>, where Na<sub>o</sub> = 140.7 mM, K<sub>o</sub> = 5.4 mM, Cl<sub>o</sub> = 146.2, and Ca<sub>o</sub> = 2.5. Particularly, the calcium concentration is of importance, given that it affects the driving force of calcium and thus the IV relationship directly. In addition to the changed values of extracellular concentrations, we fixated the intracellular concentrations of sodium (to 0 mM), potassium (to 153 mM), and chloride (to 130 mM) to match concentrations in the patch-clamp pipette, given that in the long-term, diffusion would distribute the ions in approximately such way. We decided not to fix calcium levels in the model to the pipette concentrations (which was calcium-free), given that calcium entry via I<sub>CaL</sub> and the resulting release from the SR might last throughout the inactivating pulse, affecting I<sub>CaL</sub> function in a persistent way.</p><p>A second exception is the protocol of induction of early afterdepolarisations (EADs) based on <xref ref-type="bibr" rid="bib34">Guo et al. (2011)</xref>. In this case, Na<sub>o</sub> = 137, Cl<sub>o</sub> = 148, and Ca<sub>o</sub> = 2.</p><p>Third, for the P2/P1 protocol (Appendix 1-7), the concentrations were used as in <xref ref-type="bibr" rid="bib27">Fülöp et al. (2004)</xref>: Cl<sub>i</sub> = 130 mM, Cl<sub>o</sub> = 157 mM, Na<sub>o</sub> = 144 mM, Ca<sub>o</sub> = 2.5 mM, K<sub>o</sub> = 5.6 mM, K<sub>i</sub> = 153 mM, Na<sub>i</sub> = 0 mM.</p></sec></sec><sec id="s21-2"><title>15.1.2 Hypertrophic cardiomyopathy and hyperkalemia representation</title><sec id="s21-2-1"><title>15.1.2.1 Hypertrophic cardiomyopathy</title><p>Most of ionic remodelling was based on a comprehensive study by <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>. All remodelling of HCM cells versus healthy cells was preferentially based on current density, protein expression if current density was not available, or mRNA expression if neither of the previous two measurements was available. The degree of remodelling was based on data means in the Coppini et al. study; where two subunits of a complex underlying a current were altered, an average of the two values corresponding to increase/reduction was used. Based on current density, I<sub>NaL</sub> was increased by 165%, I<sub>CaL</sub> by 25%, and I<sub>to</sub> was reduced by 80%. In addition, consistent with the study, the time constant of fast inactivation (both voltage and calcium-driven) was increased by 35%, and the time constant of slow inactivation was increased by 20%. Based on protein expression, NCX was increased by 50%, J<sub>up</sub> was reduced by 35%, and J<sub>rel</sub> by 30%. Based on mRNA, I<sub>K1</sub> was reduced by 30%, I<sub>Kr</sub> by 35%, and I<sub>Ks</sub> by 55%. In addition, I<sub>NaK</sub> was reduced by 30% (<xref ref-type="bibr" rid="bib59">Passini et al., 2016</xref>), and calcium affinity of troponin was increased slightly by reducing the K<sub>trp</sub> by 7% (<xref ref-type="bibr" rid="bib69">Robinson et al., 2007</xref>).</p></sec><sec id="s21-2-2"><title>15.1.2.2 Hyperkalemia</title><p>Extracellular potassium level was raised from 5 mM with an increment of 0.5 mM up to 10 mM. Effective refractory period was determined using S1-S2 protocol, recording the highest S2 coupling interval duration which did not lead to propagation. Hyperkalemic conditions were simulated in a fibre, see below.</p></sec></sec><sec id="s21-3"><title>15.1.3 Fibre simulation</title><p>The 1D fibre tissue simulations (hyperkalemia and Appendix 1-11) were conducted using the open-source software CHASTE. The homogeneous 1D tissue fibres had a length of 4 cm consisting of 200 nodes, with a conductivity of 1.64 mS/cm to achieve a diffusion coefficient of 1.171 cm<sup>2</sup>/s (<xref ref-type="bibr" rid="bib8">Bueno-Orovio et al., 2008</xref>). All the fibres were paced for 20 beats before analysis. For the purpose of measurement of APD or effective refractory period, a stimulus was considered ‘propagating’ if the peak of membrane potential at the half-point of the fibre was above 0. Stimuli which did not propagate did not have their APD or refractory period measured.</p></sec><sec id="s21-4"><title>15.1.4 Populations of models and drug safety assessment</title><p>To assess the performance of the newly developed model for studies of populations of models, we constructed two populations of models using the ToR-ORd model as baseline, and the experimentally-calibrated population of models methodology (<xref ref-type="bibr" rid="bib6">Britton et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Muszkiewicz et al., 2016</xref>; <xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>). A total of nine ionic conductances were randomly varied: fast and late Na<sup>+</sup> current (G<sub>Na</sub> and G<sub>NaL</sub> respectively), transient outward K<sup>+</sup> current (G<sub>to</sub>), rapid and slow delayed rectifier K<sup>+</sup> current (G<sub>Kr</sub> and G<sub>Ks</sub>), inward rectified K<sup>+</sup> current (G<sub>K1</sub>), Na<sup>+</sup>-Ca2<sup>+</sup> exchanger (G<sub>NCX</sub>), Na<sup>+</sup>-K<sup>+</sup> pump (G<sub>NaK</sub>) and the L-type Ca2<sup>+</sup> current (P<sub>Ca</sub>). Two variability ranges were considered: [50-150]% and [0–200]% with respect to the baseline values, consistent with the reference study (<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>). The number of models passing calibration to experimental biomarkers was 2666 out of 3000 models generated for the [50-150]% population, and 817 out of 3000 for the [0–200]% population.</p><p>To assess the suitability of the newly developed model for prediction of drug-induced pro-arrhythmic risk, we also replicated the results of our previous study on human in silico drug trials in population of human models (<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>), by testing the same 62 reference compounds at multiple concentrations on the [0–200%] population of models described above. Results were compared in terms of occurrence of drug-induced repolarisation abnormalities (RA) in the population and TdP score. CredibleMeds (<xref ref-type="bibr" rid="bib85">Woosley and Romero, 2015</xref>) was used as gold standard for TdP risk, dividing the reference compounds in four categories: 1, high risk; 2, possible risk; 3, conditional risk; 4, safe (when not included in CredibleMeds).</p><p>All the population of models described above were constructed using the Virtual Assay software (v3.2.1119, 2019 Oxford University Innovation) (<xref ref-type="bibr" rid="bib60">Passini et al., 2017</xref>). Further analysis of the results was performed in Matlab (Mathworks Inc Natwick, MA).</p></sec><sec id="s21-5"><title>15.1.5 Transmurality, 3D simulation, and pseudo-ECG measurement</title><p>The formulation of transmurality (representation of endocardial, midmyocardial, and epicardial cells) was retained as in <xref ref-type="bibr" rid="bib56">O'Hara et al. (2011)</xref>, with two exceptions. First, the increase of I<sub>CaL</sub> conductance from endocardium to midmyocardium was reduced to 2-fold, which corresponds to the mean of the data (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>, Figure 10). Second, the increase of I<sub>to</sub> from endocardium to both midmyocardium and epicardium was reduced to 2-fold to avoid excessive notch following the peak of the AP. Membrane potential traces of the three cell types at 1 Hz pacing are given in <xref ref-type="fig" rid="app1fig9">Appendix 1—figure 9</xref>.</p><fig id="app1fig9" position="float"><label>Appendix 1—figure 9.</label><caption><title>Action potential morphology for three cell subtypes at 1 Hz pacing.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig9-v3.tif"/></fig><p>The propagation of the electrical activity in the human ventricles was modelled using the heart bidomain equations and solved with the Chaste software (<xref ref-type="bibr" rid="bib63">Pitt-Francis et al., 2009</xref>). A cardiac magnetic resonance (CMR)-informed torso ventricular model was used. The ventricular element size was set to 0.4 mm to ensure numerical convergence of the finite element software Chaste for electrophysiological simulations (<xref ref-type="bibr" rid="bib22">Dutta et al., 2016</xref>; <xref ref-type="bibr" rid="bib63">Pitt-Francis et al., 2009</xref>).</p><p>The presented ToR-ORd model was used to represent the membrane kinetics. Transmural and apex to base cell electrophysiological heterogeneities based on experimental and clinical data from <xref ref-type="bibr" rid="bib57">Okada et al. (2011)</xref>; <xref ref-type="bibr" rid="bib20">Drouin et al. (1995)</xref>; <xref ref-type="bibr" rid="bib75">Taggart (2001)</xref>; <xref ref-type="bibr" rid="bib3">Boukens et al. (2015)</xref> were incorporated in the biventricular heart model. Transmural heterogeneities were modelled using three layers as in <xref ref-type="bibr" rid="bib46">Lyon et al. (2018)</xref> of endocardial (45% of the transmural width), mid-myocardial (25%) and epicardial cells (30%) with different AP properties as shown above. Apex-to-base heterogeneities were modelled by including a gradual increase of I<sub>Ks</sub> conductance from base to apex resulting in APD differences of 25 ms.</p><p>Heart fibre directions were generated using the Streeter rule-based method (<xref ref-type="bibr" rid="bib73">Streeter et al., 1969</xref>), and tissue conductivities were set to generate realistic conduction velocities for the ToR-ORd cell model, numerical scheme, and mesh resolution. The longitudinal intracellular conductivity of 1.64 mS/cm in a 1D fibre model resulted in a physiological conduction velocity of ~65 cm/s (<xref ref-type="bibr" rid="bib74">Taggart et al., 2000</xref>). As (<xref ref-type="bibr" rid="bib10">Cardone-Noott et al., 2016</xref>) used 1.5 mS/cm, intracellular orthotropic conductivities and the axisymmetric extracellular conductivities were obtained by using a scaling factor of 1.0934 to the ones in <xref ref-type="bibr" rid="bib10">Cardone-Noott et al. (2016)</xref>.</p><p>Sinus rhythm was simulated at 1 Hz using a phenomenological activation model with early endocardial activation sites and a fast endocardial layer representing a tightly-packed endocardial Purkinje network (<xref ref-type="bibr" rid="bib10">Cardone-Noott et al., 2016</xref>) and adapted to the ventricular geometry (<xref ref-type="bibr" rid="bib51">Mincholé et al., 2019</xref>).</p><p>Simulation of the pseudo-ECG was computed by calculating the extracellular potentials in the virtual standard 12-lead electrode positions (<xref ref-type="bibr" rid="bib46">Lyon et al., 2018</xref>) from the ventricular geometry following the dipole model (<xref ref-type="bibr" rid="bib30">Gima and Rudy, 2002</xref>) as:<disp-formula id="equ10"><mml:math id="m10"><mml:mi>ϕ</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo>∫</mml:mo><mml:mrow><mml:mi mathvariant="normal">Ω</mml:mi></mml:mrow><mml:mrow/></mml:msubsup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>D</mml:mi><mml:mo>∇</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mo>∇</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mfenced close="‖" open="‖" separators="|"><mml:mrow><mml:mi mathvariant="bold-italic">r</mml:mi><mml:mo>-</mml:mo><mml:mi mathvariant="bold-italic">e</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="bold-italic">r</mml:mi></mml:math></disp-formula>where <inline-formula><mml:math id="inf25"><mml:mi mathvariant="bold-italic">e</mml:mi><mml:mo>=</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>y</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>z</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math></inline-formula> are the electrode position coordinates, <inline-formula><mml:math id="inf26"><mml:mi>D</mml:mi></mml:math></inline-formula> is the diffusion tensor, and <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the membrane potential. The integral is calculated over the whole myocardium volume,<inline-formula><mml:math id="inf28"> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">Ω</mml:mi></mml:math></inline-formula>.</p></sec><sec id="s21-6"><title>15.1.6 Timely killing of crashing simulations during multiobjective GA</title><p>We found it crucial to modify the behaviour of @ode15s in our simulations, using Matlab ODE Events to limit 1 s of simulated time to 5 s of runtime (with the runtime being &lt;0.5 s in normal conditions), killing a simulation upon exceeding the limit. When parameters of the models are randomly perturbed during GA fitting, it is possible to achieve a combination which leads to model instability and eventual crash. However, as ode15s attempts to reduce time step in such a case, it takes up to 6 hr to crash, blocking CPU cores and stalling the whole generation. With the timely killing of unstable simulations, we could run 30 generations with population size of 2500 in ca. 30 hr on an Azure virtual machine with 64 cores, using parallel fitness evaluation.</p></sec></sec><sec id="s22" sec-type="appendix"><title>15.2 Evaluation pipeline and HTML reporter</title><p>In addition to the model code itself, we also provide a model evaluation pipeline. This allows simulation of the single-cell calibration and validation criteria using a standard model function (I.e. all except I<sub>CaL</sub> properties such as I-V relationship, or disease models, where modified model codes are used.). After the simulation of a comprehensive set of protocols, an HTML report is produced (<xref ref-type="fig" rid="app1fig10">Appendix 1—figure 10</xref>), providing a clickable mapping between criteria and figures showing how the model fulfils them. Icons adjacent to the criteria allow rapid assessment of whether the model behaves well in the given criterion. Any model with appropriate interface of inputs and outputs can be simulated. It is particularly easy to simulate variants of the ToR-ORd model, for example with changed conductances of currents, as the same structure of parameters that is passed to the model simulation wrapper can be passed to this evaluation pipeline. Given that the evaluation code and subsequent report generation are fully automated, it is easy to extend the pipeline to compute and visualise other evaluation criteria.</p><fig id="app1fig10" position="float"><label>Appendix 1—figure 10.</label><caption><title>Evaluation pipeline.</title><p>The left menu shows a list of evaluation criteria with the adjacent icon indicating whether they are fulfilled by the model. The right pane contains figures visualising the model performance in the criteria. The figures can be either viewed by scrolling or by clicking the corresponding entry in the left menu. The report header contains a timestamp of the report generation and a slider which controls the size of figures in the right pane. The whole report is written in HTML, as automatically generated from Matlab code, and can be viewed in any internet browser.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48890-app1-fig10-v3.tif"/></fig><p>The whole process of report generation (and storage of included plots) can be run separately for calibration and validation criteria (with separately stored figures), facilitating unbiased model development, where the model can be assessed using the calibration criteria only, without the user observing any validation results. It is nevertheless possible to also generate a report for only validation criteria, or both calibration and validation.</p><p>Below are given the criteria evaluated, along with how the rating of the model is defined (PASS = good behaviour in a given criterion, FAIL = problematic behaviour, NA = feature not automatically compared to data, usually because of difficulty of accurate rating; this code is also used when a plot is only an illustration, such as examples of action potential shape at different pacing frequencies). Unless specified otherwise, FAIL is given when PASS is not fulfilled.</p></sec><sec id="s23" sec-type="appendix"><title>15.2.1 Calibration criteria</title><list list-type="order"><list-item><p>Action potential morphology. PASS ~ AP from 10 to 500 ms is within the 10–90% quantile range of the Szeged dataset. The first 10 ms are ignored so as not to limit the model in its peak potential, as this is strongly modulated by cell coupling (the available AP data are based on small-tissue samples).</p></list-item><list-item><p>Sample traces showing the AP and calcium transient at different pacing frequencies. Always NA, this is just an illustrator figures useful for an eyeballing-type of assessment.</p></list-item><list-item><p>Calcium transient properties (time to peak, duration at 90% recovery. PASS ~ both features are within estimated standard deviation of data given in <xref ref-type="bibr" rid="bib15">Coppini et al. (2013)</xref>.</p></list-item><list-item><p>Negative inotropy of 50% I<sub>Na</sub> + 50% I<sub>NaL</sub> block. PASS if such treatment induces a reduction in transient amplitude.</p></list-item><list-item><p>APD shortening with 50% I<sub>CaL</sub> block. PASS if such treatment induces APD shortening.</p></list-item><list-item><p>The effect of 50% I<sub>K1</sub> block on membrane potential. PASS if such treatment induces depolarisation.</p></list-item><list-item><p>EAD formation. PASS if dV/dt exceeds 0.05 after 50 ms of the AP. This is assessed at 4000 ms bcl, 85% I<sub>Kr</sub> block, and concentrations as given in section 1.3.1.</p></list-item><list-item><p>Alternans formation. PASS if alternans of amplitude more than 5 ms is formed at any frequency faster than 300 ms base cycle length. The plots generated can be also used to assess dynamic restitution of APD.</p></list-item></list><p>Conduction velocity is not assessed, as it requires simulating a fibre using other tools than Matlab.</p><sec id="s23-1"><title>15.2.2 Validation criteria</title><list list-type="order"><list-item><p>Four simulated drug blocks from <xref ref-type="bibr" rid="bib23">Dutta et al. (2017a)</xref>:</p><list list-type="bullet"><list-item><p>E-4031 (I<sub>Kr</sub> blocker)</p></list-item><list-item><p>HMR-1556 (I<sub>Ks</sub> blocker)</p></list-item><list-item><p>Mexiletine (I<sub>NaL</sub>, I<sub>Kr</sub>, I<sub>CaL</sub> blocker)</p></list-item><list-item><p>Nisoldipine (I<sub>CaL</sub> blocker)</p></list-item></list></list-item><list-item><p>Each is simulated separately, and each is scored as PASS if the model prediction is within the standard deviation of the data.</p></list-item><list-item><p>APD accommodation. Always NA, as it is challenging how to define agreement with data exactly.</p></list-item><list-item><p>S1-S2 protocol. Always NA, just a comparison to data is given.</p></list-item></list><p>Effects of hyperkalemia, POM and drug safety testing, or 3D heart simulation are not assessed automatically, as they requires simulation tools other than Matlab.</p></sec></sec><sec id="s24" sec-type="appendix"><title>15.3 Summary of updated equations</title><p>Below are the equations which have been added and/or changed in the ORd model. The equations follow the naming convention of the ORd model with the exception of I<sub>Na</sub>, I<sub>(Ca)Cl</sub>, I<sub>Clb</sub>, and I<sub>K1</sub>, which are based on different models. Membrane potential is expressed as <inline-formula><mml:math id="inf29"><mml:mi>V</mml:mi></mml:math></inline-formula>.</p><sec id="s24-1"><title>15.3.1 I<sub>Na</sub></title><p>The <xref ref-type="bibr" rid="bib33">Grandi et al. (2010)</xref> model of I<sub>Na</sub> was used as a baseline, which was extended to account for the effect of CaMKII via modulation of the <inline-formula><mml:math id="inf30"><mml:mi>h</mml:mi></mml:math></inline-formula> gate (a shift by 6 mV) and the 1.46 times increase of the time constant of <inline-formula><mml:math id="inf31"><mml:mi>j</mml:mi></mml:math></inline-formula> (recovery from inactivation), consistent with (<xref ref-type="bibr" rid="bib56">O'Hara et al., 2011</xref>). The current was included within the membrane adjacent to the main cytosolic pool as in ORd. The equations underlying describing the Grandi model were extracted from the model source code.<disp-formula id="equ11"><mml:math id="m11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>m</mml:mi><mml:mrow><mml:mi mathvariant="normal">∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mtext> </mml:mtext><mml:mfrac><mml:mrow><mml:mn>56.86</mml:mn><mml:mo>+</mml:mo><mml:mi>V</mml:mi></mml:mrow><mml:mn>9.03</mml:mn></mml:mfrac></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.1292</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>45.79</mml:mn></mml:mrow><mml:mn>15.54</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mtext> </mml:mtext><mml:mn>0.06487</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:mn>4.823</mml:mn></mml:mrow><mml:mn>51.12</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mtext> </mml:mtext></mml:mrow></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mrow><mml:mi mathvariant="normal">∞</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>m</mml:mi></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ12"><mml:math id="m12"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mn>0.057</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mtext> </mml:mtext><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>80</mml:mn></mml:mrow><mml:mn>6.8</mml:mn></mml:mfrac></mml:mrow></mml:msup><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext> </mml:mtext><mml:mi>V</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>−</mml:mo><mml:mn>40</mml:mn><mml:mtext> </mml:mtext><mml:mi>m</mml:mi><mml:mi>V</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn><mml:mspace width="thinmathspace"/><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mn>2.7</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mn>0.079</mml:mn><mml:mo>⋅</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mn>3.1</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:msup><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mn>0.3485</mml:mn><mml:mo>⋅</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup></mml:mtd><mml:mtd><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext> </mml:mtext><mml:mi>V</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>−</mml:mo><mml:mn>40</mml:mn><mml:mtext> </mml:mtext><mml:mi>m</mml:mi><mml:mi>V</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mn>0.77</mml:mn><mml:mrow><mml:mn>0.13</mml:mn><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mtext> </mml:mtext><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>10.66</mml:mn></mml:mrow><mml:mrow><mml:mn>11.</mml:mn><mml:mspace linebreak="newline"/><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>a</mml:mi><mml:mi>h</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi mathvariant="normal">∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>71.55</mml:mn></mml:mrow><mml:mn>7.43</mml:mn></mml:mfrac></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi mathvariant="normal">∞</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>h</mml:mi></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ13"><mml:math id="m13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mn>2.5428</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mn>0.2444</mml:mn><mml:mo>⋅</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mn>6.948</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:msup><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.04391</mml:mn><mml:mo>⋅</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>37.78</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mn>0.311</mml:mn><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>79.23</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext> </mml:mtext><mml:mi>V</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>−</mml:mo><mml:mn>40</mml:mn><mml:mtext> </mml:mtext><mml:mi>m</mml:mi><mml:mi>V</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn></mml:mtd><mml:mtd><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>b</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mn>0.02424</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.01052</mml:mn><mml:mo>⋅</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.1378</mml:mn><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>40.14</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mi>f</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mtext> </mml:mtext><mml:mi>V</mml:mi><mml:mi mathvariant="normal">&amp;</mml:mi><mml:mo>&lt;</mml:mo><mml:mo>−</mml:mo><mml:mn>40</mml:mn><mml:mtext> </mml:mtext><mml:mi>m</mml:mi><mml:mi>V</mml:mi></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mn>0.6</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mn>0.057</mml:mn><mml:mo>⋅</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>0.1</mml:mn><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>32</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:mtd><mml:mtd><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>a</mml:mi><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>j</mml:mi><mml:mrow><mml:mi mathvariant="normal">∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>71.55</mml:mn></mml:mrow><mml:mn>7.43</mml:mn></mml:mfrac></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>j</mml:mi><mml:mrow><mml:mi mathvariant="normal">∞</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ14"><mml:math id="m14"><mml:msub><mml:mrow><mml:mi>h</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>71.55</mml:mn><mml:mo>+</mml:mo><mml:mn>6</mml:mn></mml:mrow><mml:mrow><mml:mn>7.43</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ15"><mml:math id="m15"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>h</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>h</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>h</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ16"><mml:math id="m16"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.46</mml:mn><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula><disp-formula id="equ17"><mml:math id="m17"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>j</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>j</mml:mi><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ18"><mml:math id="m18"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>N</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>11.7802</mml:mn></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ19"><mml:math id="m19"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>N</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>∙</mml:mo><mml:mi>h</mml:mi><mml:mo>∙</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>N</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>h</mml:mi><mml:mi>p</mml:mi><mml:mo>∙</mml:mo><mml:mi>j</mml:mi><mml:mi>p</mml:mi> <mml:mi/><mml:mo>)</mml:mo></mml:math></disp-formula>where <inline-formula><mml:math id="inf32"><mml:mi>h</mml:mi><mml:mi>p</mml:mi></mml:math></inline-formula> is the phosphorylated <inline-formula><mml:math id="inf33"><mml:mi>h</mml:mi></mml:math></inline-formula> gate, <inline-formula><mml:math id="inf34"><mml:mi>j</mml:mi><mml:mi>p</mml:mi></mml:math></inline-formula> is the phosphorylated <inline-formula><mml:math id="inf35"><mml:mi>j</mml:mi></mml:math></inline-formula> gate, and <inline-formula><mml:math id="inf36"> <mml:mi/><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>N</mml:mi><mml:mi>a</mml:mi><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the fraction of CaMKII-phosphorylated sodium channels.</p></sec><sec id="s24-2"><title>15.3.2 I<sub>NaL</sub></title><p>As the ORd model assumes the time constant of I<sub>NaL</sub> activation to be the same as the one of I<sub>Na</sub>, <inline-formula><mml:math id="inf37"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub> <mml:mi/></mml:math></inline-formula> of I<sub>NaL</sub> in ToR-ORd was likewise set to <inline-formula><mml:math id="inf38"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> of the extended Grandi I<sub>Na</sub> model as described above.<disp-formula id="equ20"><mml:math id="m20"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.1292</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>45.79</mml:mn></mml:mrow><mml:mn>15.54</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:mtext> </mml:mtext><mml:mn>0.06487</mml:mn><mml:mo>⋅</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>−</mml:mo><mml:mn>4.823</mml:mn></mml:mrow><mml:mn>51.12</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mtext> </mml:mtext></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>In addition, the conductance was changed:<disp-formula id="equ21"><mml:math id="m21"><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo>,</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.1292</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>45.79</mml:mn></mml:mrow><mml:mrow><mml:mn>15.54</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mo>+</mml:mo> <mml:mi/><mml:mn>0.06487</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:mn>4.823</mml:mn></mml:mrow><mml:mrow><mml:mn>51.12</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup> <mml:mi/></mml:mrow></mml:msup></mml:math></disp-formula></p></sec><sec id="s24-3"><title>15.3.3 I<sub>CaL</sub></title><sec id="s24-3-1"><title>15.3.3.1 Activation</title><p>Steady-state activation was reformulated as the following Gompertz function restricted to [0,1].<disp-formula id="equ22"><mml:math id="m22"><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0279</mml:mn></mml:math></disp-formula></p></sec><sec id="s24-3-2"><title>15.3.3.2 Localisation</title><p>20% of I<sub>CaL</sub> was placed within the membrane adjacent to the main cytosolic ionic pool (<inline-formula><mml:math id="inf39"><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo> <mml:mi/><mml:mfenced separators="|"><mml:mrow><mml:mn>1.0763</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1.007</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>0.0829</mml:mn><mml:mo>∙</mml:mo><mml:mi>V</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mi mathvariant="normal">f</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi> <mml:mi/><mml:mi>V</mml:mi><mml:mo>≤</mml:mo><mml:mn>31.4978</mml:mn> <mml:mi/></mml:mrow><mml:mrow><mml:mn>1</mml:mn> <mml:mi/><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">w</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi></mml:mrow></mml:mfenced></mml:math></inline-formula>); 80% is included within membrane adjacent to the 'subspace' compartment (<inline-formula><mml:math id="inf40"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>). Total I<sub>CaL</sub> (the sodium and potassium currents carried by the channel are treated analogously) is given as follows:<disp-formula id="equ23"><mml:math id="m23"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p><p>The two parts of I<sub>CaL</sub> differ in the driving force (which differs between subspace and main ionic pool based on potentially different ionic concentrations), and <inline-formula><mml:math id="inf41"><mml:mi>n</mml:mi></mml:math></inline-formula>, the variable determining the degree of calcium inactivation. We separated the original <inline-formula><mml:math id="inf42"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.8</mml:mn><mml:msub><mml:mrow><mml:mo>∙</mml:mo><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>0.2</mml:mn><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> variable into <inline-formula><mml:math id="inf43"><mml:mi>n</mml:mi></mml:math></inline-formula> (fraction of calcium-inactivated I<sub>CaL</sub> channels in the junctional subspace) and <inline-formula><mml:math id="inf44"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> (fraction of calcium-inactivated I<sub>CaL</sub> channels in the main cytosolic ionic pool). These are updated as <inline-formula><mml:math id="inf45"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in the original model, except that <inline-formula><mml:math id="inf46"><mml:mi>n</mml:mi></mml:math></inline-formula> is updated using the calcium concentration in the main cytosolic pool, rather than in junctional subspace.</p></sec></sec><sec id="s24-4"><title>15.3.3.3 Driving force</title><p>Driving force is modelled using the Goldman-Hodgkin-Katz equation as in the original model, but this is computed separately for I<sub>CaL</sub> adjacent to junctional subspace compartment and the main cytosolic ionic pool, using corresponding ionic concentrations and activity coefficients. Activity coefficient <inline-formula><mml:math id="inf47"><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> (activity of ionic specie X, such as Ca, Na, or K in the junctional subspace compartment) is computed dynamically based on Davies equation:<disp-formula id="equ24"><mml:math id="m24"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mrow><mml:mi>X</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi>A</mml:mi><mml:mo>⋅</mml:mo><mml:msubsup><mml:mi>z</mml:mi><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mtext> </mml:mtext><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>⋅</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:msqrt><mml:mi>I</mml:mi></mml:msqrt><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msqrt><mml:mi>I</mml:mi></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>−</mml:mo><mml:mn>0.3</mml:mn><mml:mo>⋅</mml:mo><mml:mi>I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf48"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>X</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mi>A</mml:mi><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow> <mml:mi/><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:msqrt><mml:mi>I</mml:mi></mml:msqrt></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msqrt><mml:mi>I</mml:mi></mml:msqrt></mml:mrow></mml:mfrac><mml:mo>-</mml:mo><mml:mn>0.3</mml:mn><mml:mo>∙</mml:mo><mml:mi>I</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msup></mml:math></inline-formula>, <inline-formula><mml:math id="inf49"><mml:mi>A</mml:mi><mml:mo>=</mml:mo><mml:mn>1.82</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mn>6</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mn>74</mml:mn><mml:mo>∙</mml:mo><mml:mn>310</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1.5</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> is the charge of X, and <inline-formula><mml:math id="inf50"><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow> <mml:mi/></mml:mrow></mml:msubsup></mml:math></inline-formula> is the ionic strength:<disp-formula id="equ25"><mml:math id="m25"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mo>⋅</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msubsup><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf51"><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn><mml:mo>∙</mml:mo><mml:mrow><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>∙</mml:mo><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> is the molarity (I.e. the concentrations used throughout the model, which are given in mM, are divided by 1000 to convert them to M.) of the i-th ion (ToR-ORd takes into account calcium, sodium, potassium, and chloride) in the given compartment, and <inline-formula><mml:math id="inf52"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is its charge.</p><p>In total, three values of ionic strength are used in ToR-ORd for one ionic specie, one for each of the following compartments: extracellular, main intracellular pool, and junctional subspace. This then yields three corresponding activity coefficients for the given ionic specie.</p><sec id="s24-4-1"><title>15.3.3.4 Other changes</title><p><disp-formula id="equ26"><mml:math id="m26"><mml:msub><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula><disp-formula id="equ27"><mml:math id="m27"><mml:msub><mml:mrow><mml:mi>j</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo> <mml:mi/><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>+</mml:mo><mml:mn>18.08</mml:mn></mml:mrow><mml:mrow><mml:mn>2.7916</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ28"><mml:math id="m28"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>j</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>j</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi>j</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>τ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mi>c</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ29"><mml:math id="m29"><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>500</mml:mn> <mml:mi/><mml:mo>(</mml:mo><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">d</mml:mi> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">b</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">h</mml:mi> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">u</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">n</mml:mi> <mml:mi mathvariant="normal"/><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">f</mml:mi> <mml:mi mathvariant="normal"/><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub> <mml:mi/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi> <mml:mi/><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula></p></sec></sec><sec id="s24-5"><title>15.3.4 I<sub>To</sub></title><p><disp-formula id="equ30"><mml:math id="m30"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>8.3757</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup></mml:math></disp-formula></p></sec><sec id="s24-6"><title>15.3.5 I<sub>Kr</sub></title><p>The Lu-Vandenberg (<xref ref-type="bibr" rid="bib44">Lu et al., 2001</xref>) model was used, with structure given in <xref ref-type="fig" rid="fig1">Figure 1B</xref> of the main manuscript. The model is used as published, except with slightly increased <inline-formula><mml:math id="inf53"><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.16</mml:mn></mml:math></inline-formula>, and different conductance. In this section, <inline-formula><mml:math id="inf54"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> without a subscript stands for the fraction of channels in the inactivated state, not for a current.<disp-formula id="equ31"><mml:math id="m31"><mml:mi>I</mml:mi></mml:math></disp-formula><disp-formula id="equ32"><mml:math id="m32"> <mml:mi/><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mn>96485</mml:mn></mml:math></disp-formula><disp-formula id="equ33"><mml:math id="m33"><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mn>8314</mml:mn></mml:math></disp-formula><disp-formula id="equ34"><mml:math id="m34"><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mn>310</mml:mn></mml:math></disp-formula><disp-formula id="equ35"><mml:math id="m35"><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ36"><mml:math id="m36"><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.1161</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>0.299</mml:mn><mml:mo>∙</mml:mo><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ37"><mml:math id="m37"><mml:mi>β</mml:mi><mml:mo>=</mml:mo><mml:mn>0.2442</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1.604</mml:mn> <mml:mi/><mml:mo>∙</mml:mo> <mml:mi/><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ38"><mml:math id="m38"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.25</mml:mn><mml:mo>∙</mml:mo><mml:mn>0.1235</mml:mn></mml:math></disp-formula><disp-formula id="equ39"><mml:math id="m39"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.1911</mml:mn></mml:math></disp-formula><disp-formula id="equ40"><mml:math id="m40"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0578</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>0.971</mml:mn><mml:mo>∙</mml:mo><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ41"><mml:math id="m41"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.349</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1.062</mml:mn> <mml:mi/><mml:mo>∙</mml:mo> <mml:mi/><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ42"><mml:math id="m42"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.2533</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>0.5953</mml:mn><mml:mo>∙</mml:mo><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ43"><mml:math id="m43"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.25</mml:mn><mml:mo>∙</mml:mo><mml:mn>0.0522</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>0.8209</mml:mn> <mml:mi/><mml:mo>∙</mml:mo> <mml:mi/><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ44"><mml:math id="m44"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mi>I</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi>C</mml:mi><mml:mn>2</mml:mn><mml:mi>T</mml:mi><mml:mi>o</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ45"><mml:math id="m45"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.85</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>1.842</mml:mn> <mml:mi/><mml:mo>∙</mml:mo> <mml:mi/><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ46"><mml:math id="m46"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>β</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>α</mml:mi></mml:math></disp-formula><disp-formula id="equ47"><mml:math id="m47"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>α</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo> <mml:mi/> <mml:mi/><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>β</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula><disp-formula id="equ48"><mml:math id="m48"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>O</mml:mi><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>I</mml:mi><mml:msub><mml:mrow><mml:mo>∙</mml:mo><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>C</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mn>2</mml:mn><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>I</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula><disp-formula id="equ49"><mml:math id="m49"><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0321</mml:mn></mml:math></disp-formula></p><p><inline-formula><mml:math id="inf55"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo> <mml:mi/><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msqrt><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:mfrac></mml:msqrt> <mml:mi/><mml:mo>∙</mml:mo><mml:mi>O</mml:mi><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math></inline-formula> stands for extracellular potassium concentration.</p></sec><sec id="s24-7"><title>15.3.6 I<sub>Ks</sub></title><p><disp-formula id="equ50"><mml:math id="m50"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>G</mml:mi><mml:mrow><mml:mi>K</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0011</mml:mn></mml:mrow></mml:mstyle></mml:math></disp-formula></p></sec><sec id="s24-8"><title>15.3.7 I<sub>K1</sub></title><p>The formulation below is based on <xref ref-type="bibr" rid="bib11">Carro et al. (2011)</xref>, updated to take into account that extracellular potassium in our model is 5 mM, rather than 5.4.<disp-formula id="equ51"><mml:math id="m51"><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0011</mml:mn></mml:math></disp-formula><disp-formula id="equ52"><mml:math id="m52"><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>4.094</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>0.1217</mml:mn><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>49.934</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ53"><mml:math id="m53"><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>15.72</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>0.0674</mml:mn><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>3.257</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>0.0618</mml:mn><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mn>594.31</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>0.1629</mml:mn><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>14.207</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ54"><mml:math id="m54"><mml:mi>K</mml:mi><mml:msub><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>b</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub> <mml:mi/></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ55"><mml:math id="m55"><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.6992</mml:mn></mml:math></disp-formula></p></sec><sec id="s24-9"><title>15.3.8 I<sub>NaCa</sub></title><p><disp-formula id="equ56"><mml:math id="m56"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msqrt><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>5</mml:mn></mml:mrow></mml:mfrac></mml:msqrt><mml:mo>∙</mml:mo><mml:mi>K</mml:mi><mml:msub><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>S</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula></p><p>Fraction of NCX in the junctional subspace was set to 0.35.</p></sec><sec id="s24-10"><title>15.3.9 I<sub>NaK</sub></title><p><disp-formula id="equ57"><mml:math id="m57"><mml:msub><mml:mrow><mml:mi>G</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>C</mml:mi><mml:mi>X</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0034</mml:mn></mml:math></disp-formula></p></sec><sec id="s24-11"><title>15.3.10 I<sub>(Ca)Cl</sub></title><p>This current is placed within the junctional subspace<disp-formula id="equ58"><mml:math id="m58"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>a</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>15.4509</mml:mn></mml:math></disp-formula></p></sec><sec id="s24-12"><title>15.3.11 I<sub>Clb</sub></title><p><disp-formula id="equ59"><mml:math id="m59"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi></mml:mrow></mml:mfenced><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>0.2843</mml:mn><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>0.1</mml:mn></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac></mml:math></disp-formula></p></sec><sec id="s24-13"><title>15.3.12 I<sub>Kb</sub></title><p><disp-formula id="equ60"><mml:math id="m60"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>l</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.98</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula><disp-formula id="equ61"><mml:math id="m61"><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>-</mml:mo> <mml:mi/><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:mn>10.8968</mml:mn></mml:mrow><mml:mrow><mml:mn>23.9871</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula></p></sec><sec id="s24-14"><title>15.3.13 I<sub>Cab</sub></title><p><disp-formula id="equ62"><mml:math id="m62"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>0.0189</mml:mn><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>E</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></disp-formula><disp-formula id="equ63"><mml:math id="m63"><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mi>F</mml:mi><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ64"><mml:math id="m64"><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mi>V</mml:mi><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mo>∙</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:mfrac></mml:math></disp-formula></p><p>The second half of the right hand side (from <inline-formula><mml:math id="inf56"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>5.9194</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mo>∙</mml:mo><mml:mn>4</mml:mn><mml:mo>∙</mml:mo><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi><mml:mo>∙</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>∙</mml:mo><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>∙</mml:mo><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac></mml:math></inline-formula> on, inclusive) is the Goldman-Hodgkin-Katz driving force; <inline-formula><mml:math id="inf57"><mml:mi>v</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>t</mml:mi></mml:math></inline-formula> is the activity coefficient of intracellular calcium (in the main ionic pool), and <inline-formula><mml:math id="inf58"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the activity coefficient of extracellular calcium.</p></sec><sec id="s24-15"><title>15.3.14 I<sub>Nab</sub></title><p><disp-formula id="equ65"><mml:math id="m65"><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:msub></mml:math></disp-formula></p></sec><sec id="s24-16"><title>15.3.15 J<sub>rel</sub></title><p><disp-formula id="equ66"><mml:math id="m66"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mi>a</mml:mi><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.9238</mml:mn><mml:mo>∙</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:math></disp-formula><disp-formula id="equ67"><mml:math id="m67"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.7</mml:mn></mml:math></disp-formula><disp-formula id="equ68"><mml:math id="m68"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>N</mml:mi><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>J</mml:mi><mml:mi>S</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula><disp-formula id="equ69"><mml:math id="m69"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mi>∞</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>M</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:mo>(</mml:mo><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>L</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>∞</mml:mi><mml:mo>,</mml:mo><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>J</mml:mi><mml:mi>S</mml:mi><mml:mi>R</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></disp-formula></p></sec><sec id="s24-17"><title>15.3.16 J<sub>up</sub></title><p><disp-formula id="equ70"><mml:math id="m70"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1.5378</mml:mn><mml:mo>∙</mml:mo><mml:mfenced separators="|"><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>∅</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>M</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>∅</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>M</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub><mml:mo>∙</mml:mo><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>M</mml:mi><mml:mi>K</mml:mi></mml:mrow></mml:msub> <mml:mi/></mml:math></disp-formula><disp-formula id="equ71"><mml:math id="m71"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>J</mml:mi><mml:mrow><mml:mi>u</mml:mi><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>2.75</mml:mn><mml:mo>⋅</mml:mo><mml:mn>0.005425</mml:mn><mml:mo>⋅</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>0.00092</mml:mn><mml:mo>−</mml:mo><mml:mn>0.00017</mml:mn><mml:mo>+</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mtext> </mml:mtext></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:math></disp-formula><disp-formula id="equ72"><mml:math id="m72"><mml:msub><mml:mrow><mml:mi>J</mml:mi></mml:mrow><mml:mrow><mml:mi>u</mml:mi><mml:mi>p</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>0.005425</mml:mn><mml:mo>∙</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>0.00092</mml:mn><mml:mo>-</mml:mo><mml:mn>0.00017</mml:mn><mml:mo>+</mml:mo><mml:mi>C</mml:mi><mml:msub><mml:mrow><mml:mi>a</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub> <mml:mi/></mml:mrow></mml:mfrac></mml:math></disp-formula></p></sec></sec></boxed-text></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.48890.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Faraldo-Gómez</surname><given-names>José D</given-names></name><role>Reviewing Editor</role><aff><institution>National Heart, Lung and Blood Institute, National Institutes of Health</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Hund</surname><given-names>Thomas</given-names> </name><role>Reviewer</role><aff><institution>The Ohio State University</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Maleckar</surname><given-names>Molly</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This work constitutes a significant advancement in the field of theoretical cardiac electrophysiology. Not only is the proposed mathematical model of the human ventricular myocyte an improvement over existing models, in terms of its correspondence with experimental data and its potential to accelerate therapeutic developments in human cardiac electrophysiology; in addition, the calibration and validation of this model also exemplifies a rigorous methodology that will hopefully become standard in this field.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by José D. Faraldo-Gómez as Reviewing Editor and Naama Barkai as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Thomas Hund (Reviewer #1); Molly Maleckar (Reviewer #3).</p><p>Although it is customary for <italic>eLife</italic> to condense reviewers' reports into a concise decision letter, in this case the Reviewing Editor believes it would be best to enclose these reports as originally submitted. Based on these reports, we would like to invite you to submit a revised version of your manuscript that addresses the questions and concerns raised.</p><p><italic>Reviewer #1:</italic></p><p>This paper presents a modified model of the human ventricular action potential based on a published model from the Rudy group (O'hara Rudy – ORd model). Changes were made to improve the ability of the model to reproduce different aspects of the action potential – especially the plateau potential and APD accommodation. To achieve this goal, Tomek et al. modified the L-Type calcium channel, as well as replacing the formulation of the sodium channel and rapid delayed rectifier channel. The L-Type channel was modified by re-deriving the ionic activity, and treating it as variable in subspaces and time. The L-Type was then also refit using the activation curve normalized to the GHK driving force, rather than the Nerst driving force as was done previously. Additionally, the formulation of the sodium channel was replaced with a version from Grandi et al., 2010, and I<sub>Kr</sub> was replaced with a version from Lu et al., 2001. The changes were than fit to data from the original O'Hara Rudy paper and elsewhere. Finally, the model was validated against APD accommodation from O'Hara, 2011, drug safety predictions, and more, including ECG results from whole heart simulations. This model introduces several notable improvements to the O'Hara Rudy model that will be of interest to mathematical modeling researchers.</p><p>1) Chloride current is added to the model without fitting or showing how it affects the model. Additionally, it would be helpful to have a justification of why these currents were added, as well as validated.</p><p>2) In Figure 2, inclusion of the other main dataset used by O'Hara to fit the L-Type channel would help in the comparison of the new L-Type formulation to the old formulation. (Fulop et al., 2004).</p><p>3) In Figure 5, the fit of the fifth drug, BaCl<sub>2</sub>, would still be interesting to see as it was used in both O'Hara and Dutta et al., 2017, despite BaCl<sub>2</sub> having off-target effects.</p><p>4) Please review all equations for typos.</p><p><italic>Reviewer #2:</italic></p><p>Tomek et al. have put a tremendous amount of effort into improving the O'Hara et al. mathematical model of the human ventricular myocyte. The correspondence of the new model with experimental data is quite impressive, and the authors have done a laudable job of separating the calibration and validation steps in model development. Because these steps have often been combined and/or blurred in previous work in this field, the study provides additional rigor by separating the two steps. Moreover, given the central importance of the O'Hara et al. model in the field, there is a need for improvements, and this work most likely represents a major step in the right direction. These are all reasons to like the paper.</p><p>All of that being said, there are certain aspects of the manuscript that are rather confusing and need to be improved. Although the comments below may seem excessive to the authors, it did in fact take multiple readings and considerable additional thinking for this reviewer to fully comprehend some of what the authors had done. It can be a difficult goal to achieve, but the authors should aim for a paper that can be readily understood, even by non-experts, after a single reading. The manuscript doesn't meet that standard at present.</p><p>1) One of the most interesting aspects of the manuscript is the discussion of activity coefficients, I<sub>CaL</sub> current-voltage plots, and the extraction of activation curves (subsection “In-depth revision of the L-type calcium current”). The reviewer absolutely concurs that because many formulations have been inherited from previous models, often without rigorous examination of these formulations, it is entirely appropriate to examine these assumptions and re-formulate currents if necessary. However, this discussion is ultimately unconvincing, and the presentation needs to be modified for this section to be fully understood.</p><p>1a) The discussion of the activity coefficients is interesting and will be informative to readers unfamiliar with this primary literature. However, although the authors make a compelling case that different activity coefficients, i.e. closer to 0.6, should be used, the manuscript leaves out the most important question, namely: how do these changes affect the I-V curves?</p><p>1b) Speaking of I-V curves, examination of Figure 1D makes a convincing case that the new model has a different shape and matches the experimental data better. However, it's not clear why this occurs – what allows this better fit? Is this due to the changes in activity coefficients? Is it just from the better activation curve shown in Figure 1C? Another fact that can affect this curve is the relative permeability of the channel to Na and K compared with Ca. It's odd that this is never addressed in the manuscript. Did the authors modify this to try to fit the curves better, or were these numbers considered fixed based on original data?</p><p>1c) The term &quot;driving force&quot; is used in the manuscript in a way that is inconsistent with prior literature. One of the appeals of Ohmic formulations is that driving force is expressed in units of volts, and conductance can be derived from current plots by simple division. But with a GHK formulation, things are not so simple. The term called &quot;driving force&quot; here does not appear to be in units of volts, so what exactly is this term representing?</p><p>1d) Finally, on this same topic, the Discussion states: &quot;Activation curve of the current in previous cardiac models was based on the use of Nernst driving force in experimental studies, but the models then used Goldman-Hodgkin-Katz driving force to compute the current.&quot; Again, it's not completely clear how the authors derive one set of numbers (i.e. activation at defined voltages) from a different set of numbers (i.e. current at those same voltages). As I have been writing this, it has occurred to me that perhaps the units of driving force are less relevant, as long as one set of numbers can be multiplied by a different set of numbers to ultimately produce current. However, the fact that I've had to think so hard about this demonstrates that the manuscript needs to do better. Because the I<sub>CaL</sub> formulation is claimed in the Discussion as &quot;the greatest theoretical contribution of this work,&quot; the explanations here need to be crystal clear. Perhaps the supplement should contain flow charts of the conventional method for extracting I<sub>CaL</sub> activation versus how the new approach improves this, as well as plots showing how the changes to the activity coefficients influence the IV curves.</p><p>2) The discussion of Na current blockade and inotropy is relatively weak. Perhaps the authors need to reproduce some original experimental data, or, at the very least, provide some numbers extracted from the earlier studies. The description of Figure 3 discusses the &quot;negative inotropy&quot; previously reported with Na channel blockers, but with no numbers provided. The change in Ca transient amplitude shown in Figure 3C is very small, probably undetectable experimentally. If experiments have reported a 50% decrease in contraction strength, I would say that neither model is consistent, although ToR-ORd is slightly better. Obviously the heatmaps in 3E and 3F provide additional information, but in general here the correspondence with data can be discussed in a more quantitative way. In the Discussion, the phrase &quot;good response of the ToR-ORd model to sodium blockade&quot; sticks out as rather vague.</p><p>2a) Again on the Na channel block-inotropy issue. The authors have an opportunity to obtain new mechanistic insight here given that the response of the two models is different. My suspicion is that it might have less to do with the AP morphology, as speculated in the Discussion, and more to do with intracellular [Na] regulation. However, since mechanisms are not explored, we don't know which idea is correct. It might be considered beyond the scope of this study to obtain this mechanistic insight, but it's an interesting question, and the new model provides a means for addressing it.</p><p>3) The description of hyperkalemia simulation in Figure 8 should be improved. First, the text claims that Figure 8A shows a &quot;progressive&quot; increase in resting potential and slowing of upstroke velocity. But since the figure only shows 2 examples, it's hard to see that this is progressive. Second, PRR is used in this description but has not been previously defined. It took a few seconds to figure out what the authors meant. Is it really necessary to have an abbreviation for a term that's only used once in the manuscript?</p><p>4) The last paragraph of the Discussion, discussing future directions, should be modified. This paragraph states: &quot;Similarly to most existing cardiac models, the equations governing the release depend directly on the L-type calcium current, rather than on the calcium concentration adjacent to the ryanodine receptors, which is the case in cardiomyocytes. Future development of the ryanodine receptor model and calcium handling will extend the applicability of the model.…&quot;</p><p>The first sentence is correct, the second is not. The challenge is not to improve the representation of the ryanodine receptor. This will not fix the problems; the problems arise from the fact that Ca release in cells is controlled locally rather than globally – this is why whole cell models, that use a single variable to describe ryanodine receptor gating, need to use shortcuts such as making release directly dependent on I<sub>CaL</sub>. This general problem was rigorously analyzed by Stern way back in 1992 (PMID: 1330031). For more discussion, see also PMIDs: 15465866, 20346962, 21586292.</p><p>It's great to discuss potential future improvements to the EC coupling part of the model, but these discussions should acknowledge that the issue is not just improving the RyR model, but that stochastic triggering of locally-controlled Ca sparks will need to be described.</p><p><italic>Reviewer #3:</italic></p><p>Mature models and simulation techniques in human cardiac electrophysiology can now be exploited to accelerate therapeutic development and validation e.g. devices, drug development/cardiotoxicity. The authors identify key weaknesses in a model of the human ventricular action potential (ORd, which has been chosen previously by an expert-led initiative to represent the human ventricular AP in validation studies incorporating models and simulation), and present an updated (novel) model of the human AP, the ToR-ORd, to address these.</p><p>Overall, the work addresses an important need: in order to effectively translate value from models and simulations in the hoped-for context of human ventricular electrophysiology, the primary model's weaknesses must absolutely be addressed for utility, and so I would consider this work far beyond incremental and a very useful contribution in terms of model to the field at this juncture. The work also nicely leverages a plethora of prior experimental work using direct electrophysiological measurements for calibration and validation. In general, the work is very well organized and well-written.</p><p>Comments:</p><p>- Cogent, well-motivated Introduction. Weaknesses of ORd (AP plateau potential, APD adaptation and response to sodium current block) and solutions (L-type calcium, excitation contraction coupling and hERG current re-assessment and reformulations) clear.</p><p>- Overall goal to design, develop, calibrate and validate the novel ToR-ORd model, with aim of reproducing all key depolarization, repolarization and calcium dynamics properties in healthy human ventricular cells and when these are under drug block, as well as in diseased conditions e.g. hyperkalemia and hypertrophic cardiomyopathy is both timely and useful.</p><p>- Importantly, calibration and validation processes are independent, using independent datasets</p><p>- &quot;The I<sub>CaL</sub> current was deeply revisited, particularly with respect to its driving force, based on biophysical principles.&quot; – well-motivated, needed, seldom done, valuable to other models. &quot;This allows accurate representation of the driving force when ionic concentrations are disturbed,&quot;</p><p>- Really encouraging to see disease-based, multi-scale validation of this nature. Impact for translational work made abundantly clear.</p><p>Concerns/areas to address:</p><p>1) Given the journal's wide appeal, there is a need to better introduce the strategy and process going into the Materials and methods section, from &quot;We initially performed the evaluation of the ORd model (O'Hara et al., 2011) against calibration criteria…&quot;. While I appreciated the simplicity of explanation in general, this guiding summary can be improved to clarify what was initially done and why and how the strategy developed</p><p>2) It's also not immediately clear what the calibration criteria actually are (Table 1) – I assume that, in addition to the listed references, that these exist in a supplement somewhere and it would be great to point the reader to this</p><p>3) &quot;Simulations with the existing versions of the ORd model failed to fulfil key criteria such as AP morphology, calcium transient duration, several properties of the L-type calcium current, negative inotropic effect of sodium blockers, or the depolarising effect of I<sub>K1</sub> block&quot; – where is this shown? Is there a supplementary figure?</p><p>4) In-depth revisions based on fundamental physical principles is a much-needed process. Some motivation and/or discussion of the state of the art in this particular field (i.e. how some attention to the underlying biophysics was laid by the wayside in model redevelopment, experimental assimilation, and subsequent versioning, and conjectures as to why e.g. computational tools like versioning tools did not exist, would be appropriate</p><p>5) Given the progressive, savvy lean of this work, it seems reasonable to ask why authors did not consider making the code available in other formats, e.g. python as well, or at least justify/mention the relevance of language and tools for reuse/reproducibility/versioning. Similarly, reference to other recent forays into systematic model improvement, e.g. functional curation and web lab, seems warranted</p><p>6) Results: &quot;This [ToR-ORd model yields negative I<sub>CaL</sub> values in such conditions] is a direct consequence of the updates to the extracellular/intracellular calcium activity coefficients, which supports its credibility and it is important for cases of elevated I<sub>CaL</sub>, such as under ß-adrenergic stimulation.&quot; – while this is likely true, it also seems likely a throwaway – were any simulations run using the model to demonstrate the importance in this vein? Important how?</p><p>7) Results/Figure 3: Besides noting that the ToR-ORd is consistent with observed negative inotropy of sodium blockers, it is unclear from text how updated model compares in terms of available experimental data, i.e. &quot;A mild increase in inotropy may be achieved only under near-exclusive I<sub>Na</sub> block.&quot; – or whether this comparison is available at all.</p><p>8) Figure 5A, B, C – the slope of the APD90 dependence on BCL for the ToR-ORd differs consistently from that of the data for BCLs &gt; 1s – any musings as to mechanism? Either briefly in main text or supplement.</p><p>9) Figure 6C: would strengthen the case for the ToR-ORd further to compare restitution for ORd in a fibre under same protocol?</p><p>10) Seems like suitability of ToR-ORd for drug safety testing is clear – and discussion around this is adequate and encouraging. However, there still does not seem to be a marked improvement in the example given over the ORd (Figure 7), particularly in terms of false negatives. Authors note &quot;further improvement to the score is likely with development of a population optimised towards drug safety assessment&quot; – so it will be interesting to see results there.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.48890.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>1) Chloride current is added to the model without fitting or showing how it affects the model. Additionally, it would be helpful to have a justification of why these currents were added, as well as validated.</p></disp-quote><p>The chloride currents were parametrised exactly as in Grandi et al., 2010, (only the conductances were adjusted). We have now added a more detailed description of their effect and justification in the Materials and methods.</p><p>“The motivation to add these currents was to facilitate the shaping of post-peak AP morphology (via I<sub>(Ca)Cl</sub>), with I<sub>Clb</sub> playing a dual role stemming from its reversal potential of ca. -50 mV. It slightly reduces plateau potentials during the action potential, but during the diastole, it depolarises the cell slightly, improving the reaction to I<sub>K1</sub> block as explained in the next subsection.”</p><disp-quote content-type="editor-comment"><p>2) In Figure 2, inclusion of the other main dataset used by O'Hara to fit the L-Type channel would help in the comparison of the new L-Type formulation to the old formulation. (Fulop et al., 2004).</p></disp-quote><p>Thank you for the comment. We have now simulated this protocol and added it as Appendix 1—figure 4, with a mention in the main manuscript. Simulated data with the ToR-ORd are similar to the experimental recordings and the ones obtained with the ORd in that a) the short pulse-curve lies above the long-pulse curve, b) the shorter coupling interval is associated with less current availability. Both models yield an offset with respect to the experimental data. This could be due to a) Difference in I<sub>CaL</sub> behaviour/density and/or calcium loading (affecting inactivation) between the Fülöp (P2/P1 protocol) and Magyar (the main basis for the I<sub>CaL</sub> model) studies i.e., it is possible that even the living cells could manifest different properties. It could be also linked to mechanisms of I<sub>CaL</sub> inactivation not represented in the model (e.g. the inactivation by the calcium flow through the channel, represented e.g., by Mahajan et al., 2008). If we accelerate I<sub>CaL</sub> inactivation, we observed that the model stopped being capable of manifesting EADs, which is a very important feature, and losing it would make the model less useful than in the current form. We speculate that a more complex model structure as well as calcium-sensitive SR release may be required to achieve a model with sufficiently fast inactivation, but which is nevertheless capable of manifesting EADs. This is future work that we will most likely work on in the future, but it is currently well beyond the scope of this paper.</p><disp-quote content-type="editor-comment"><p>3) In Figure 5, the fit of the fifth drug, BaCl<sub>2</sub>, would still be interesting to see as it was used in both O'Hara and Dutta et al., 2017, despite BaCl<sub>2</sub> having off-target effects.</p></disp-quote><p>Thank you for this comment. We have now included an explanation in the manuscript as to why we chose not to include a comparison to BaCl<sub>2</sub> (Main text subsection “Validation: Drug-induced effects on rate dependence of APD” and Appendix 1 subsection “Validation: Drug block and APD”). This is fundamentally due to the uncertainty concerning its multichannel effects on several potassium currents, in addition to I<sub>K1</sub>. It was previously shown that BaCl<sub>2</sub> blocks also I<sub>Kr</sub> and I<sub>Ks</sub> at the used concentration (Weerapura et al., 2000; Gibor et al., 2004). Furthermore, as shown in (DOI 10.1371/journal.pone.0053255), even a lower dose of BaCl<sub>2</sub> prolongs the AP plateau and early phase of repolarization, thus at membrane potentials at which I<sub>K1</sub> is not activated. This supports the supposition that BaCl<sub>2</sub> is likely to block I<sub>Kr</sub> and I<sub>Ks</sub>, in addition to I<sub>K1</sub>, but to an uncertain degree. Furthermore, pure block of I<sub>K1</sub> in the ORd model results in APD prolongation from around -50mV only, which indicates a clear discrepancy with the experimental data.</p><disp-quote content-type="editor-comment"><p>4) Please review all equations for typos.</p></disp-quote><p>Thank you, we have double-checked the equations.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…] All of that being said, there are certain aspects of the manuscript that are rather confusing and need to be improved. Although the comments below may seem excessive to the authors, it did in fact take multiple readings and considerable additional thinking for this reviewer to fully comprehend some of what the authors had done. It can be a difficult goal to achieve, but the authors should aim for a paper that can be readily understood, even by non-experts, after a single reading. The manuscript doesn't meet that standard at present.</p><p>1) One of the most interesting aspects of the manuscript is the discussion of activity coefficients, I<sub>CaL</sub> current-voltage plots, and the extraction of activation curves (subsection “In-depth revision of the L-type calcium current”). The reviewer absolutely concurs that because many formulations have been inherited from previous models, often without rigorous examination of these formulations, it is entirely appropriate to examine these assumptions and re-formulate currents if necessary. However, this discussion is ultimately unconvincing, and the presentation needs to be modified for this section to be fully understood.</p></disp-quote><p>Thank you for highlighting the importance of this point. Following the reviewer’s suggestions, we have substantially expanded the description of the implications of the reformulation of the I<sub>CaL</sub> properties, with new results and discussion. This is explained in more detailed in the following sub-points.</p><disp-quote content-type="editor-comment"><p>1a) The discussion of the activity coefficients is interesting and will be informative to readers unfamiliar with this primary literature. However, although the authors make a compelling case that different activity coefficients, i.e. closer to 0.6, should be used, the manuscript leaves out the most important question, namely: how do these changes affect the I-V curves?</p></disp-quote><p>Thanks for the comment. We have now introduced/expanded sections in Appendix 1, subsections “I<sub>CaL</sub> updates and the I-V relationship”, “I<sub>CaL</sub> reversal and ionic activity coefficients” and “Role of I<sub>CaL</sub> properties and AP morphology in calcium transient changes by sodium blockade” to explain the effect of the revision of the activity coefficients more clearly. The shape of the I-V relationship is affected predominantly by the update of the activation curve as shown in Appendix 1—figure 2. This supports the case that the activation curve needs to be extracted by considering the Goldman-Hodgkin-Katz (GHK) driving force in models which use the GHK equation to compute the L-type calcium current (as explained in the Materials and methods subsection “Activation curve extraction”).</p><p>The activity coefficients themselves have an important contribution in the improved response to sodium block (Appendix 1 subsection “Role of I<sub>CaL</sub> properties and AP morphology in calcium transient changes by sodium blockade”) and also in avoiding the reversal of the I<sub>CaL</sub> to outward current (Figure 2F), which is exhibited by the ORd model, (Appendix 1—figure 6).</p><disp-quote content-type="editor-comment"><p>1b) Speaking of I-V curves, examination of Figure 1D makes a convincing case that the new model has a different shape and matches the experimental data better. However, it's not clear why this occurs – what allows this better fit? Is this due to the changes in activity coefficients? Is it just from the better activation curve shown in Figure 1C? Another fact that can affect this curve is the relative permeability of the channel to Na and K compared with Ca. It's odd that this is never addressed in the manuscript. Did the authors modify this to try to fit the curves better, or were these numbers considered fixed based on original data?</p></disp-quote><p>As mentioned in the previous comment, we have now dissected the role of activation curve versus activity coefficients in Appendix 1, subsections “I<sub>CaL</sub> updates and the I-V relationship”, “I<sub>CaL</sub> reversal and ionic activity coefficients” and “Role of I<sub>CaL</sub> properties and AP morphology in calcium transient changes by sodium blockade”. The relative permeability to Na and K was kept as in the original ORd model; their ratio to Ca permeability was kept constant, given that the data were not challenged by new evidence.</p><disp-quote content-type="editor-comment"><p>1c) The term &quot;driving force&quot; is used in the manuscript in a way that is inconsistent with prior literature. One of the appeals of Ohmic formulations is that driving force is expressed in units of volts, and conductance can be derived from current plots by simple division. But with a GHK formulation, things are not so simple. The term called &quot;driving force&quot; here does not appear to be in units of volts, so what exactly is this term representing?</p></disp-quote><p>This is addressed together with the following comment.</p><disp-quote content-type="editor-comment"><p>1d) Finally, on this same topic, the Discussion states: &quot;Activation curve of the current in previous cardiac models was based on the use of Nernst driving force in experimental studies, but the models then used Goldman-Hodgkin-Katz driving force to compute the current.&quot; Again, it's not completely clear how the authors derive one set of numbers (i.e. activation at defined voltages) from a different set of numbers (i.e. current at those same voltages). As I have been writing this, it has occurred to me that perhaps the units of driving force are less relevant, as long as one set of numbers can be multiplied by a different set of numbers to ultimately produce current. However, the fact that I've had to think so hard about this demonstrates that the manuscript needs to do better. Because the I<sub>CaL</sub> formulation is claimed in the Discussion as &quot;the greatest theoretical contribution of this work,&quot; the explanations here need to be crystal clear. Perhaps the supplement should contain flow charts of the conventional method for extracting I<sub>CaL</sub> activation versus how the new approach improves this, as well as plots showing how the changes to the activity coefficients influence the IV curves.</p></disp-quote><p>Thank you for this suggestion. We have addressed this issue by adding a block of text at the start of the Materials and methods subsection “In-depth revision of the L-type calcium current”which clarifies the term “driving force” in the manuscript (a number that multiplies conductance/permeability and gating variables to produce total current). In addition, we have included a diagram and explanation in Appendix 1—figure 3 illustrating the extraction of activation curve. Together with the newly added Appendix subsections “ICaL updates and the I-V relationship”, “ICaL reversal and ionic activity coefficients” and “Role of ICaL properties and AP morphology in calcium transient changes by sodium blockade”, the manuscript now gives quantitative insight into the effects of the updates to I<sub>CaL</sub> introduced in our work.</p><disp-quote content-type="editor-comment"><p>2) The discussion of Na current blockade and inotropy is relatively weak. Perhaps the authors need to reproduce some original experimental data, or, at the very least, provide some numbers extracted from the earlier studies. The description of Figure 3 discusses the &quot;negative inotropy&quot; previously reported with Na channel blockers, but with no numbers provided. The change in Ca transient amplitude shown in Figure 3C is very small, probably undetectable experimentally. If experiments have reported a 50% decrease in contraction strength, I would say that neither model is consistent, although ToR-ORd is slightly better. Obviously the heatmaps in 3E and 3F provide additional information, but in general here the correspondence with data can be discussed in a more quantitative way. In the Discussion, the phrase &quot;good response of the ToR-ORd model to sodium blockade&quot; sticks out as rather vague.</p></disp-quote><p>We have now added a more detailed comparison to available clinical data in the manuscript, subsection “Calibration: Inotropic effects of sodium blockers”).</p><p>The 15% reduction in CaT amplitude observed with sodium block in fibre simulations with the ToR-ORd model (Appendix 1 subsection “Summary of literature on sodium blockers, I<sub>Na</sub>, and I<sub>NaL</sub> reduction”) is consistent with experimental measurements (showing changes of 9-28%, depending on the study and index of contractility). A quantitative comparison is challenging given the different measures of inotropic properties. Furthermore, the degree of I<sub>Na</sub> and I<sub>NaL</sub> block is estimated rather than known with precision, as also discussed in Appendix 1. Thus, the drugs studied may block I<sub>Na</sub> and I<sub>NaL</sub> in a different ratio than 50:50 (suggesting I<sub>NaL</sub> block may be stronger than I<sub>Na</sub> block; Appendix 1, subsection “Role of I<sub>CaL</sub> properties and AP morphology in calcium transient changes by sodium blockade”), potentially also altering the CaT amplitude reduction in simulations.</p><disp-quote content-type="editor-comment"><p>2a) Again on the Na channel block-inotropy issue. The authors have an opportunity to obtain new mechanistic insight here given that the response of the two models is different. My suspicion is that it might have less to do with the AP morphology, as speculated in the Discussion, and more to do with intracellular [Na] regulation. However, since mechanisms are not explored, we don't know which idea is correct. It might be considered beyond the scope of this study to obtain this mechanistic insight, but it's an interesting question, and the new model provides a means for addressing it.</p></disp-quote><p>We have now offered mechanistic insight into this issue in Appendix 1, subsection “Calibration: I<sub>CaL</sub> block and I<sub>Kr</sub> replacement”. We provide the results of additional simulations using AP clamping and selective addition of I<sub>CaL</sub> updates to dissect how the different updates contribute to the sodium block simulation results. The data demonstrate the importance of AP morphology, as shown in Appendix—table 1, and also Appendix 1—figure 7. We agree with the reviewer that further investigations into sodium regulation could be the focus of future studies.</p><disp-quote content-type="editor-comment"><p>3) The description of hyperkalemia simulation in Figure 8 should be improved. First, the text claims that Figure 8A shows a &quot;progressive&quot; increase in resting potential and slowing of upstroke velocity. But since the figure only shows 2 examples, it's hard to see that this is progressive. Second, PRR is used in this description but has not been previously defined. It took a few seconds to figure out what the authors meant. Is it really necessary to have an abbreviation for a term that's only used once in the manuscript?</p></disp-quote><p>Thank you for bringing this to our attention; we rewrote PRR as postrepolarization refractoriness, and we removed the “progressive”.</p><disp-quote content-type="editor-comment"><p>4) The last paragraph of the Discussion, discussing future directions, should be modified. This paragraph states: &quot;Similarly to most existing cardiac models, the equations governing the release depend directly on the L-type calcium current, rather than on the calcium concentration adjacent to the ryanodine receptors, which is the case in cardiomyocytes. Future development of the ryanodine receptor model and calcium handling will extend the applicability of the model.…&quot;</p><p>The first sentence is correct, the second is not. The challenge is not to improve the representation of the ryanodine receptor. This will not fix the problems; the problems arise from the fact that Ca release in cells is controlled locally rather than globally – this is why whole cell models, that use a single variable to describe ryanodine receptor gating, need to use shortcuts such as making release directly dependent on I<sub>CaL</sub>. This general problem was rigorously analyzed by Stern way back in 1992 (PMID: 1330031). For more discussion, see also PMIDs: 15465866, 20346962, 21586292.</p><p>It's great to discuss potential future improvements to the EC coupling part of the model, but these discussions should acknowledge that the issue is not just improving the RyR model, but that stochastic triggering of locally-controlled Ca sparks will need to be described.</p></disp-quote><p>Thank you for the comment. We have now rephrased this part of Discussion, acknowledging more possible future directions in line with the reviewer’s suggestions.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>Comments:</p><p>- Cogent, well-motivated Introduction. Weaknesses of ORd (AP plateau potential, APD adaptation and response to sodium current block) and solutions (L-type calcium, excitation contraction coupling and hERG current re-assessment and reformulations) clear.</p><p>- Overall goal to design, develop, calibrate and validate the novel ToR-ORd model, with aim of reproducing all key depolarization, repolarization and calcium dynamics properties in healthy human ventricular cells and when these are under drug block, as well as in diseased conditions e.g. hyperkalemia and hypertrophic cardiomyopathy is both timely and useful.</p><p>- Importantly, calibration and validation processes are independent, using independent datasets</p><p>- &quot;The ICaL current was deeply revisited, particularly with respect to its driving force, based on biophysical principles.&quot; – well-motivated, needed, seldom done, valuable to other models. &quot;This allows accurate representation of the driving force when ionic concentrations are disturbed,&quot;</p><p>- Really encouraging to see disease-based, multi-scale validation of this nature. Impact for translational work made abundantly clear.</p><p>Concerns/areas to address:</p><p>1) Given the journal's wide appeal, there is a need to better introduce the strategy and process going into the Materials and methods section, from &quot;We initially performed the evaluation of the ORd model (O'Hara et al., 2011) against calibration criteria…&quot;. While I appreciated the simplicity of explanation in general, this guiding summary can be improved to clarify what was initially done and why and how the strategy developed.</p></disp-quote><p>Thank you for this comment. We have now provided further clarifications in the section.</p><disp-quote content-type="editor-comment"><p>2) It's also not immediately clear what the calibration criteria actually are (Table 1) – I assume that, in addition to the listed references, that these exist in a supplement somewhere and it would be great to point the reader to this.</p></disp-quote><p>We have added a new section Appendix 1 subsection “Calibration criteria” which concretely discusses the calibration criteria in greater detail.</p><disp-quote content-type="editor-comment"><p>3) &quot;Simulations with the existing versions of the ORd model failed to fulfil key criteria such as AP morphology, calcium transient duration, several properties of the L-type calcium current, negative inotropic effect of sodium blockers, or the depolarising effect of I<sub>K1</sub> block&quot; – where is this shown? Is there a supplementary figure?</p></disp-quote><p>We have now clarified where the results are shown:</p><p>“Simulations with the existing versions of the ORd model failed to fulfil key criteria such as AP morphology, calcium transient duration, several properties of the L-type calcium current, negative inotropic effect of sodium blockers, or the depolarising effect of I<sub>K1</sub> block” (later shown in Figures 2, 3, and Materials and methods subsection “Calibration of I<sub>K1</sub> block and resting membrane potential”).</p><disp-quote content-type="editor-comment"><p>4) In-depth revisions based on fundamental physical principles is a much-needed process. Some motivation and/or discussion of the state of the art in this particular field (i.e. how some attention to the underlying biophysics was laid by the wayside in model redevelopment, experimental assimilation, and subsequent versioning, and conjectures as to why e.g. computational tools like versioning tools did not exist, would be appropriate.</p></disp-quote><p>Our approach of clear calibration criteria and using the genetic algorithm for parameter fitting was very helpful in identifying properties that needed revising from fundamental physical principles. This allowed to effectively identify first the I<sub>CaL</sub> properties and then the I<sub>Kr</sub> structure as the two critical aspects that required in depth revisiting, based also on AP morphology. It was very useful to be able to test the effect of different I<sub>Kr</sub> model structures, which needed manual coding from the papers. Initiatives such as cellML make this process more efficient, and this is why we share our code in such format. Also to facilitate versioning of this model, we are posting on github. We have now specified these points both in Materials and methods and Discussion.</p><disp-quote content-type="editor-comment"><p>5) Given the progressive, savvy lean of this work, it seems reasonable to ask why authors did not consider making the code available in other formats, e.g. python as well, or at least justify/mention the relevance of language and tools for reuse/reproducibility/versioning. Similarly, reference to other recent forays into systematic model improvement, e.g. functional curation and web lab, seems warranted.</p></disp-quote><p>Matlab was chosen as it’s one of the most widely used tools for cardiac simulations. Our practical experience is that it is very convenient tool for model development, given the way in which it integrates capabilities of simulation, visualisation, analysis, and introspection (via debugger which is an excellent tool to get insight into why the model behaves in a particular way).</p><p>CellML was chosen as the leading standard of model formulations, and as it can be used in simulators such as Chaste or OpenCOR, and as it may be imported into other platforms including the Myokit library which can convert CellML to Python or C, making it a very flexible format. Furthermore, we also provide an evaluation pipeline to facilitate model validation and future work. We extended the Materials and methods subsection “Evaluation pipeline and code” to explicitly point the reader to all these options, which we trust will facilitate the uptake of the model.</p><disp-quote content-type="editor-comment"><p>6) Results: &quot;This [ToR-ORd model yields negative I<sub>CaL</sub> values in such conditions] is a direct consequence of the updates to the extracellular/intracellular calcium activity coefficients, which supports its credibility and it is important for cases of elevated I<sub>CaL</sub>, such as under ß-adrenergic stimulation.&quot; – while this is likely true, it also seems likely a throwaway – were any simulations run using the model to demonstrate the importance in this vein? Important how?</p></disp-quote><p>Many thanks for raising this important question. We have now added Appendix 1, subsection “I<sub>CaL</sub> reversal and ionic activity coefficients”, explaining this in greater detail, demonstrating the difference the updated activity coefficients make in the GHK equation.</p><disp-quote content-type="editor-comment"><p>7) Results/Figure 3: Besides noting that the ToR-ORd is consistent with observed negative inotropy of sodium blockers, it is unclear from text how updated model compares in terms of available experimental data, i.e. &quot;A mild increase in inotropy may be achieved only under near-exclusive I<sub>Na</sub> block.&quot; – or whether this comparison is available at all.</p></disp-quote><p>We agree this is very important and we’ve added a paragraph at the end of Results subsection “Calibration: Inotropic effects of sodium blockers”.</p><disp-quote content-type="editor-comment"><p>8) Figure 5A, B, C – the slope of the APD90 dependence on BCL for the ToR-ORd differs consistently from that of the data for BCLs &gt; 1s – any musings as to mechanism? Either briefly in main text or supplement.</p></disp-quote><p>Our results show that the simulated data are overall within the experimental range. There is indeed a slight difference in the slope of the APD90 dependence for long BCL between the simulated data and the mean experimental recordings. The mean experimental data for each BCL are an average of many traces, some of which may be consistent with the simulation shown. In a population-of-models approach, it is likely that there will be, in turn, models highly consistent with the data means.</p><disp-quote content-type="editor-comment"><p>9) Figure 6C: would strengthen the case for the ToR-ORd further to compare restitution for ORd in a fibre under same protocol?</p></disp-quote><p>Thank you. We have added this to the figure.</p><disp-quote content-type="editor-comment"><p>10) Seems like suitability of ToR-ORd for drug safety testing is clear – and discussion around this is adequate and encouraging. However, there still does not seem to be a marked improvement in the example given over the ORd (Figure 7), particularly in terms of false negatives. Authors note &quot;further improvement to the score is likely with development of a population optimised towards drug safety assessment&quot; – so it will be interesting to see results there.</p></disp-quote><p>Thank you. The aim of this section of the Results was to show that the accuracy for drug-induced pro-arrhythmic risk was also high and similar to the one with the ORd. We have deleted this sentence to avoid confusion as further development to improve the accuracy, which is already high, would be beyond the scope of this work.</p></body></sub-article></article>